Professor Susan Ramus

Professor

PhD University of Melbourne

Medicine & Health

School of Clinical Medicine

I co-lead the international ovarian tumor tissue analysis (OTTA) consortium, performing large scale genomics research to improve the survival of ovarian cancer patients.

I am a Professor in the School of Clinical Medicine and lead the . I am a member of the Adult Cancer Program in the Lowy Cancer Research Centre.

I lead large consortium projects on both ovarian cancer genetic susceptibility and tumour profiling. I established and co-leads the and am on the steering committee of the Ovarian Cancer Association Consortium (OCAC).

E-mail

s.ramus@unsw.edu.au

Location

School of Clinical Medicine Adult Cancer Program Level 2, Lowy Cancer Research Centre Cnr High and Botany St, UNSW

Book Chapters | 2012

Ramus SJ, 2012, 'Current status of inherited predisposition to ovarian cancer: lessons from familial ovarian cancer registries in the UK and USA.', in Odunsi K; Pejovic T (ed.), Current Multidisciplinary Oncology: Gynecologic Cancer, edn. Current Multidisciplinary Oncology, Demosmedical NY USA, pp. 105 - 114,

Book Chapters | 2009

Lawrenson K; Ramus SJ; Gayther SA, 2009, 'Somatic Genetic Development In Epithelial Ovarian Cancer.', in Welcsh P (ed.), The Role of Genetics in Breast and Reproductive Cancers, edn. Cancer Genetics-Series, Springer Science & Business Media, pp. 215 - 246,

Book Chapters | 1998

Gianelli F; Green P; Ramus SJ, 1998, 'Cleavage of mismatched bases using chemical reagents.', in Mutation Detection A Practical Approach, IRL Press, pp. 81 - 97

Book Chapters | 1997

Youil R; Ramus SJ; Cotton RGH, 1997, 'Comparison of chemical cleavage and enzyme mismatch cleavage by T4 Endonuclease VII.', in Laboratory Methods for the Detection of Mutations and Polymorphisms in DNA, CRC Press, pp. 239 - 253

Book Chapters | 1996

Ramus SJ; Cotton RGH, 1996, 'Chemical cleavage of mismatch', in Laboratory Protocols for Mutation Detection, Oxford University Press, USA, pp. 50 - 54
Journal articles | 2024

Dareng EO; Coetzee SG; Tyrer JP; Peng PC; Rosenow W; Chen S; Davis BD; Dezem FS; Seo JH; Nameki R; Reyes AL; Aben KKH; Anton-Culver H; Antonenkova NN; Aravantinos G; Bandera EV; Beane Freeman LE; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bernardini MQ; Bjorge L; Black A; Bogdanova NV; Bolton KL; Brenton JD; Budzilowska A; Butzow R; Cai H; Campbell I; Cannioto R; Chang-Claude J; Chanock SJ; Chen K; Chenevix-Trench G; Chiew YE; Cook LS; DeFazio A; Dennis J; Doherty JA; Dörk T; du Bois A; Dürst M; Eccles DM; Ene G; Fasching PA; Flanagan JM; Fortner RT; Fostira F; Gentry-Maharaj A; Giles GG; Goodman MT; Gronwald J; Haiman CA; Håkansson N; Heitz F; Hildebrandt MAT; Høgdall E; Høgdall CK; Huang RY; Jensen A; Jones ME; Kang D; Karlan BY; Karnezis AN; Kelemen LE; Kennedy CJ; Khusnutdinova EK; Kiemeney LA; Kjaer SK; Kupryjanczyk J; Labrie M; Lambrechts D; Larson MC; Le ND; Lester J; Li L; Lubiński J; Lush M; Marks JR; Matsuo K; May T; McLaughlin JR; McNeish IA; Menon U; Missmer S; Modugno F; Moffitt M; Monteiro AN; Moysich KB; Narod SA; Nguyen-Dumont T; Odunsi K; Olsson H; Onland-Moret NC; Park SK; Pejovic T; Permuth JB; Piskorz A; Prokofyeva D, 2024, 'Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions', American Journal of Human Genetics, 111, pp. 1061 - 1083,

Journal articles | 2024

Davidson AL; Michailidou K; Parsons MT; Fortuno C; Bolla MK; Wang Q; Dennis J; Naven M; Abubakar M; Ahearn TU; Alonso MR; Andrulis IL; Antoniou AC; Auvinen P; Behrens S; Bermisheva MA; Bogdanova NV; Bojesen SE; Brüning T; Byers HJ; Camp NJ; Campbell A; Castelao JE; Cessna MH; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Sahlberg KK; Børresen-Dale AL; Gram IT; Olsen KS; Engebråten O; Naume B; Geisler J; OSBREAC ; Grenaker Alnæs GI; Collée JM; Czene K; Dörk T; Eriksson M; Evans DG; Fasching PA; Figueroa JD; Flyger H; Gago-Dominguez M; García-Closas M; Glendon G; González-Neira A; Grassmann F; Gronwald J; Guénel P; Hadjisavvas A; Haeberle L; Hall P; Hamann U; Hartman M; Ho PJ; Hooning MJ; Hoppe R; Howell A; Amor D; Andrews L; Antill Y; Balleine R; Beesley J; Bennett I; Bogwitz M; Bodek S; Botes L; Brennan M; Brown M; Buckley M; Burke J; Butow P; Caldon L; Campbell I; Cao M; Chakrabarti A; Chauhan D; Chauhan M; Christian A; Cohen P; Colley A; Crook A; Cui J; Courtney E; Cummings M; Dawson SJ; deFazio A; Delatycki M; Dickson R; Dixon J; Edwards S; Farshid G; Fellows A; Fenton G; Field M; Flanagan J; Fong P; Forrest L, 2024, 'Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset', American Journal of Human Genetics,

Journal articles | 2024

Köbel M; Kang EY; Lee S; Terzic T; Karnezis AN; Ghatage P; Woo L; Lee CH; Meagher NS; Ramus SJ; Gorringe KL, 2024, 'Infiltrative pattern of invasion is independently associated with shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian carcinoma', Histopathology, 84, pp. 1095 - 1110,

Journal articles | 2024

Nelson BH; Hamilton PT; Phung MT; Milne K; Harris B; Thornton S; Stevens DL; Kalaria S; Singh K; Laumont CM; Moss E; Alimujiang A; Meagher NS; Bolithon A; Fereday S; Kennedy CJ; Hendley J; Ariyaratne D; Alsop K; Traficante N; Goode EL; Karnezis AN; Shen H; Richardson J; McKinnon Deurloo C; Chase A; Grout B; Doherty JA; Harris HR; Cushing-Haugen KL; Anglesio MS; Heinze K; Huntsman D; Talhouk A; Hanley GE; Alsop J; Jimenez-Linan M; Pharoah PD; Boros J; Brand AH; Harnett PR; Sharma R; Hecht JL; Sasamoto N; Terry KL; Karlan BY; Lester J; Carney ME; Goodman MT; Hernandez BY; Wilkens LR; Behrens S; Turzanski Fortner R; Fasching PA; Bisinotto C; Candido Dos Reis FJ; Ghatage P; Köbel M; Elishaev E; Modugno F; Cook LS; Le ND; Gentry-Maharaj A; Menon U; García MJ; Rodriguez-Antona C; Farrington KM; Kelemen LE; Kommoss S; Staebler A; Garsed DW; Brenton JD; Piskorz AM; Bowtell DD; DeFazio A; Ramus SJ; Pike MC; Pearce CL, 2024, 'Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.', J Clin Invest,

Journal articles | 2024

Ramachandran D; Tyrer JP; Kommoss S; DeFazio A; Riggan MJ; Webb PM; Fasching PA; Lambrechts D; García MJ; Rodríguez-Antona C; Goodman MT; Modugno F; Moysich KB; Karlan BY; Lester J; Kjaer SK; Jensen A; Høgdall E; Goode EL; Cliby WA; Kumar A; Wang C; Cunningham JM; Winham SJ; Monteiro AN; Schildkraut JM; Cramer DW; Terry KL; Titus L; Bjorge L; Thomsen LCV; Pejovic T; Høgdall CK; McNeish IA; May T; Huntsman DG; Pfisterer J; Canzler U; Park-Simon TW; Schröder W; Belau A; Hanker L; Harter P; Sehouli J; Kimmig R; de Gregorio N; Schmalfeldt B; Baumann K; Hilpert F; Burges A; Winterhoff B; Schürmann P; Speith LM; Hillemanns P; Berchuck A; Johnatty SE; Ramus SJ; Chenevix-Trench G; Pharoah PDP; Dörk T; Heitz F; Bowtell D; Fereday S; Traficante N; Hung J; Friedlander M; Obermair A; Grant P; Beesley V; Blomfield P; Brand A; Davis A; Leung Y; Nicklin J; Quinn M; Livingstone K; O’Neill H; Williams M, 2024, 'Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease', npj Genomic Medicine, 9,

Journal articles | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang EY; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Blake Gilks C; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Rinda Soong T; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, 'Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma', Clinical Cancer Research, 30, pp. 3481 - 3498,

Journal articles | 2024

Zwimpfer TA; Pandey A; Fereday S; Coelho RJB-N; Twomey L; Ariyaratne D; Traficante N; Jacob F; Eller R; Heinzelmann-Schwarz V; Christie EL; Kennedy C; Au-Yeung G; Ramus S; Koebel M; Nelson B; Goode EL; DeFazio A; Bowtell DDL; Garsed DW, 2024, '752P Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival', Annals of Oncology, 35, pp. S571 - S571,

Journal articles | 2023

Figlioli G; Billaud A; Ahearn TU; Antonenkova NN; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Blok MJ; Bogdanova NV; Bonanni B; Burwinkel B; Camp NJ; Campbell A; Castelao JE; Cessna MH; Chanock SJ; Alnæs GIG; Sørlie T; Skjerven HK; Russnes HG; Mælandsmo GM; Lingjærde OC; Langerød A; Hofvind S; Geitvik GA; Garred Ø; Fritzman B; Borgen E; Bathen TF; Geisler J; Naume B; Engebråten O; Olsen KS; Gram IT; Børresen-Dale AL; Sahlberg KK; Czene K; Devilee P; Dörk T; Engel C; Eriksson M; Fasching PA; Figueroa JD; Gabrielson M; Gago-Dominguez M; García-Closas M; González-Neira A; Grassmann F; Guénel P; Gündert M; Hadjisavvas A; Hahnen E; Hall P; Hamann U; Harrington PA; He W; Hillemanns P; Hollestelle A; Hooning MJ; Hoppe R; Howell A; Humphreys K; Zaheed M; Young MA; Winship I; Williams R; Walker L; Visvader J; Tucker K; Trainer A; Thorne H; Taylor R; Taylor J; Spurdle A; Southey M; Simpson P; Shelling A; Sexton A; Scott C; Scott R; Saunus J; Saunders C; Salisbury E; Skandarajah A; Saleh M; Robinson B; Rickard E; Ramus S; Pieper E; Phillips K; Pearn A; Patterson B; Pathak G; Pang JM; Pachter N; Ortega DG; O’Sullivan S; O’Connell S, 2023, 'FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women', European Journal of Human Genetics, 31, pp. 578 - 587,

Journal articles | 2023

Fu Z; Brooks MM; Irvin S; Jordan S; Aben KKH; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Brooks-Wilson A; Chang-Claude J; Cook LS; Cramer DW; Cushing-Haugen KL; Doherty JA; Ekici AB; Fasching PA; Fortner RT; Gayther SA; Gentry-Maharaj A; Giles GG; Goode EL; Goodman MT; Harris HR; Hein A; Kaaks R; Kiemeney LA; Köbel M; Kotsopoulos J; Le ND; Lee AW; Matsuo K; McGuire V; McLaughlin JR; Menon U; Milne RL; Moysich KB; Pearce CL; Pike MC; Qin B; Ramus SJ; Riggan MJ; Rothstein JH; Schildkraut JM; Sieh W; Sutphen R; Terry KL; Thompson PJ; Titus L; van Altena AM; White E; Whittemore AS; Wu AH; Zheng W; Ziogas A; Taylor SE; Tang L; Songer T; Wentzensen N; Webb PM; Risch HA; Modugno F, 2023, 'Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis', Journal of the National Cancer Institute, 115, pp. 539 - 551,

Journal articles | 2023

Heinze K; Cairns ES; Thornton S; Harris B; Milne K; Grube M; Meyer C; Karnezis AN; Fereday S; Garsed DW; Leung SCY; Chiu DS; Moubarak M; Harter P; Heitz F; McAlpine JN; DeFazio A; Bowtell DDL; Goode EL; Pike M; Ramus SJ; Pearce CL; Staebler A; K€obel M; Kommoss S; Talhouk A; Nelson BH; Anglesio MS, 2023, 'The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas', Clinical Cancer Research, 29, pp. 3471 - 3483,

Journal articles | 2023

Hurwitz LM; Webb PM; Jordan SJ; Doherty JA; Harris HR; Goodman MT; Shvetsov YB; Modugno F; Moysich KB; Schildkraut JM; Berchuck A; Anton-Culver H; Ziogas A; Menon U; Ramus SJ; Wu AH; Pearce CL; Wentzensen N; Tworoger SS; Pharoah PDP; Trabert B, 2023, 'Association of Frequent Aspirin Use with Ovarian Cancer Risk According to Genetic Susceptibility', JAMA Network Open, 6, pp. E230666,

Journal articles | 2023

Kang EY; Weir A; Meagher NS; Farrington K; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Bolithon A; Popovic G; Leung B; Tang K; Lambie N; Millstein J; Alsop J; Anglesio MS; Ataseven B; Barlow E; Beckmann MW; Berger J; Bisinotto C; Bösmüller H; Boros J; Brand AH; Brooks-Wilson A; Brucker SY; Carney ME; Casablanca Y; Cazorla-Jiménez A; Cohen PA; Conrads TP; Cook LS; Coulson P; Courtney-Brooks M; Cramer DW; Crowe P; Cunningham JM; Cybulski C; Darcy KM; El-Bahrawy MA; Elishaev E; Erber R; Farrell R; Fereday S; Fischer A; García MJ; Gayther SA; Gentry-Maharaj A; Gilks CB; Grube M; Harnett PR; Harrington SP; Harter P; Hartmann A; Hecht JL; Heikaus S; Hein A; Heitz F; Hendley J; Hernandez BY; Polo SH; Heublein S; Hirasawa A; Høgdall E; Høgdall CK; Horlings HM; Huntsman DG; Huzarski T; Jewell A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Khabele D; Kommoss FKF; Kruitwagen RFPM; Lambrechts D; Le ND; Lener M; Lester J; Leung Y; Linder A; Loverix L; Lubiński J; Madan R; Maxwell GL; Modugno F; Neuhausen SL; Olawaiye A; Olbrecht S; Orsulic S; Palacios J; Pearce CL; Pike MC; Quinn CM; Mohan GR; Rodríguez-Antona C; Ruebner M; Ryan A; Salfinger SG, 2023, 'CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study', Cancer, 129, pp. 697 - 713,

Journal articles | 2023

Köbel M; Kang EY; Weir A; Rambau PF; Lee CH; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubiński J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramón y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; García MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U, 2023, 'p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study', Journal of Pathology: Clinical Research, 9, pp. 208 - 222,

Journal articles | 2023

Meagher NS; Hamilton P; Milne K; Thornton S; Harris B; Weir A; Alsop J; Bisinoto C; Brenton JD; Brooks-Wilson A; Chiu DS; Cushing-Haugen KL; Fereday S; Garsed DW; Gayther SA; Gentry-Maharaj A; Gilks B; Jimenez-Linan M; Kennedy CJ; Le ND; Piskorz AM; Riggan MJ; Shah M; Singh N; Talhouk A; Widschwendter M; Bowtell DDL; Candido dos Reis FJ; Cook LS; Fortner RT; García MJ; Harris HR; Huntsman DG; Karnezis AN; Köbel M; Menon U; Pharoah PDP; Doherty JA; Anglesio MS; Pike MC; Pearce CL; Friedlander ML; DeFazio A; Nelson BH; Ramus SJ, 2023, 'Profiling the immune landscape in mucinous ovarian carcinoma', Gynecologic Oncology, 168, pp. 23 - 31,

Journal articles | 2023

Morra A; Mavaddat N; Muranen TA; Ahearn TU; Allen J; Andrulis IL; Auvinen P; Becher H; Behrens S; Blomqvist C; Bojesen SE; Bolla MK; Brauch H; Camp NJ; Carvalho S; Castelao JE; Cessna MH; Chang-Claude J; Chenevix-Trench G; Sahlberg KK; Børresen-Dale AL; Gram IT; Olsen KS; Engebråten O; Naume B; Geisler J; OSBREAC ; Grenaker Alnæs GI; Czene K; Decker B; Dennis J; Dörk T; Dorling L; Dunning AM; Ekici AB; Eriksson M; Evans DG; Fasching PA; Figueroa JD; Flyger H; Gago-Dominguez M; García-Closas M; Geurts-Giele WRR; Giles GG; Guénel P; Gündert M; Hahnen E; Hall P; Hamann U; Harrington PA; He W; Heikkilä P; Hooning MJ; Hoppe R; Howell A; Humphreys K; Amor D; Andrews L; Antill Y; Balleine R; Beesley J; Bennett I; Bogwitz M; Botes L; Brennan M; Brown M; Buckley M; Burke J; Butow P; Caldon L; Campbell I; Cao M; Chakrabarti A; Chauhan D; Chauhan M; Christian A; Cohen P; Colley A; Crook A; Cui J; Courtney E; Cummings M; Dawson SJ; DeFazio A; Delatycki M; Dickson R; Dixon J; Edkins T; Edwards S; Farshid G; Fellows A; Fenton G; Field M; Flanagan J; Fong P; Forrest L; Fox S; French J; Friedlander M; Gaff C, 2023, 'The impact of coding germline variants on contralateral breast cancer risk and survival', American Journal of Human Genetics, 110, pp. 475 - 486,

Journal articles | 2023

Morra A; Schreurs MAC; Andrulis IL; Anton-Culver H; Augustinsson A; Beckmann MW; Behrens S; Bojesen SE; Bolla MK; Brauch H; Broeks A; Buys SS; Camp NJ; Castelao JE; Cessna MH; Chang-Claude J; Chung WK; Sahlberg KK; Børresen-Dale AL; Gram IT; Olsen KS; Engebråten O; Naume B; Geisler J; Grenaker Alnæs GI; Colonna SV; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Dennis J; Devilee P; Dörk T; Dunning AM; Dwek M; Easton DF; Eccles DM; Eriksson M; Evans DG; Fasching PA; Fehm TN; Figueroa JD; Flyger H; Gabrielson M; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Genkinger J; Grassmann F; Gündert M; Hahnen E; Haiman CA; Hamann U; Harrington PA; Hartikainen JM; Hoppe R; Hopper JL; Houlston RS; Howell A; Clarke C; Marsh D; Scott R; Baxter R; Yip D; Carpenter J; Davis A; Pathmanathan N; Simpson P; Graham JD; Sachchithananthan M; Amor D; Andrews L; Antill Y; Balleine R; Beesley J; Bennett I; Bogwitz M; Botes L; Brennan M; Brown M; Buckley M; Burke J; Butow P; Caldon L; Campbell I; Cao M; Chakrabarti A; Chauhan D; Chauhan M; Chenevix-Trench G; Christian A; Cohen P; Colley A; Crook A; Cui J; Courtney E; Cummings M; Dawson SJ; DeFazio A, 2023, 'Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival', Cancer Medicine, 12, pp. 16142 - 16162,

Journal articles | 2023

O’Mahony DG; Ramus SJ; Southey MC; Meagher NS; Hadjisavvas A; John EM; Hamann U; Imyanitov EN; Andrulis IL; Sharma P; Daly MB; Hake CR; Weitzel JN; Jakubowska A; Godwin AK; Arason A; Bane A; Simard J; Soucy P; Caligo MA; Mai PL; Claes KBM; Teixeira MR; Chung WK; Lazaro C; Hulick PJ; Toland AE; Pedersen IS; Mourits MJE; Neuhausen SL; Vega A; de la Hoya M; Nevanlinna H; Dhawan M; Zampiga V; Danesi R; Varesco L; Gismondi V; Vellone VG; James PA; Janavicius R; Nikitina-Zake L; Nielsen FC; van Overeem Hansen T; Pejovic T; Borg A; Rantala J; Offit K; Montagna M; Nathanson KL; Domchek SM; Osorio A; García MJ; Karlan BY; Lesueur F; De Fazio A; Bowtell D; McGuffog L; Leslie G; Parsons MT; Dörk T; Speith LM; dos Santos ES; da Costa AABA; Radice P; Peterlongo P; Papi L; Engel C; Hahnen E; Schmutzler RK; Wappenschmidt B; Easton DF; Tischkowitz M; Singer CF; Tan YY; Whittemore AS; Sieh W; Brenton JD; Yannoukakos D; Fostira F; Konstantopoulou I; Soukupova J; Vocka M; Chenevix-Trench G; Pharoah PDP; Antoniou AC; Goldgar DE; Spurdle AB; Michailidou K, 2023, 'Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2', British Journal of Cancer, 128, pp. 2283 - 2294,

Journal articles | 2023

Phung MT; Webb PM; DeFazio A; Fereday S; Lee AW; Bowtell DDL; Fasching PA; Goode EL; Goodman MT; Karlan BY; Lester J; Matsuo K; Modugno F; Brenton JD; Van Gorp T; Pharoah PDP; Schildkraut JM; McLean K; Meza R; Mukherjee B; Richardson J; Grout B; Chase A; McKinnon Deurloo C; Terry KL; Hanley GE; Pike MC; Berchuck A; Ramus SJ; Pearce CL, 2023, 'Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery', Gynecologic Oncology, 168, pp. 68 - 75,

Journal articles | 2023

Pitiyarachchi O; Lee YC; Sim HW; Srirangan S; Mapagu C; Kirk J; Harnett PR; Balleine RL; Bowtell DDL; Samimi G; Brand AH; Marsh DJ; Beale P; Anderson L; Bouantoun N; Provan P; Ramus SJ; DeFazio A; Friedlander M, 2023, 'Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma', Translational Oncology, 31,

Journal articles | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Kobel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, 'Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma', Cancer Epidemiology Biomarkers and Prevention, 32, pp. 542 - 549,

Journal articles | 2023

Weir A; Kang EY; Meagher NS; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Gentry-Maharaj A; Ryan A; Singh N; Widschwendter M; Alsop J; Anglesio MS; Beckmann MW; Berger J; Bisinotto C; Boros J; Brand AH; Brenton JD; Brooks-Wilson A; Carney ME; Cunningham JM; Cushing-Haugen KL; Cybulski C; Elishaev E; Erber R; Fereday S; Fischer A; Paz-Ares L; Gayarre J; Gilks BC; Grube M; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Heublein S; Huang Y; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kommoss FKF; Koziak JM; Kraemer B; Le ND; Lesnock J; Lester J; Lubiński J; Menkiszak J; Ney B; Olawaiye A; Orsulic S; Osorio A; Robles-Díaz L; Ruebner M; Shah M; Sharma R; Shvetsov YB; Steed H; Talhouk A; Taylor SE; Traficante N; Vierkant RA; Wang C; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DDL; Candido dos Reis FJ; Cook LS; DeFazio A; DeFazio A; Traficante N; Harnett P; Doherty JA; Fasching PA; García MJ; Goode EL; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kommoss S; Modugno F; Schildkraut JM; Sinn HP; Staebler A; Kelemen LE; Ford CE; Menon U; Pharoah PDP; Köbel M; Ramus SJ, 2023, 'Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study', British Journal of Cancer, 128, pp. 137 - 147,

Journal articles | 2022

Brieger KK; Phung MT; Mukherjee B; Bakulski KM; Anton-Culver H; Bandera EV; Bowtell DDL; Cramer DW; DeFazio A; Doherty JA; Fereday S; Fortner RT; Gentry-Maharaj A; Goode EL; Goodman MT; Harris HR; Matsuo K; Menon U; Modugno F; Moysich KB; Qin B; Ramus SJ; Risch HA; Rossing MA; Schildkraut JM; Trabert B; Vierkant RA; Winham SJ; Wentzensen N; Wu AH; Ziogas A; Khoja L; Cho KR; McLean K; Richardson J; Grout B; Chase A; McKinnon Deurloo C; Odunsi K; Nelson BH; Brenton JD; Terry KL; Pharoah PDP; Berchuck A; Hanley GE; Webb PM; Pike MC; Pearce CL, 2022, 'High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival', Cancer Epidemiology Biomarkers and Prevention, 31, pp. 443 - 452,

Journal articles | 2022

Dareng EO; Tyrer JP; Barnes DR; Jones MR; Yang X; Aben KKH; Adank MA; Agata S; Andrulis IL; Anton-Culver H; Antonenkova NN; Aravantinos G; Arun BK; Augustinsson A; Balmana J; Bandera EV; Barkardottir RB; Barrowdale D; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Bjorge L; Black A; Bogdanova NV; Bonanni B; Borg A; Brenton JD; Budzilowska A; Butzow R; Buys SS; Cai H; Caligo MA; Campbell I; Cannioto R; Cassingham H; Chang-Claude J; Chanock SJ; Chen K; Chiew Y-E; Chung WK; Claes KBM; Colonna S; Cook LS; Couch FJ; Daly MB; Dao F; Davies E; de la Hoya M; de Putter R; Dennis J; DePersia A; Devilee P; Diez O; Ding YC; Doherty JA; Domchek SM; Dork T; du Bois A; Durst M; Eccles DM; Eliassen HA; Engel C; Evans GD; Fasching PA; Flanagan JM; Fortner RT; Machackova E; Friedman E; Ganz PA; Garber J; Gensini F; Giles GG; Glendon G; Godwin AK; Goodman MT; Greene MH; Gronwald J; Hahnen E; Haiman CA; Hakansson N; Hamann U; Hansen TVO; Harris HR; Hartman M; Heitz F; Hildebrandt MAT; Hogdall E; Hogdall CK; Hopper JL; Huang R-Y; Huff C; Hulick PJ; Huntsman DG; Imyanitov EN; Isaacs C; Jakubowska A; James PA; Janavicius R; Jensen A; Johannsson OT; John EM; Jones ME; Kang D; Karlan BY; Karnezis A; Kelemen LE; Khusnutdinova E; Kiemeney LA; Kim B-G; Kjaer SK; Komenaka I; Kupryjanczyk J; Kurian AW; Kwong A; Lambrechts D; Larson MC; Lazaro C; Le ND; Leslie G; Lester J; Lesueur F; Levine DA; Li L; Li J; Loud JT; Lu KH; Lubinski J; Mai PL; Manoukian S; Marks JR; Matsuno RK; Matsuo K; May T; McGuffog L; McLaughlin JR; McNeish IA; Mebirouk N; Menon U; Miller A; Milne RL; Minlikeeva A; Modugno F; Montagna M; Moysich KB; Munro E; Nathanson KL; Neuhausen SL; Nevanlinna H; Yie JNY; Nielsen HR; Nielsen FC; Nikitina-Zake L; Odunsi K; Offit K; Olah E; Olbrecht S; Olopade OI; Olson SH; Olsson H; Osorio A; Papi L; Park SK; Parsons MT; Pathak H; Pedersen IS; Peixoto A; Pejovic T; Perez-Segura P; Permuth JB; Peshkin B; Peterlongo P; Piskorz A; Prokofyeva D; Radice P; Rantala J; Riggan MJ; Risch HA; Rodriguez-Antona C; Ross E; Rossing MA; Runnebaum I; Sandler DP; Santamarina M; Soucy P; Schmutzler RK; Setiawan VW; Shan K; Sieh W; Simard J; Singer CF; Sokolenko AP; Song H; Southey MC; Steed H; Stoppa-Lyonnet D; Sutphen R; Swerdlow AJ; Tan YY; Teixeira MR; Teo SH; Terry KL; Terry MB; Thomassen M; Thompson PJ; Thomsen LCV; Thull DL; Tischkowitz M; Titus L; Toland AE; Torres D; Trabert B; Travis R; Tung N; Tworoger SS; Valen E; van Altena AM; van der Hout AH; Van Nieuwenhuysen E; van Rensburg EJ; Vega A; Edwards DV; Vierkant RA; Wang F; Wappenschmidt B; Webb PM; Weinberg CR; Weitzel JN; Wentzensen N; White E; Whittemore AS; Winham SJ; Wolk A; Woo Y-L; Wu AH; Yan L; Yannoukakos D; Zavaglia KM; Zheng W; Ziogas A; Zorn KK; Kleibl Z; Easton D; Lawrenson K; DeFazio A; Sellers TA; Ramus SJ; Pearce CL; Monteiro AN; Cunningham JM; Goode EL; Schildkraut JM; Berchuck A; Chenevix-Trench G; Gayther SA; Antoniou AC; Pharoah PDP, 2022, 'Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)', EUROPEAN JOURNAL OF HUMAN GENETICS, 30, pp. 630 - 631,

Journal articles | 2022

Dareng EO; Tyrer JP; Barnes DR; Jones MR; Yang X; Aben KKH; Adank MA; Agata S; Andrulis IL; Anton-Culver H; Antonenkova NN; Aravantinos G; Arun BK; Augustinsson A; Balmaña J; Bandera EV; Barkardottir RB; Barrowdale D; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Bjorge L; Black A; Bogdanova NV; Bonanni B; Borg A; Brenton JD; Budzilowska A; Butzow R; Buys SS; Cai H; Caligo MA; Campbell I; Cannioto R; Cassingham H; Chang-Claude J; Chanock SJ; Chen K; Chiew YE; Chung WK; Claes KBM; Colonna S; Cook LS; Couch FJ; Daly MB; Dao F; Davies E; de la Hoya M; de Putter R; Dennis J; DePersia A; Devilee P; Diez O; Ding YC; Doherty JA; Domchek SM; Dörk T; du Bois A; Dürst M; Eccles DM; Eliassen HA; Engel C; Evans GD; Fasching PA; Flanagan JM; Fortner RT; Machackova E; Friedman E; Ganz PA; Garber J; Gensini F; Giles GG; Glendon G; Godwin AK; Goodman MT; Greene MH; Gronwald J; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hansen TVO; Harris HR; Hartman M; Heitz F; Hildebrandt MAT; Høgdall E; Høgdall CK; Hopper JL; Huang RY; Huff C; Hulick PJ; Huntsman DG; Imyanitov EN; van der Hout AH; Isaacs C; Jakubowska A; James PA, 2022, 'Polygenic risk modeling for prediction of epithelial ovarian cancer risk', European Journal of Human Genetics, 30, pp. 349 - 362,

Journal articles | 2022

Devries AA; Dennis J; Tyrer JP; Peng PC; Coetzee SG; Reyes AL; Plummer JT; Davis BD; Chen SS; Dezem FS; Aben KKH; Anton-Culver H; Antonenkova NN; Beckmann MW; Beeghly-Fadiel A; Berchuck A; Bogdanova NV; Bogdanova-Markov N; Brenton JD; Butzow R; Campbell I; Chang-Claude J; Chenevix-Trench G; Cook LS; Defazio A; Doherty JA; Dork T; Eccles DM; Eliassen AH; Fasching PA; Fortner RT; Giles GG; Goode EL; Goodman MT; Gronwald J; Hakansson N; Hildebrandt MAT; Huff C; Huntsman DG; Jensen A; Kar S; Karlan BY; Khusnutdinova EK; Kiemeney LA; Kjaer SK; Kupryjanczyk J; Labrie M; Lambrechts D; Le ND; Lubinski J; May T; Menon U; Milne RL; Modugno F; Monteiro AN; Moysich KB; Odunsi K; Olsson H; Pearce CL; Pejovic T; Ramus SJ; Riboli E; Riggan MJ; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Sieh W; Song H; Sutphen R; Terry KL; Thompson PJ; Titus L; Tworoger SS; Van Nieuwenhuysen E; Edwards DV; Webb PM; Wentzensen N; Whittemore AS; Wolk A; Wu AH; Ziogas A; Freedman ML; Lawrenson K; Pharoah PDP; Easton DF; Gayther SA; Jones MR, 2022, 'Copy number variants are ovarian cancer risk alleles at known and novel risk loci', Journal of the National Cancer Institute, 114, pp. 1533 - 1544,

Journal articles | 2022

Garsed DW; Pandey A; Fereday S; Kennedy CJ; Takahashi K; Alsop K; Hamilton PT; Hendley J; Chiew YE; Traficante N; Provan P; Ariyaratne D; Au-Yeung G; Bateman NW; Bowes L; Brand A; Christie EL; Cunningham JM; Friedlander M; Grout B; Harnett P; Hung J; McCauley B; McNally O; Piskorz AM; Saner FAM; Vierkant RA; Wang C; Winham SJ; Pharoah PDP; Brenton JD; Conrads TP; Maxwell GL; Ramus SJ; Pearce CL; Pike MC; Nelson BH; Goode EL; DeFazio A; Bowtell DDL, 2022, 'The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer', Nature Genetics, 54, pp. 1853 - 1864,

Journal articles | 2022

Heinze K; Nazeran TM; Lee S; Krämer P; Cairns ES; Chiu DS; Leung SCY; Kang EY; Meagher NS; Kennedy CJ; Boros J; Kommoss F; Vollert HW; Heitz F; du Bois A; Harter P; Grube M; Kraemer B; Staebler A; Kommoss FKF; Heublein S; Sinn HP; Singh N; Laslavic A; Elishaev E; Olawaiye A; Moysich K; Modugno F; Sharma R; Brand AH; Harnett PR; DeFazio A; Fortner RT; Lubinski J; Lener M; Tołoczko-Grabarek A; Cybulski C; Gronwald H; Gronwald J; Coulson P; El-Bahrawy MA; Jones ME; Schoemaker MJ; Swerdlow AJ; Gorringe KL; Campbell I; Cook L; Gayther SA; Carney ME; Shvetsov YB; Hernandez BY; Wilkens LR; Goodman MT; Mateoiu C; Linder A; Sundfeldt K; Kelemen LE; Gentry-Maharaj A; Widschwendter M; Menon U; Bolton KL; Alsop J; Shah M; Jimenez-Linan M; Pharoah PDP; Brenton JD; Cushing-Haugen KL; Harris HR; Doherty JA; Gilks B; Ghatage P; Huntsman DG; Nelson GS; Tinker AV; Lee CH; Goode EL; Nelson BH; Ramus SJ; Kommoss S; Talhouk A; Köbel M; Anglesio MS, 2022, 'Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8⁺ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas', Journal of Pathology, 256, pp. 388 - 401,

Journal articles | 2022

Hurwitz LM; Townsend MK; Jordan SJ; Patel AV; Teras LR; Lacey JV; Doherty JA; Harris HR; Goodman MT; Shvetsov YB; Modugno F; Moysich KB; Robien K; Prizment A; Schildkraut JM; Berchuck A; Fortner RT; Chan AT; Wentzensen N; Hartge P; Sandler DP; O'Brien KM; Anton-Culver H; Ziogas A; Menon U; Ramus SJ; Pearce CL; Wu AH; White E; Peters U; Webb PM; Tworoger SS; Trabert B, 2022, 'Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia', Journal of Clinical Oncology, 40, pp. 4207 - 4217,

Journal articles | 2022

Kang EY; Millstein J; Popovic G; Meagher NS; Bolithon A; Talhouk A; Chiu DS; Anglesio MS; Leung B; Tang K; Lambie N; Pavanello M; Da-anoy A; Lambrechts D; Loverix L; Olbrecht S; Bisinotto C; Garcia-Donas J; Ruiz-Llorente S; Yagüe-Fernandez M; Edwards RP; Elishaev E; Olawaiye A; Taylor S; Ataseven B; du Bois A; Harter P; Lester J; Høgdall CK; Armasu SM; Huang Y; Vierkant RA; Wang C; Winham SJ; Heublein S; Kommoss FKF; Cramer DW; Sasamoto N; van-Wagensveld L; Lycke M; Mateoiu C; Joseph J; Pike MC; Odunsi K; Tseng CC; Pearce CL; Bilic S; Conrads TP; Hartmann A; Hein A; Jones ME; Leung Y; Beckmann MW; Ruebner M; Schoemaker MJ; Terry KL; El-Bahrawy MA; Coulson P; Etter JL; LaVigne-Mager K; Andress J; Grube M; Fischer A; Neudeck N; Robertson G; Farrell R; Barlow E; Quinn C; Hettiaratchi A; Casablanca Y; Erber R; Stewart CJR; Tan A; Yu Y; Boros J; Brand AH; Harnett PR; Kennedy CJ; Nevins N; Morgan T; Fasching PA; Vergote I; Swerdlow AJ; Candido dos Reis FJ; Maxwell GL; Neuhausen SL; Barquin-Garcia A; Modugno F; Moysich KB; Crowe PJ; Hirasawa A; Heitz F; Karlan BY; Goode EL; Sinn P; Horlings HM; Høgdall E; Sundfeldt K; Kommoss S; Staebler A, 2022, 'MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma', Virchows Archiv, 480, pp. 855 - 871,

Journal articles | 2022

Kumar A; Wang C; Sheedy SP; McCauley BM; Winham SJ; Ramus SJ; Anglesio MS; Kim B; Torres D; Keeney GL; Cliby WA; Goode EL, 2022, 'Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer', Gynecologic Oncology, 166, pp. 508 - 514,

Journal articles | 2022

Lee A; Yang X; Tyrer J; Gentry-Maharaj A; Ryan A; Mavaddat N; Cunningham AP; Carver T; Archer S; Leslie G; Kalsi J; Gaba F; Manchanda R; Gayther S; Ramus SJ; Walter FM; Tischkowitz M; Jacobs I; Menon U; Easton DF; Pharoah P; Antoniou AC, 2022, 'Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors', Journal of Medical Genetics, 59, pp. 632 - 643,

Journal articles | 2022

Li S; Silvestri V; Leslie G; Rebbeck TR; Neuhausen SL; Hopper JL; Nielsen HR; Lee A; Yang X; Mcguffog L; Parsons MT; Andrulis IL; Arnold N; Belotti M; Borg Å; Buecher B; Buys SS; Caputo SM; Chung WK; Colas C; Colonna SV; Cook J; Daly MB; De La Hoya M; De Pauw A; Delhomelle H; Eason J; Engel C; Evans DG; Faust U; Fehm TN; Fostira F; Fountzilas G; Frone M; Garcia-Barberan V; Garre P; Gauthier-Villars M; Gehrig A; Glendon G; Goldgar DE; Golmard L; Greene MH; Hahnen E; Hamann U; Hanson H; Hassan T; Hentschel J; Horvath J; Izatt L; Janavicius R; Jiao Y; John EM; Karlan BY; Kim SW; Konstantopoulou I; Kwong A; Laugé A; Lee JW; Lesueur F; Mebirouk N; Meindl A; Mouret-Fourme E; Musgrave H; Ngeow Yuen Yie J; Niederacher D; Park SK; Pedersen IS; Ramser J; Ramus SJ; Rantala J; Rashid MU; Reichl F; Ritter J; Rump A; Santamariña M; Saule C; Schmidt G; Schmutzler RK; Senter L; Shariff S; Singer CF; Southey MC; Stoppa-Lyonnet D; Sutter C; Tan Y; Teo SH; Terry MB; Thomassen M; Tischkowitz M; Toland AE; Torres D; Vega A; Wagner SA; Wang-Gohrke S; Wappenschmidt B; Weber BHF; Yannoukakos D; Spurdle AB; Easton DF; Chenevix-Trench G, 2022, 'Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants', Journal of Clinical Oncology, 40, pp. 1529 - 1541,

Journal articles | 2022

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubinski J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F, 2022, 'Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes', Clinical Cancer Research, 28, pp. 5383 - 5395,

Journal articles | 2022

2022, 'Multi-modal immune profiling of mucinous ovarian carcinoma: analysis from the Ovarian Tumor Tissue Analysis/Multidisciplinary Ovarian Cancer Outcomes Group consortia', JOURNAL OF IMMUNOLOGY, 208,

Journal articles | 2021

Glubb DM; Thompson DJ; Aben KKH; Alsulimani A; Amant F; Annibali D; Attia J; Barricarte A; Beckmann MW; Berchuck A; Bermisheva M; Bernardini MQ; Bischof K; Bjorge L; Bodelon C; Brand AH; Brenton JD; Brinton LA; Bruinsma F; Buchanan DD; Burghaus S; Butzow R; Cai H; Carney ME; Chanock SJ; Chen C; Chen XQ; Chen Z; Cook LS; Cunningham JM; De Vivo I; deFazio A; Doherty JA; Dörk T; du Bois A; Dunning AM; Dürst M; Edwards T; Edwards RP; Ekici AB; Ewing A; Fasching PA; Ferguson S; Flanagan JM; Fostira F; Fountzilas G; Friedenreich CM; Gao B; Gaudet MM; Gawełko J; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harris HR; Harter P; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Høgdall E; Høgdall CK; Holliday EG; Huntsman DG; Huzarski T; Jakubowska A; Jensen A; Jones ME; Karlan BY; Karnezis A; Kelley JL; Khusnutdinova E; Killeen JL; Kjaer SK; Klapdor R; Köbel M; Konopka B; Konstantopoulou I; Kopperud RK; Koti M; Kraft P; Kupryjanczyk J; Lambrechts D; Larson MC; Le Marchand L; Lele S; Lester J; Li AJ; Liang D; Liebrich C; Lipworth L; Lissowska J; Lu L; Lu KH; Macciotta A; Mattiello A; May T; McAlpine JN; McGuire V, 2021, 'Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers', Cancer Epidemiology Biomarkers and Prevention, 30, pp. 217 - 228,

Journal articles | 2021

Kang EY; Cheasley D; LePage C; Wakefield MJ; da Cunha Torres M; Rowley S; Salazar C; Xing Z; Allan P; Bowtell DDL; Mes-Masson AM; Provencher DM; Rahimi K; Kelemen LE; Fasching PA; Doherty JA; Goodman MT; Goode EL; Deen S; Pharoah PDP; Brenton JD; Sieh W; Mateoiu C; Sundfeldt K; Cook LS; Le ND; Anglesio MS; Gilks CB; Huntsman DG; Kennedy CJ; Traficante N; Chenevix-Trench G; Green A; Webb P; De Fazio A; Gertig D; Traficante N; Fereday S; Moore S; Hung J; Harrap K; Sadkowsky T; Pandeya N; Malt M; Mellon A; Robertson R; Bergh TV; Jones M; Mackenzie P; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Ferguson K; Martin K; Martyn A; Ranieri B; White J; Jayde V; Mamers P; Bowes L; Galletta L; Giles D; Hendley J; Alsop K; Schmidt T; Shirley H; Ball C; Young C; Viduka S; Tran H; Bilic S; Glavinas L; Brooks J; Stuart-Harris R; Kirsten F; Rutovitz J; Clingan P; Glasgow A; Proietto A; Braye S; Otton G; Shannon J; Bonaventura T; Stewart J; Begbie S; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Pavlakis N, 2021, 'Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses', Modern Pathology, 34, pp. 194 - 206,

Journal articles | 2021

Kar SP; Considine DPC; Tyrer JP; Plummer JT; Chen S; Dezem FS; Barbeira AN; Rajagopal PS; Rosenow WT; Moreno F; Bodelon C; Chang-Claude J; Chenevix-Trench G; deFazio A; Dörk T; Ekici AB; Ewing A; Fountzilas G; Goode EL; Hartman M; Heitz F; Hillemanns P; Høgdall E; Høgdall CK; Huzarski T; Jensen A; Karlan BY; Khusnutdinova E; Kiemeney LA; Kjaer SK; Klapdor R; Köbel M; Li J; Liebrich C; May T; Olsson H; Permuth JB; Peterlongo P; Radice P; Ramus SJ; Riggan MJ; Risch HA; Saloustros E; Simard J; Szafron LM; Titus L; Thompson CL; Vierkant RA; Winham SJ; Zheng W; Doherty JA; Berchuck A; Lawrenson K; Im HK; Manichaikul AW; Pharoah PDP; Gayther SA; Schildkraut JM, 2021, 'Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer', Human Genetics and Genomics Advances, 2,

Journal articles | 2021

Lee AW; Rosenzweig S; Wiensch A; Ramus SJ; Menon U; Gentry-Maharaj A; Ziogas A; Anton-Culver H; Whittemore AS; Sieh W; Rothstein JH; Mcguire V; Wentzensen N; Bandera EV; Qin B; Terry KL; Cramer DW; Titus L; Schildkraut JM; Berchuck A; Goode EL; Kjaer SK; Jensen A; Jordan SJ; Ness RB; Modugno F; Moysich K; Thompson PJ; Goodman MT; Carney ME; Chang-Claude J; Rossing MA; Harris HR; Doherty JA; Risch HA; Khoja L; Alimujiang A; Phung MT; Brieger K; Mukherjee B; Pharoah PDP; Wu AH; Pike MC; Webb PM; Pearce CL, 2021, 'Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies', Journal of the National Cancer Institute, 113, pp. 301 - 308,

Journal articles | 2021

Song H; Dicks EM; Tyrer J; Intermaggio M; Chenevix-Trench G; Bowtell DD; Traficante N; Group A; Brenton J; Goranova T; Hosking K; Piskorz A; Van Oudenhove E; Doherty J; Harris HR; Rossing MA; Duerst M; Dork T; Bogdanova NV; Modugno F; Moysich K; Odunsi K; Ness R; Karlan BY; Lester J; Jensen A; Krüger Kjaer S; Høgdall E; Campbell IG; Lázaro C; Pujara MA; Cunningham J; Vierkant R; Winham SJ; Hildebrandt M; Huff C; Li D; Wu X; Yu Y; Permuth JB; Levine DA; Schildkraut JM; Riggan MJ; Berchuck A; Webb PM; Group OS; Cybulski C; Gronwald J; Jakubowska A; Lubinski J; Alsop J; Harrington P; Chan I; Menon U; Pearce CL; Wu AH; De Fazio A; Kennedy CJ; Goode E; Ramus S; Gayther S; Pharoah P, 2021, 'Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer', Journal of Medical Genetics, 58, pp. 305 - 313,

Journal articles | 2021

Xu X; Wang Y; Bryce NS; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents', British Journal of Cancer, 125, pp. 265 - 276,

Journal articles | 2020

Barnes DR; Rookus MA; McGuffog L; Leslie G; Mooij TM; Dennis J; Mavaddat N; Adlard J; Ahmed M; Aittomäki K; Andrieu N; Andrulis IL; Arnold N; Arun BK; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Benitez J; Berthet P; Białkowska K; Blanco AM; Blok MJ; Bonanni B; Boonen SE; Borg Å; Bozsik A; Bradbury AR; Brennan P; Brewer C; Brunet J; Buys SS; Caldés T; Caligo MA; Campbell I; Christensen LL; Chung WK; Claes KBM; Colas C; Collonge-Rame MA; Delnatte C; Faivre L; Giraud S; Lasset C; Mari V; Mebirouk N; Mouret-Fourme E; Schuster H; Stoppa-Lyonnet D; Antoniou A; Cook J; Davidson R; Easton D; Eeles R; Evans DG; Frost D; Hanson H; Izatt L; Ong KR; Side L; O’Shaughnessy-Kirwan A; Tischkowitz M; Walker L; Daly MB; de la Hoya M; de Putter R; Devilee P; Diez O; Ding YC; Domchek SM; Dorfling CM; Dumont M; Ejlertsen B; Engel C; Foretova L; Fostira F; Friedlander M; Friedman E; Ganz PA; Garber J; Gehrig A; Gerdes AM; Gesta P; Glendon G; Godwin AK; Goldgar DE, 2020, 'Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants', Genetics in Medicine, 22, pp. 1653 - 1666,

Journal articles | 2020

Brieger KK; Peterson S; Lee AW; Mukherjee B; Bakulski KM; Alimujiang A; Anton-Culver H; Anglesio MS; Bandera EV; Berchuck A; Bowtell DDL; Chenevix-Trench G; Cho KR; Cramer DW; DeFazio A; Doherty JA; Fortner RT; Garsed DW; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Harris HR; Høgdall E; Huntsman DG; Shen H; Jensen A; Johnatty SE; Jordan SJ; Kjaer SK; Kupryjanczyk J; Lambrechts D; McLean K; Menon U; Modugno F; Moysich K; Ness R; Ramus SJ; Richardson J; Risch H; Rossing MA; Trabert B; Wentzensen N; Ziogas A; Terry KL; Wu AH; Hanley GE; Pharoah P; Webb PM; Pike MC; Pearce CL, 2020, 'Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival', Gynecologic Oncology, 158, pp. 702 - 709,

Journal articles | 2020

Fachal L; Aschard H; Beesley J; Barnes DR; Allen J; Kar S; Pooley KA; Dennis J; Michailidou K; Turman C; Soucy P; Lemaçon A; Lush M; Tyrer JP; Ghoussaini M; Marjaneh MM; Jiang X; Agata S; Aittomäki K; Alonso MR; Andrulis IL; Anton-Culver H; Antonenkova NN; Arason A; Arndt V; Aronson KJ; Arun BK; Auber B; Auer PL; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bialkowska K; Blanco AM; Blomqvist C; Blot W; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Borg A; Bosse K; Brauch H; Brenner H; Briceno I; Brock IW; Brooks-Wilson A; Brüning T; Burwinkel B; Buys SS; Cai Q; Caldés T; Caligo MA; Camp NJ; Campbell I; Canzian F; Carroll JS; Carter BD; Castelao JE; Chiquette J; Christiansen H; Chung WK; Claes KBM; Clarke CL; Mari V; Berthet P; Castera L; Vaur D; Lallaoui H; Bignon YJ; Uhrhammer N; Bonadona V; Lasset C; Révillion F; Vennin P; Muller D; Gomes DM; Ingster O; Coupier I; Pujol P; Collonge-Rame MA; Mortemousque I; Bera O; Rose M; Baurand A; Bertolone G; Faivre L; Dreyfus H; Leroux D; Venat-Bouvet L; Bézieau S; Delnatte C; Chiesa J; Gilbert-Dussardier B; Gesta P; Prieur FP, 2020, 'Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes', Nature Genetics, 52, pp. 56 - 73,

Journal articles | 2020

Lee A; Yang X; Tyrer J; Gentry-Maharaj A; Ryan A; Mavaddat N; Cunningham A; Carver T; Archer S; Leslie G; Kalsi J; Gaba F; Manchanda R; Gayther S; Ramus S; Walter F; Tischkowitz M; Jacobs I; Menon U; Easton D; Pharoah PPD; Antoniou A, 2020, 'A Comprehensive Epithelial Tubo-Ovarian Cancer Risk Prediction Model Incorporating Genetic and Epidemiological Risk Factors', ,

Journal articles | 2020

Martins FC; Couturier DL; Paterson A; Karnezis AN; Chow C; Nazeran TM; Odunsi A; Gentry-Maharaj A; Vrvilo A; Hein A; Talhouk A; Osorio A; Hartkopf AD; Brooks-Wilson A; DeFazio A; Fischer A; Hartmann A; Hernandez BY; McCauley BM; Karpinskyj C; de Sousa CB; Høgdall C; Tiezzi DG; Herpel E; Taran FA; Modugno F; Keeney G; Nelson G; Steed H; Song H; Luk H; Benitez J; Alsop J; Koziak JM; Lester J; Rothstein JH; de Andrade JM; Lundvall L; Paz-Ares L; Robles-Díaz L; Wilkens LR; Garcia MJ; Intermaggio MP; Alcaraz ML; Brett MA; Beckmann MW; Jimenez-Linan M; Anglesio M; Carney ME; Schneider M; Traficante N; Pejovic N; Singh N; Le N; Sinn P; Ghatage P; Erber R; Edwards R; Vierkant R; Ness RB; Leung S; Orsulic S; Brucker SY; Kaufmann SH; Fereday S; Gayther S; Winham SJ; Kommoss S; Pejovic T; Longacre TA; McGuire V; Rhenius V; Sieh W; Shvetsov YB; Whittemore AS; Staebler A; Karlan BY; Rodriguez-Antona C; Bowtell DD; Goode EL; Høgdall E; Candido dos Reis FJ; Gronwald J; Chang-Claude J; Moysich KB; Kelemen LE; Cook LS; Goodman MT; Fasching PA; Crawford R; Deen S; Menon U; Huntsman DG; Köbel M; Ramus SJ; Pharoah PDP; Brenton JD, 2020, 'Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium', British Journal of Cancer, 123, pp. 793 - 802,

Journal articles | 2020

Millstein J; Budden T; Goode EL; Anglesio MS; Talhouk A; Intermaggio MP; Leong HS; Chen S; Elatre W; Gilks B; Nazeran T; Volchek M; Bentley RC; Wang C; Chiu DS; Kommoss S; Leung SCY; Senz J; Lum A; Chow V; Sudderuddin H; Mackenzie R; George J; Bowtell DD; Chenevix-Trench G; Green A; Webb P; deFazio A; Gertig D; Traficante N; Fereday S; Moore S; Hung J; Harrap K; Sadkowsky T; Pandeya N; Malt M; Mellon A; Robertson R; Vanden Bergh T; Jones M; Mackenzie P; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Ferguson K; Martin K; Martyn A; Ranieri B; White J; Jayde V; Mamers P; Bowes L; Galletta L; Giles D; Hendley J; Alsop K; Schmidt T; Shirley H; Ball C; Young C; Viduka S; Tran H; Bilic S; Glavinas L; Brooks J; Stuart-Harris R; Kirsten F; Rutovitz J; Clingan P; Glasgow A; Proietto A; Braye S; Otton G; Shannon J; Bonaventura T; Stewart J; Begbie S; Friedlander M; Bell D; Baron-Hay S; Ferrier,a A; Gard G; Nevell D; Pavlakis N; Valmadre S; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D, 2020, 'Prognostic gene expression signature for high-grade serous ovarian cancer', Annals of Oncology, 31, pp. 1240 - 1250,

Journal articles | 2020

Modugno F; Fu Z; Jordan SJ; Group A; Chang-Claude J; Fortner RT; Goodman MT; Moysich KB; Schildkraut JM; Berchuck A; Bandera EV; Qin B; Sutphen R; McLaughlin JR; Menon U; Ramus SJ; Gayther SA; Gentry-Maharaj A; Karpinskyj C; Pearce CL; Wu AH; Risch HA; Webb PM, 2020, 'Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case–control studies', European Journal of Epidemiology, 35, pp. 1025 - 1042,

Journal articles | 2020

Pavanello M; Chan IHY; Ariff A; Pharoah PDP; Gayther SA; Ramus SJ, 2020, 'Rare germline genetic variants and the risks of epithelial ovarian cancer', Cancers, 12, pp. 1 - 23,

Journal articles | 2020

Talhouk A; George J; Wang C; Budden T; Tan TZ; Chiu DS; Kommoss S; Leong HS; Chen S; Intermaggio MP; Gilks B; Nazeran TM; Volchek M; Elatre W; Bentley RC; Senz J; Lum A; Chow V; Sudderuddin H; Mackenzie R; Leong SCY; Liu G; Johnson D; Chen B; Alsop J; Banerjee SN; Behrens S; Bodelon C; Brand AH; Brinton L; Carney ME; Chiew YE; Cushing-Haugen KL; Cybulski C; Ennis D; Fereday S; Fortner RT; García-Donas J; Gentry-Maharaj A; Glasspool R; Goranova T; Greene CS; Haluska P; Harris HR; Hendley J; Hernandez BY; Herpel E; Jimenez-Linan M; Karpinskyj C; Kaufmann SH; Keeney GL; Kennedy CJ; Kobel M; Koziak JM; Larson MC; Lester J; Lewsley LA; Lissowska J; Lubiński J; Luk H; Macintyre G; Mahner S; McNeish IA; Menkiszak J; Nevins N; Osorio A; Oszurek O; Palacios J; Hinsley S; Pearce CL; Pike MC; Piskorz AM; Ray-Coquard I; Rhenius V; Rodriguez-Antona C; Sharma R; Sherman ME; de Silva D; Singh N; Sinn P; Slamon D; Song H; Steed H; Stronach EA; Thompson PJ; Tołoczko A; Trabert B; Traficante N; Tseng CC; Widschwendter M; Wilkens LR; Winham SJ; Winterhoff B; Beeghly-Fadiel A; Benitez J; Berchuck A; Brenton JD; Brown R; Chang-Claude J; Chenevix-Trench G, 2020, 'Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE)', Clinical Cancer Research, 26, pp. 5411 - 5423,

Journal articles | 2020

Yang X; Leslie G; Doroszuk A; Schneider S; Allen J; Decker B; Dunning AM; Redman J; Scarth J; Plaskocinska I; Luccarini C; Shah M; Pooley K; Dorling L; Leei A; Adank MA; Adlard J; Aittomäki K; Andrulis IL; Ang P; Barwell J; Bernstein JL; Bobolis K; Borg Å; Blomqvist C; Claes KBM; Concannon P; Cuggia A; Culver JO; Damiola F; De Pauw A; Diez O; Dolinsky JS; Domchek SM; Engel C; Evans DG; Fostira F; Garber J; Golmard L; Goode EL; Gruber SB; Hahnen E; Hake C; Heikkinen T; Hurley JE; Janavicius R; Kleibl Z; Kleiblova P; Konstantopoulou I; Kvist A; Laduca H; Lee ASG; Lesueur F; Maher ER; Mannermaa A; Manoukian S; McFarland R; McKinnon W; Meindl A; Metcalfe K; Taib NAM; Moilanen J; Nathanson KL; Neuhausen S; Ng PS; Nguyen-Dumont T; Nielsen SM; Obermair F; Offit K; Olopade OI; Ottini L; Penkert J; Pylkäs K; Radice P; Ramus SJ; Rudaitis V; Side L; Silva-Smith R; Silvestri V; Skytte AB; Slavin T; Soukupova J; Tondini C; Trainer AH; Unzeitig G; Usha L; Van Overeem Hansen T; Whitworth J; Wood M; Yip CH; Yoon SY; Yussuf A; Zogopoulos G; Goldgar D; Hopper JL; Chenevix-Trench G; Pharoah P; George SHL; Balmaña J; Houdayer C, 2020, 'Cancer risks associated with germline PALB2 pathogenic variants: An international study of 524 families', Journal of Clinical Oncology, 38, pp. 674 - 685,

Journal articles | 2020

Yang X; Song H; Leslie G; Engel C; Hahnen E; Auber B; Horváth J; Kast K; Niederacher D; Turnbull C; Houlston R; Hanson H; Loveday C; Dolinsky JS; Laduca H; Ramus SJ; Menon U; Rosenthal AN; Jacobs I; Gayther SA; DIcks E; Nevanlinna H; Aittomäki K; Pelttari LM; Ehrencrona H; Borg Å; Kvist A; Rivera B; Hansen TVO; Djursby M; Lee A; Dennis J; Bowtell DD; Traficante N; DIez O; Balmaña J; Gruber SB; Chenevix-Trench G; Investigators K; Jensen A; Kjær SK; Høgdall E; Castéra L; Garber J; Janavicius R; Osorio A; Golmard L; Vega A; Couch FJ; Robson M; Gronwald J; Domchek SM; Culver JO; De La Hoya M; Easton DF; Foulkes WD; Tischkowitz M; Meindl A; Schmutzler RK; Pharoah PDP; Antoniou AC, 2020, 'Ovarian and Breast Cancer Risks Associated with Pathogenic Variants in RAD51C and RAD51D', Journal of the National Cancer Institute, 112, pp. 1242 - 1250,

Journal articles | 2020

Zhang H; Ahearn TU; Lecarpentier J; Barnes D; Beesley J; Qi G; Jiang X; O’Mara TA; Zhao N; Bolla MK; Dunning AM; Dennis J; Wang Q; Ful ZA; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Aronson KJ; Arun BK; Auer PL; Azzollini J; Barrowdale D; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bialkowska K; Blanco A; Blomqvist C; Bogdanova NV; Bojesen SE; Bonanni B; Bondavalli D; Borg A; Brauch H; Brenner H; Briceno I; Broeks A; Brucker SY; Brüning T; Burwinkel B; Buys SS; Byers H; Caldés T; Caligo MA; Calvello M; Campa D; Castelao JE; Chang-Claude J; Chanock SJ; Christiaens M; Christiansen H; Chung WK; Claes KBM; Clarke CL; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Diez O; Domchek SM; Dörk T; Dwek M; Eccles DM; Ekici AB; Evans DG; Fasching PA; Figueroa J; Foretova L; Fostira F; Friedman E; Frost D; Gago-Dominguez M; Gapstur SM; Garber J; García-Sáenz JA; Gaudet MM; Gayther SA; Giles GG; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Greene MH; Gronwald J; Guénel P; Häberle L; Hahnen E; Haiman CA; Hake CR; Hall P; Hamann U; Harkness EF; Heemskerk-Gerritsen BAM; Hillemanns P, 2020, 'Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses', Nature Genetics, 52, pp. 572 - 581,

Journal articles | 2020

de Fazio A; Garsed DW; Pandey A; Fereday S; Alsop K; Wouters MCA; Gibson-Wright B; Saner F; Beach JA; Milne K; Kennedy CJ; Hendley J; Traficante N; Ramus SJ; Köbel M; Nelson BH; Goode EL; Pearce CL; Pike MC; Bowtell DDL, 2020, 'The MOCOG study: Learning from extraordinary responders to improve treatment outcomes for women with ovarian cancer', Pathology, 52, pp. S30 - S31,

Journal articles | 2019

Bodelon C; Keith Killian J; Sampson JN; Anderson WF; Matsuno R; Brinton LA; Lissowska J; Anglesio MS; Bowtell DDL; Doherty JA; Ramus SJ; Talhouk A; Sherman ME; Wentzensen N, 2019, 'Molecular classification of epithelial ovarian cancer based on methylation profiling: Evidence for survival heterogeneity', Clinical Cancer Research, 25, pp. 5937 - 5946,

Journal articles | 2019

Buckley MA; Woods NT; Tyrer JP; Mendoza-Fandiño G; Lawrenson K; Hazelett DJ; Najafabadi HS; Gjyshi A; Carvalho RS; Lyra PC; Coetzee SG; Shen HC; Yang AW; Earp MA; Yoder SJ; Risch H; Chenevix-Trench G; Ramus SJ; Phelan CM; Coetzee GA; Noushmehr H; Hughes TR; Sellers TA; Goode EL; Pharoah PD; Gayther SA; Monteiro ANA; Chen YA; Fridley BL; Aben KKH; Kiemeney LA; Anton-Culver H; Ziogas A; Bruinsma F; Milne RL; Bandera EV; Giles GG; Bean YT; Pejovic T; Beckmann MW; Hein A; Bjorge L; Fasching PA; Thomsen LCV; Kopperud RK; Bischof K; Bogdanova N; Dörk T; Hillemanns P; Brinton LA; Wentzensen N; Yang H; Brooks-Wilson A; Bunker CH; Butzow R; Nevanlinna H; Pelttari LM; Campbell IG; Southey MC; Modugno F; Carty K; Glasspool R; McNeish I; Paul J; Siddiqui N; Chang-Claude J; Rudolph A; Cook LS; Cramer DW; Terry KL; Cunningham JM; Cybulski C; Gronwald J; Jakubowska A; Lubinski J; Dansonka-Mieszkowska A; Kupryjanczyk J; Rzepecka IK; Du Bois A; Harter P; Dicks E; Song H; Doherty JA; Rossing MA; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Gao YT; Gentry-Maharaj A; Goodman MT; Thompson PJ; Hasmad HN; Teo SH; Hildebrandt MAT; Wu X; Hogdall E; Jensen A; Kjaer SK, 2019, 'Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus', Cancer Research, 79, pp. 467 - 481,

Journal articles | 2019

Figlioli G; Bogliolo M; Catucci I; Caleca L; Lasheras SV; Pujol R; Kiiski JI; Muranen TA; Barnes DR; Dennis J; Michailidou K; Bolla MK; Leslie G; Aalfs CM; Balleine R; Baxter R; Braye S; Carpenter J; Dahlstrom J; Forbes J; Lee CS; Marsh D; Morey A; Pathmanathan N; Scott R; Simpson P; Spigelman A; Wilcken N; Yip D; Zeps N; Adank MA; Adlard J; Agata S; Cadoo K; Agnarsson BA; Ahearn T; Aittomäki K; Ambrosone CB; Andrews L; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Arun BK; Asseryanis E; Auber B; Auvinen P; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Barwell J; Beane Freeman LE; Beauparlant CJ; Beckmann MW; Behrens S; Benitez J; Berger R; Bermisheva M; Blanco AM; Blomqvist C; Bogdanova NV; Bojesen A; Bojesen SE; Bonanni B; Borg A; Brady AF; Brauch H; Brenner H; Brüning T; Burwinkel B; Buys SS; Caldés T; Caliebe A; Caligo MA; Campa D; Campbell IG; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Claes KBM; Clarke CL; Collavoli A; Conner TA; Cox DG; Cybulski C; Czene K; Daly MB; de la Hoya M; Devilee P; Diez O; Ding YC; Dite GS; Ditsch N; Domchek SM; Dorfling CM; dos-Santos-Silva I; Durda K, 2019, 'The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer', npj Breast Cancer, 5,

Journal articles | 2019

Grant DJ; Manichaikul A; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Moorman PG; Peres LC; Peters ES; Schwartz AG; Terry PD; Wang XQ; Keku TO; Hoyo C; Berchuck A; Sandler DP; Taylor JA; O’Brien KM; Velez Edwards DR; Edwards TL; Beeghly-Fadiel A; Wentzensen N; Pearce CL; Wu AH; Whittemore AS; McGuire V; Sieh W; Rothstein JH; Modugno F; Ness R; Moysich K; Rossing MA; Doherty JA; Sellers TA; Permuth-Way JB; Monteiro AN; Levine DA; Setiawan VW; Haiman CA; LeMarchand L; Wilkens LR; Karlan BY; Menon U; Ramus S; Gayther S; Gentry-Maharaj A; Terry KL; Cramer DW; Goode EL; Larson MC; Kaufmann SH; Cannioto R; Odunsi K; Etter JL; Huang RY; Bernardini MQ; Tone AA; May T; Goodman MT; Thompson PJ; Carney ME; Tworoger SS; Poole EM; Lambrechts D; Vergote I; Vanderstichele A; Van Nieuwenhuysen E; Anton-Culver H; Ziogas A; Brenton JD; Bjorge L; Salvensen HB; Kiemeney LA; Massuger LFAG; Pejovic T; Bruegl A; Moffitt M; Cook L; Le ND; Brooks-Wilson A; Kelemen LE; Pharoah PDP; Song H; Campbell I; Eccles D; DeFazio A; Kennedy CJ; Schildkraut JM, 2019, 'Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women', Cancer Medicine, 8, pp. 2503 - 2513,

Journal articles | 2019

Jiang X; Finucane HK; Schumacher FR; Schmit SL; Tyrer JP; Han Y; Michailidou K; Lesseur C; Kuchenbaecker KB; Dennis J; Conti DV; Casey G; Gaudet MM; Huyghe JR; Albanes D; Aldrich MC; Andrew AS; Andrulis IL; Anton-Culver H; Antoniou AC; Antonenkova NN; Arnold SM; Aronson KJ; Arun BK; Bandera EV; Barkardottir RB; Barnes DR; Batra J; Beckmann MW; Benitez J; Benlloch S; Berchuck A; Berndt SI; Bickeböller H; Bien SA; Blomqvist C; Boccia S; Bogdanova NV; Bojesen SE; Bolla MK; Brauch H; Brenner H; Brenton JD; Brook MN; Brunet J; Brunnström H; Buchanan DD; Burwinkel B; Butzow R; Cadoni G; Caldés T; Caligo MA; Campbell I; Campbell PT; Cancel-Tassin G; Cannon-Albright L; Campa D; Caporaso N; Carvalho AL; Chan AT; Chang-Claude J; Chanock SJ; Chen C; Christiani DC; Claes KBM; Claessens F; Clements J; Collée JM; Correa MC; Couch FJ; Cox A; Cunningham JM; Cybulski C; Czene K; Daly MB; deFazio A; Devilee P; Diez O; Gago-Dominguez M; Donovan JL; Dörk T; Duell EJ; Dunning AM; Dwek M; Eccles DM; Edlund CK; Edwards DRV; Ellberg C; Evans DG; Fasching PA; Ferris RL; Liloglou T; Figueiredo JC; Fletcher O; Fortner RT; Fostira F; Franceschi S; Friedman E; Gallinger SJ; Ganz PA, 2019, 'Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)', Nature Communications, 10,

Journal articles | 2019

Jiang X; Finucane HK; Schumacher FR; Schmit SL; Tyrer JP; Han Y; Michailidou K; Lesseur C; Kuchenbaecker KB; Dennis J; Conti DV; Casey G; Gaudet MM; Huyghe JR; Albanes D; Aldrich MC; Andrew AS; Andrulis IL; Anton-Culver H; Antoniou AC; Antonenkova NN; Arnold SM; Aronson KJ; Arun BK; Bandera EV; Barkardottir RB; Barnes DR; Batra J; Beckmann MW; Benitez J; Benlloch S; Berchuck A; Berndt SI; Bickeböller H; Bien SA; Blomqvist C; Boccia S; Bogdanova NV; Bojesen SE; Bolla MK; Brauch H; Brenner H; Brenton JD; Brook MN; Brunet J; Brunnström H; Buchanan DD; Burwinkel B; Butzow R; Cadoni G; Caldés T; Caligo MA; Campbell I; Campbell PT; Cancel-Tassin G; Cannon-Albright L; Campa D; Caporaso N; Carvalho AL; Chan AT; Chang-Claude J; Chanock SJ; Chen C; Christiani DC; Claes KBM; Claessens F; Clements J; Collée JM; Correa MC; Couch FJ; Cox A; Cunningham JM; Cybulski C; Czene K; Daly MB; deFazio A; Devilee P; Diez O; Gago-Dominguez M; Donovan JL; Dörk T; Duell EJ; Dunning AM; Dwek M; Eccles DM; Edlund CK; Edwards DRV; Ellberg C; Evans DG; Fasching PA; Ferris RL; Liloglou T; Figueiredo JC; Fletcher O; Fortner RT; Fostira F; Franceschi S; Friedman E; Gallinger SJ; Ganz PA, 2019, 'Shared heritability and functional enrichment across six solid cancers', Nature Communications, 10,

Journal articles | 2019

Meagher NS; Wang L; Rambau PF; Intermaggio MP; Huntsman DG; Wilkens LR; El-Bahrawy MA; Ness RB; Odunsi K; Steed H; Herpel E; Anglesio MS; Zhang B; Lambie N; Swerdlow AJ; Lubiński J; Vierkant RA; Goode EL; Menon U; Toloczko-Grabarek A; Oszurek O; Bilic S; Talhouk A; García-Closas M; Wang Q; Tan A; Farrell R; Kennedy CJ; Jimenez-Linan M; Sundfeldt K; Etter JL; Menkiszak J; Goodman MT; Klonowski P; Leung Y; Winham SJ; Moysich KB; Behrens S; Kluz T; Edwards RP; Gronwald J; Modugno F; Hernandez BY; Chow C; Kelemen LE; Keeney GL; Carney ME; Natanzon Y; Robertson G; Sharma R; Gayther SA; Alsop J; Luk H; Karpinskyj C; Campbell I; Sinn P; Gentry-Maharaj A; Coulson P; Chang-Claude J; Shah M; Widschwendter M; Tang K; Schoemaker MJ; Koziak JM; Cook LS; Brenton JD; Daley F; Kristjansdottir B; Mateoiu C; Larson MC; Harnett PR; Jung A; deFazio A; Gorringe KL; Pharoah PDP; Minoo P; Stewart C; Bathe OF; Gui X; Cohen P; Ramus SJ; Köbel M, 2019, 'A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases', Modern Pathology, 32, pp. 1834 - 1846,

Journal articles | 2019

Qian F; Rookus MA; Leslie G; Risch HA; Greene MH; Aalfs CM; Adank MA; Adlard J; Agnarsson BA; Ahmed M; Aittomäki K; Andrulis IL; Arnold N; Arun BK; Ausems MGEM; Azzollini J; Barrowdale D; Barwell J; Benitez J; Białkowska K; Bonadona V; Borde J; Borg A; Bradbury AR; Brunet J; Buys SS; Caldés T; Caligo MA; Campbell I; Carter J; Chiquette J; Chung WK; Claes KBM; Collée JM; Collonge-Rame MA; Couch FJ; Daly MB; Delnatte C; Diez O; Domchek SM; Dorfling CM; Eason J; Easton DF; Eeles R; Engel C; Evans DG; Faivre L; Feliubadaló L; Foretova L; Friedman E; Frost D; Ganz PA; Garber J; Garcia-Barberan V; Gehrig A; Glendon G; Godwin AK; Gómez Garcia EB; Hamann U; Hauke J; Hopper JL; Hulick PJ; Imyanitov EN; Isaacs C; Izatt L; Jakubowska A; Janavicius R; John EM; Karlan BY; Kets CM; Laitman Y; Lázaro C; Leroux D; Lester J; Lesueur F; Loud JT; Lubiński J; Łukomska A; McGuffog L; Mebirouk N; Meijers-Heijboer HEJ; Meindl A; Miller A; Montagna M; Mooij TM; Mouret-Fourme E; Nathanson KL; Nehoray B; Neuhausen SL; Nevanlinna H; Nielsen FC; Offit K; Olah E; Ong KR; Oosterwijk JC; Ottini L; Parsons MT; Peterlongo P; Pfeiler G; Pradhan N, 2019, 'Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers', British Journal of Cancer, 121, pp. 180 - 192,

Journal articles | 2019

Qian F; Wang S; Mitchell J; McGuffog L; Barrowdale D; Leslie G; Oosterwijk JC; Chung WK; Gareth Evans D; Engel C; Kast K; Aalfs CM; Adank MA; Adlard J; Agnarsson BA; Aittomäki K; Alducci E; Andrulis IL; Arun BK; Ausems MGEM; Azzollini J; Barouk-Simonet E; Barwell J; Belotti M; Benitez J; Berger A; Borg A; Bradbury AR; Brunet J; Buys SS; Caldes T; Caligo MA; Campbell I; Caputo SM; Chiquette J; Claes KBM; Margriet Collée J; Couch FJ; Coupier I; Daly MB; Davidson R; Diez O; Domchek SM; Donaldson A; Dorfling CM; Eeles R; Feliubadaló L; Foretova L; Fowler J; Friedman E; Frost D; Ganz PA; Garber J; Garcia-Barberan V; Glendon G; Godwin AK; Gómez Garcia EB; Gronwald J; Hahnen E; Hamann U; Henderson A; Hendricks CB; Hopper JL; Hulick PJ; Imyanitov EN; Isaacs C; Izatt L; Izquierdo Á; Jakubowska A; Kaczmarek K; Kang E; Karlan BY; Kets CM; Kim SW; Kim Z; Kwong A; Laitman Y; Lasset C; Lee MH; Lee JW; Lee J; Lester J; Lesueur F; Loud JT; Lubinski J; Mebirouk N; Meijers-Heijboer HEJ; Meindl A; Miller A; Montagna M; Mooij TM; Morrison PJ; Mouret-Fourme E; Nathanson KL; Neuhausen SL; Nevanlinna H; Niederacher D; Nielsen FC; Nussbaum RL; Offit K, 2019, 'Height and body mass index as Modifiers of breast cancer risk in BRCA1/2 mutation carriers: A Mendelian randomization study', Journal of the National Cancer Institute, 111, pp. 350 - 364,

Journal articles | 2019

Saner FAM; Herschtal A; Nelson BH; deFazio A; Goode EL; Ramus SJ; Pandey A; Beach JA; Fereday S; Berchuck A; Lheureux S; Pearce CL; Pharoah PD; Pike MC; Garsed DW; Bowtell DDL, 2019, 'Going to extremes: determinants of extraordinary response and survival in patients with cancer', Nature Reviews Cancer, 19, pp. 339 - 348,

Journal articles | 2019

Yang Y; Wu L; Shu X; Lu Y; Shu XO; Cai Q; Beeghly-Fadiel A; Li B; Ye F; Berchuck A; Anton-Culver H; Banerjee S; Benitez J; Bjørge L; Brenton JD; Butzow R; Campbell IG; Chang-Claude J; Chen K; Cook LS; Cramer DW; De Fazio A; Dennis J; Doherty JA; Eccles DM; Edwards DV; Fasching PA; Fortner RT; Gayther SA; Giles GG; Glasspool RM; Goode EL; Goodman MT; Gronwald J; Harris HR; Heitz F; Hildebrandt MA; Høgdall E; Høgdall CK; Huntsman DG; Kar SP; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Koushik A; Lambrechts D; Le ND; Levine DA; Massuger LF; Matsuo K; May T; McNeish IA; Menon U; Modugno F; Monteiro AN; Moorman PG; Moysich KB; Ness RB; Nevanlinna H; Olsson H; Charlotte Onland-Moret N; Park SK; Paul J; Pearce CL; Pejovic T; Phelan CM; Pike MC; Ramus SJ; Riboli E; Rodriguez-Antona C; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Shan K; Siddiqui N; Sieh W; Stampfer MJ; Sutphen R; Swerdlow AJ; Szafron LM; Teo SH; Tworoger SS; Tyrer JP; Webb PM; Wentzensen N; White E; Willett WC; Wolk A; Woo YL; Wu AH; Yan L; Yannoukakos D; Chenevix-Trench G; Sellers TA; Pharoah PDP; Zheng W; Long J, 2019, 'Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk', Cancer Research, 79, pp. 505 - 517,

Journal articles | 2018

Block MS; Vierkant RA; Rambau PF; Winham SJ; Wagner P; Traficante N; Toloczko A; Tiezzi DG; Taran FA; Sinn P; Sieh W; Sharma R; Rothstein JH; Ramón y Cajal T; Paz-Ares L; Oszurek O; Orsulic S; Ness RB; Nelson G; Modugno F; Menkiszak J; McGuire V; McCauley BM; Mack M; Lubinski J; Longacre TA; Li Z; Lester J; Kennedy CJ; Kalli KR; Jung AY; Johnatty SE; Jimenez-Linan M; Jensen A; Intermaggio MP; Hung J; Herpel E; Hernandez BY; Hartkopf AD; Harnett PR; Ghatage P; García-Bueno JM; Gao B; Fereday S; Eilber U; Edwards RP; de Sousa CB; de Andrade JM; Chudecka-Glaz A; Chenevix-Trench G; Cazorla A; Brucker SY; Bowtell DD; Green A; Webb P; de Fazio A; Gertig D; Moore S; Harrap K; Sadkowsky T; Pandeya N; Malt M; Mellon A; Robertson R; Vanden Bergh T; Jones M; Mackenzie P; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Ferguson K; Martin K; Martyn A; Ranieri B; White J; Jayde V; Mamers P; Bowes L; Galletta L; Giles D; Hendley J; Alsop K; Schmidt T; Shirley H; Ball C; Young C; Viduka S; Tran H; Bilic S; Glavinas L; Brooks J; Stuart-Harris R, 2018, 'MyD88 and TLR4 Expression in Epithelial Ovarian Cancer', Mayo Clinic Proceedings, 93, pp. 307 - 320,

Journal articles | 2018

Dixon-Suen SC; Nagle CM; Thrift AP; Pharoah PDP; Ewing A; Pearce CL; Zheng W; Chenevix-Trench G; Fasching PA; Beckmann MW; Lambrechts D; Vergote I; Lambrechts S; Van Nieuwenhuysen E; Rossing MA; Doherty JA; Wicklund KG; Chang-Claude J; Jung AY; Moysich KB; Odunsi K; Goodman MT; Wilkens LR; Thompson PJ; Shvetsov YB; Dörk T; Park-Simon TW; Hillemanns P; Bogdanova N; Butzow R; Nevanlinna H; Pelttari LM; Leminen A; Modugno F; Ness RB; Edwards RP; Kelley JL; Heitz F; Du Bois A; Harter P; Schwaab I; Karlan BY; Lester J; Orsulic S; Rimel BJ; Kjær SK; Høgdall E; Jensen A; Goode EL; Fridley BL; Cunningham JM; Winham SJ; Giles GG; Bruinsma F; Milne RL; Southey MC; Hildebrandt MAT; Wu X; Lu KH; Liang D; Levine DA; Bisogna M; Schildkraut JM; Berchuck A; Cramer DW; Terry KL; Bandera EV; Olson SH; Salvesen HB; Thomsen LCV; Kopperud RK; Bjorge L; Kiemeney LA; Massuger LFAG; Pejovic T; Bruegl A; Cook LS; Le ND; Swenerton KD; Brooks-Wilson A; Kelemen LE; Lubiński J; Huzarski T; Gronwald J; Menkiszak J; Wentzensen N; Brinton L; Yang H; Lissowska J; Høgdall CK; Lundvall L; Song H; Tyrer JP; Campbell I; Eccles D; Paul J; Glasspool R; Siddiqui N; Whittemore AS; Sieh W, 2018, 'Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study', British Journal of Cancer, 118, pp. 1123 - 1129,

Journal articles | 2018

Earp M; Tyrer JP; Winham SJ; Lin HY; Chornokur G; Dennis J; Aben KKH; Anton-Culver H; Antonenkova N; Bandera EV; Bean YT; Beckmann MW; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Bunker CH; Butzow R; Campbell IG; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; Despierre E; Doherty JA; Dörk T; Du Bois A; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harter P; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Hogdall CK; Høgdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Jung AY; Karlan BY; Kellar M; Kiemeney LA; Lim BK; Kjaer SK; Krakstad C; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lele S; Lester J; Levine DA; Li Z; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LFAG; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Odunsi K; Olson SH; Orlow I; Orsulic S; Paul J; Pejovic T; Pelttari LM; Permuth JB; Pike MC; Poole EM; Rosen B; Rossing MA; Rothstein JH; Runnebaum IB, 2018, 'Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility', PLoS ONE, 13,

Journal articles | 2018

Kar SP; Berchuck A; Gayther SA; Goode EL; Moysich KB; Pearce CL; Ramus SJ; Schildkraut JM; Sellers TA; Pharoah PDP, 2018, 'Common genetic variation and susceptibility to ovarian cancer: Current insights and future directions', Cancer Epidemiology Biomarkers and Prevention, 27, pp. 395 - 404,

Journal articles | 2018

Kelemen LE; Earp M; Fridley BL; Chenevix-Trench G; Fasching PA; Beckmann MW; Ekici AB; Hein A; Lambrechts D; Lambrechts S; Van Nieuwenhuysen E; Vergote I; Rossing MA; Doherty JA; Chang-Claude J; Behrens S; Moysich KB; Cannioto R; Lele S; Odunsi K; Goodman MT; Shvetsov YB; Thompson PJ; Wilkens LR; Dörk T; Antonenkova N; Bogdanova N; Hillemanns P; Runnebaum IB; Bois AD; Harter P; Heitz F; Schwaab I; Butzow R; Pelttari LM; Nevanlinna H; Modugno F; Edwards RP; Kelley JL; Ness RB; Karlan BY; Lester J; Orsulic S; Walsh C; Kjaer SK; Jensen A; Cunningham JM; Vierkant RA; Giles GG; Bruinsma F; Southey MC; Hildebrandt MAT; Liang D; Lu K; Wu X; Sellers TA; Levine DA; Schildkraut JM; Iversen ES; Terry KL; Cramer DW; Tworoger SS; Poole EM; Bandera EV; Olson SH; Orlow I; Thomsen LCV; Bjorge L; Krakstad C; Tangen IL; Kiemeney LA; Aben KKH; Massuger LFAG; Van Altena AM; Pejovic T; Bean Y; Kellar M; Cook LS; Le ND; Brooks-Wilson A; Gronwald J; Cybulski C; Jakubowska A; Lubiński J; Wentzensen N; Brinton LA; Lissowska J; Hogdall E; Engelholm SA; Hogdall C; Lundvall L; Nedergaard L; Pharoah PDP; Dicks E; Song H; Tyrer JP; McNeish I; Siddiqui N; Carty K; Glasspool R, 2018, 'rs495139 in the TYMS-ENOSF1 region and risk of ovarian carcinoma of mucinous histology', International Journal of Molecular Sciences, 19,

Journal articles | 2018

Liu G; Mukherjee B; Lee S; Lee AW; Wu AH; Bandera EV; Jensen A; Rossing MA; Moysich KB; Chang-Claude J; Doherty JA; Gentry-Maharaj A; Kiemeney L; Gayther SA; Modugno F; Massuger L; Goode EL; Fridley BL; Terry KL; Cramer DW; Ramus SJ; Anton-Culver H; Ziogas A; Tyrer JP; Schildkraut JM; Kjaer SK; Webb PM; Ness RB; Menon U; Berchuck A; Pharoah PD; Risch H; Pearce CL, 2018, 'Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence', American Journal of Epidemiology, 187, pp. 366 - 377,

Journal articles | 2018

Lu Y; Beeghly-Fadiel A; Wu L; Guo X; Li B; Schildkraut JM; Im HK; Chen YA; Permuth JB; Reid BM; Teer JK; Moysich KB; Andrulis IL; Anton-Culver H; Arun BK; Bandera EV; Barkardottir RB; Barnes DR; Benitez J; Bjorge L; Brenton J; Butzow R; Caldes T; Caligo MA; Campbell I; Chang-Claude J; Claes KBM; Couch FJ; Cramer DW; Daly MB; DeFazio A; Dennis J; Diez O; Domchek SM; D rk T; Easton DF; Eccles DM; Fasching PA; Fortner RET; Fountzilas G; Friedman E; Ganz PA; Garber J; Giles GG; Godwin AK; Goldgar DE; Goodman MT; Greene MH; Gronwald J; Hamann U; Heitz F; Hildebrandt MAT; Høgdall CK; Hollestelle A; Hulick PJ; Huntsman DG; Imyanitov EN; Isaacs C; Jakubowska A; James P; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Kwong A; Le ND; Leslie G; Lesueur F; Levine DA; Mattiello A; May T; McGuffog L; McNeish IA; Merritt MA; Modugno F; Montagna M; Neuhausen SL; Nevanlinna H; Nielsen FC; Nikitina-Zake L; Nussbaum RL; Offit K; Olah E; Olopade OI; Olson SH; Olsson HK; Osorio A; Park SK; Parsons MT; Peeters PHM; Pejovic T; Peterlongo P; Phelan CM; Pujana MA; Ramus SJ; Rennert G; Risch H; Rodriguez GC; Rodríguez-Antona C; Romieu I, 2018, 'A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk', Cancer Research, 78, pp. 5419 - 5430,

Journal articles | 2018

Manchanda R; Patel S; Gordeev VS; Antoniou AC; Smith S; Lee A; Hopper JL; MacInnis RJ; Turnbull C; Ramus SJ; Gayther SA; Pharoah PDP; Menon U; Jacobs I; Legood R, 2018, 'Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women', Journal of the National Cancer Institute, 110, pp. 714 - 725,

Journal articles | 2018

Meagher NS; Schuster K; Voss A; Budden T; Pang CNI; deFazio A; Ramus SJ; Friedlander ML, 2018, 'Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials', Gynecologic Oncology, 150, pp. 527 - 533,

Journal articles | 2018

Ong JS; Hwang LD; Cuellar-Partida G; Martin NG; Chenevix-Trench G; Quinn MCJ; Cornelis MC; Gharahkhani P; Webb PM; MacGregor S; Bryne E; Fasching PA; Hein A; Burghaus S; Beckmann MW; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Vanderstichele A; Swerdlow AJ; Jones M; Orr N; Schoemaker M; Edwards DV; Brenton J; Benítez J; García MJ; Rodriguez-Antona CR; Rossing MA; Fortner RT; Riboli E; Chang-Claude J; Eilber U; Wang-Gohrke S; Yannoukakos D; Goodman MT; Bogdanova N; Dörk T; Duerst M; Hillemanns P; Runnebaum IB; Antonenkova N; Butzow R; Nevanlinna H; Pelttari LM; Edwards RP; Kelley JL; Modugno F; Moysich KB; Ness RB; Cannioto R; Heitz F; Karlan B; Olsson H; Kjaer SK; Jensen A; Giles GG; Bruinsma F; Hildebrandt MAT; Liang D; Wu X; Le Marchand L; Setiawan VW; Permuth JB; Bisogna M; Dao F; Levine DA; Cramer DW; Terry KL; Tworoger SS; Stampfer M; Willet W; Missmer S; Bjorge L; Kopperud RK; Bischof K; Vestrheim Thomsen LC; Kiemeney LA; Massuger LFAG; Pejovic T; Brooks-Wilson A; Olson SH; McGuire V; Rothstein JH; Sieh W; Whittemore AS; Cook LS; Le ND; Blake Gilks C; Gronwald J; Jakubowska A; Lubiński J; Kluz T; Wentzensen N; Brinton L; Trabert B; Lissowska J; Høgdall E; Høgdall CK; Sandler DP, 2018, 'Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: A Mendelian randomization study', International Journal of Epidemiology, 47, pp. 450 - 459,

Journal articles | 2018

Rambau PF; Vierkant RA; Intermaggio MP; Kelemen LE; Goodman MT; Herpel E; Pharoah PD; Kommoss S; Jimenez-Linan M; Karlan BY; Gentry-Maharaj A; Menon U; Polo SH; Candido Dos Reis FJ; Doherty JA; Gayther SA; Sharma R; Larson MC; Harnett PR; Hatfield E; de Andrade JM; Nelson GS; Steed H; Schildkraut JM; Carney ME; Høgdall E; Whittemore AS; Widschwendter M; Kennedy CJ; Wang F; Wang Q; Wang C; Armasu SM; Daley F; Coulson P; Jones ME; Anglesio MS; Chow C; de Fazio A; García-Closas M; Brucker SY; Cybulski C; Harris HR; Hartkopf AD; Huzarski T; Jensen A; Lubiński J; Oszurek O; Benitez J; Mina F; Staebler A; Taran FA; Pasternak J; Talhouk A; Rossing MA; Hendley J; Edwards RP; Fereday S; Modugno F; Ness RB; Sieh W; El-Bahrawy MA; Winham SJ; Lester J; Kjaer SK; Gronwald J; Sinn P; Fasching PA; Chang-Claude J; Moysich KB; Bowtell DD; Hernandez BY; Luk H; Behrens S; Shah M; Jung A; Ghatage P; Alsop J; Alsop K; García-Donas J; Thompson PJ; Swerdlow AJ; Karpinskyj C; Cazorla-Jiménez A; García MJ; Deen S; Wilkens LR; Palacios J; Berchuck A; Koziak JM; Brenton JD; Cook LS; Goode EL; Huntsman DG; Ramus SJ; Köbel M, 2018, 'Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study', The journal of pathology. Clinical research, 4, pp. 250 - 261,

Journal articles | 2018

Rebbeck TR; Friebel TM; Friedman E; Hamann U; Huo D; Kwong A; Olah E; Olopade OI; Solano AR; Teo SH; Thomassen M; Weitzel JN; Chan TL; Couch FJ; Goldgar DE; Kruse TA; Palmero EI; Park SK; Torres D; van Rensburg EJ; McGuffog L; Parsons MT; Leslie G; Aalfs CM; Abugattas J; Adlard J; Agata S; Aittomäki K; Andrews L; Andrulis IL; Arason A; Arnold N; Arun BK; Asseryanis E; Auerbach L; Azzollini J; Balmaña J; Barile M; Barkardottir RB; Barrowdale D; Benitez J; Berger A; Berger R; Blanco AM; Blazer KR; Blok MJ; Bonadona V; Bonanni B; Bradbury AR; Brewer C; Buecher B; Buys SS; Caldes T; Caliebe A; Caligo MA; Campbell I; Caputo SM; Chiquette J; Chung WK; Claes KBM; Collée JM; Cook J; Davidson R; de la Hoya M; De Leeneer K; de Pauw A; Delnatte C; Diez O; Ding YC; Ditsch N; Domchek SM; Dorfling CM; Velazquez C; Dworniczak B; Eason J; Easton DF; Eeles R; Ehrencrona H; Ejlertsen B; Engel C; Engert S; Evans DG; Faivre L; Feliubadaló L; Ferrer SF; Foretova L; Fowler J; Frost D; Galvão HCR; Ganz PA; Garber J; Gauthier-Villars M; Gehrig A; Gerdes AM; Gesta P; Giannini G; Giraud S; Glendon G; Godwin AK; Greene MH, 2018, 'Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations', Human Mutation, 39, pp. 593 - 620,

Journal articles | 2018

Yang X; Leslie G; Gentry-Maharaj A; Ryan A; Intermaggio M; Lee A; Kalsi JK; Tyrer J; Gaba F; Manchanda R; Pharoah PDP; Gayther SA; Ramus SJ; Jacobs I; Menon U; Antoniou AC, 2018, 'Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study', Journal of Medical Genetics, 55, pp. 546 - 554,

Journal articles | 2017

Chen Y; Camacho SC; Silvers TR; Razak ARA; Gabrail NY; Gerecitano JF; Kalir E; Pereira E; Evans BR; Ramus SJ; Huang F; Priedigkeit N; Rodriguez E; Donovan M; Khan F; Kalir T; Sebra R; Uzilov A; Chen R; Sinha R; Halpert R; Billaud JN; Shacham S; McCauley D; Landesman Y; Rashal T; Kauffman M; Mirza MR; Mau-Sørensen M; Dottino P; Martignetti JA, 2017, 'Inhibition of the nuclear export receptor XPO1 as a therapeutic target for platinum-resistant ovarian cancer', Clinical Cancer Research, 23, pp. 1552 - 1563,

Journal articles | 2017

Dixon SC; Nagle CM; Wentzensen N; Trabert B; Beeghly-Fadiel A; Schildkraut JM; Moysich KB; DeFazio A; Risch HA; Rossing MA; Doherty JA; Wicklund KG; Goodman MT; Modugno F; Ness RB; Edwards RP; Jensen A; Kjær SK; Høgdall E; Berchuck A; Cramer DW; Terry KL; Poole EM; Bandera EV; Paddock LE; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Pike MC; Webb PM, 2017, 'Use of common analgesic medications and ovarian cancer survival: Results from a pooled analysis in the Ovarian Cancer Association Consortium', British Journal of Cancer, 116, pp. 1223 - 1228,

Journal articles | 2017

Goode EL; Block MS; Kalli KR; Vierkant RA; Chen W; Fogarty ZC; Gentry-Maharaj A; Tołoczko A; Hein A; Bouligny AL; Jensen A; Osorio A; Hartkopf AD; Ryan A; Chudecka-Głaz A; Magliocco AM; Hartmann A; Jung AY; Gao B; Hernandez BY; Fridley BL; McCauley BM; Kennedy CJ; Wang C; Karpinskyj C; de Sousa CB; Tiezzi DG; Wachter DL; Herpel E; Taran FA; Modugno F; Nelson G; Lubiński J; Menkiszak J; Alsop J; Lester J; Garcia-Donas J; Nation J; Hung J; Palacios J; Rothstein JH; Kelley JL; de Andrade JM; Robles-Diaz L; Intermaggio MP; Widschwendter M; Beckmann MW; Ruebner M; Jimenez-Linan M; Singh N; Oszurek O; Harnett PR; Rambau PF; Sinn P; Wagner P; Ghatage P; Sharma R; Edwards RP; Ness RB; Orsulic S; Brucker SY; Johnatty SE; Longacre TA; Eilber U; McGuire V; Sieh W; Natanzon Y; Li Z; Whittemore AS; deFazio A; Staebler A; Karlan BY; Gilks B; Bowtell DD; Hogdall E; Candido dos Reis FJ; Steed H; Campbell IG; Gronwald J; Benitez J; Koziak JM; Chang-Claude J; Moysich KB; Kelemen LE; Cook LS; Goodman MT; Garcia MJ; Fasching PA; Kommoss S; Deen S; Kjaer SK; Menon U; Brenton JD; Pharoah PDP; Chenevix-Trench G; Huntsman DG; Winham SJ; Kobel M; Ramus SJ, 2017, 'Dose-response association of CD8⁺ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer', JAMA Oncology, 3,

Journal articles | 2017

Kar SP; Adler E; Tyrer J; Hazelett D; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Bogdanova N; Brinton L; Butzow R; Campbell I; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Dansonka-Mieszkowska A; Doherty JA; Dörk T; Dürst M; Eccles D; Fasching PA; Flanagan J; Gentry-Maharaj A; Glasspool R; Goode EL; Goodman MT; Gronwald J; Heitz F; Hildebrandt MAT; Høgdall E; Høgdall CK; Huntsman DG; Jensen A; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Kupryjanczyk J; Lambrechts D; Levine DA; Li Q; Lissowska J; Lu KH; Lubiński J; Massuger LFAG; McGuire V; McNeish I; Menon U; Modugno F; Monteiro AN; Moysich KB; Ness RB; Nevanlinna H; Paul J; Pearce CL; Pejovic T; Permuth JB; Phelan C; Pike MC; Poole EM; Ramus SJ; Risch HA; Rossing MA; Salvesen HB; Schildkraut JM; Sellers TA; Sherman M; Siddiqui N; Sieh W; Song H; Southey M; Terry KL; Tworoger SS; Walsh C; Wentzensen N; Whittemore AS; Wu AH; Yang H; Zheng W; Ziogas A; Freedman ML; Gayther SA; Pharoah PDP; Lawrenson K, 2017, 'Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci', British Journal of Cancer, 116, pp. 524 - 535,

Journal articles | 2017

Kuchenbaecker KB; McGuffog L; Barrowdale D; Lee A; Soucy P; Dennis J; Domchek SM; Robson M; Spurdle AB; Ramus SJ; Mavaddat N; Terry MB; Neuhausen SL; Schmutzler RK; Simard J; Pharoah PDP; Offit K; Couch FJ; Chenevix-Trench G; Easton DF; Antoniou AC; Healey S; Lush M; Hamann U; Southey M; John EM; Chung WK; Daly MB; Buys SS; Goldgar DE; Dorfling CM; van Rensburg EJ; Ding YC; Ejlertsen B; Gerdes AM; Hansen TVO; Slager S; Hallberg E; Benitez J; Osorio A; Cohen N; Lawler W; Weitzel JN; Peterlongo P; Pensotti V; Dolcetti R; Barile M; Bonanni B; Azzollini J; Manoukian S; Peissel B; Radice P; Savarese A; Papi L; Giannini G; Fostira F; Konstantopoulou I; Adlard J; Brewer C; Cook J; Davidson R; Eccles D; Eeles R; Ellis S; EMBRACE ; Frost D; Hodgson S; Izatt L; Lalloo F; Ong KR; Godwin AK; Arnold N; Dworniczak B; Engel C; Gehrig A; Hahnen E; Hauke J; Kast K; Meindl A; Niederacher D; Varon-Mateeva R; Wang-Gohrke S; Wappenschmidt B; Barjhoux L; Collonge-Rame MA; Elan C; GEMO Study Collaborators ; Golmard L; Barouk-Simonet E; Lesueur F; Mazoyer S; Sokolowska J; StoppaLyonnet D; Isaacs C; Claes KBM; Poppe B; de la Hoya M; Garcia-Barberan V; Aittomäki K; Nevanlinna H, 2017, 'Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers', Journal of the National Cancer Institute, 109,

Journal articles | 2017

Minlikeeva AN; Freudenheim JL; Eng KH; Cannioto RA; Friel G; Szender JB; Segal B; Odunsi K; Mayor P; Diergaarde B; Zsiros E; Kelemen LE; Kobel M; Steed H; Defazio A; Jordan SJ; Fasching PA; Beckmann MW; Risch HA; Rossing MA; Doherty JA; Chang-Claude J; Goodman MT; Dörk T; Edwards R; Modugno F; Ness RB; Matsuo K; Mizuno M; Karlan BY; Goode EL; Kjaer SK; Høgdall E; Schildkraut JM; Terry KL; Cramer DW; Bandera EV; Paddock LE; Kiemeney LA; Massuger LFAG; Sutphen R; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Kupryjanczyk J; Jensen A; Webb PM; Moysich KB, 2017, 'History of comorbidities and survival of ovarian cancer patients, results from the ovarian cancer association consortium', Cancer Epidemiology Biomarkers and Prevention, 26, pp. 1470 - 1473,

Journal articles | 2017

Phelan CM; Kuchenbaecker KB; Tyrer JP; Kar SP; Lawrenson K; Winham SJ; Dennis J; Pirie A; Riggan MJ; Chornokur G; Earp MA; Lyra PC; Lee JM; Coetzee S; Beesley J; McGuffog L; Soucy P; Dicks E; Lee A; Barrowdale D; Lecarpentier J; Leslie G; Aalfs CM; Aben KKH; Adams M; Adlard J; Andrulis IL; Anton-Culver H; Antonenkova N; Aravantinos G; Arnold N; Arun BK; Arver B; Azzollini J; Balmaña J; Banerjee SN; Barjhoux L; Barkardottir RB; Bean Y; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Birrer MJ; Bjorge L; Black A; Blankstein K; Blok MJ; Bodelon C; Bogdanova N; Bojesen A; Bonanni B; Borg Å; Bradbury AR; Brenton JD; Brewer C; Brinton L; Broberg P; Brooks-Wilson A; Bruinsma F; Brunet J; Buecher B; Butzow R; Buys SS; Caldes T; Caligo MA; Campbell I; Cannioto R; Carney ME; Cescon T; Chan SB; Chang-Claude J; Chanock S; Chen XQ; Chiew YE; Chiquette J; Chung WK; Claes KBM; Conner T; Cook LS; Cook J; Cramer DW; Cunningham JM; D'Aloisio AA; Daly MB; Damiola F; Sakaeva DD; Dansonka-Mieszkowska A; Dao F; Davidson R; DeFazio A; Delnatte C; Doheny KF; Diez O; Ding YC; Doherty JA; Domchek SM; Dorfling CM; Dörk T, 2017, 'Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer', Nature Genetics, 49, pp. 680 - 691,

Journal articles | 2017

Præstegaard C; Jensen A; Jensen SM; Nielsen TSS; Webb PM; Nagle CM; DeFazio A; Høgdall E; Rossing MA; Doherty JA; Wicklund KG; Goodman MT; Modugno F; Moysich K; Ness RB; Edwards R; Matsuo K; Hosono S; Goode EL; Winham SJ; Fridley BL; Cramer DW; Terry KL; Schildkraut JM; Berchuck A; Bandera EV; Paddock LE; Massuger LF; Wentzensen N; Pharoah P; Song H; Whittemore A; McGuire V; Sieh W; Rothstein J; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pearce CL; Pike M; Lee AW; Sutphen R; Chang-Claude J; Risch HA; Kjaer SK, 2017, 'Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies', International Journal of Cancer, 140, pp. 2422 - 2435,

Journal articles | 2017

Reid BM; Permuth JB; Ann Chen Y; Teer JK; Monteiro ANA; Chen Z; Tyrer J; Berchuck A; Doherty JA; Goode EL; Iverson ES; Lawrenson K; Pearce CL; Pharoah PD; Phelan CM; Ramus SJ; Rossing MA; Schildkraut JM; Cheng JQ; Gayther SA, 2017, 'Integration of population-level genotype data with functional annotation reveals over-representation of long noncoding RNAs at ovarian cancer susceptibility loci', Cancer Epidemiology Biomarkers and Prevention, 26, pp. 116 - 125,

Journal articles | 2017

Samimi G; Caga-Anan CF; Dean M; Mechanic LE; Minasian LM; Sherman ME; Brody LC; Bernardini MQ; Lheureux S; Shaw PA; Kwon JS; Campbell IG; James PA; Takenaka M; Bowtell DD; Chenevix-Trench G; Friedlander M; Ramus SJ; Couch FJ; De Hullu JA; Harmsen MG; Domchek SM; Drapkin R; Mai PL; Feigelson HS; Gaudet MM; Hurley K; Robson ME; Lacbawan F; Slavin TP; Myers ER; Rezende LF; Swisher EM, 2017, 'Traceback: A proposed framework to increase identification and genetic counseling of BRCA1 and BRCA2 mutation carriers through family-based outreach', Journal of Clinical Oncology, 35, pp. 2329 - 2337,

Journal articles | 2017

Sucheston-Campbell LE; Cannioto R; Clay AI; Etter JL; Eng KH; Liu S; Battaglia S; Hu Q; Brian Szender J; Minlikeeva A; Joseph JM; Mayor P; Abrams SI; Segal BH; Wallace PK; Soh KT; Zsiros E; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Bjorge L; Bruegl A; Campbell IG; Campbell SP; Chenevix-Trench G; Cramer DW; Mieszkowska AD; Dao F; Diergaarde B; Doerk T; Doherty JA; Du Bois A; Eccles D; Engelholm SA; Fasching PA; Gayther SA; Gentry-Maharaj A; Glasspool RM; Goodman MT; Gronwald J; Harter P; Hein A; Heitz F; Hillemmanns P; Høgdall C; Høgdall EVS; Huzarski T; Jensen A; Johnatty SE; Jung A; Karlan BY; Klapdor R; Kluz T; Konopka B; Kjer SK; Kupryjanczyk J; Lambrechts D; Lester J; Lubinski J; Levine DA; Lundvall L; McGuire V; McNeish IA; Menon U; Modugno F; Ness RB; Orsulic S; Paul J; Pearce CL; Pejovic T; Pharoah P; Ramus SJ; Rothstein J; Rossing MA; Rubner M; Schildkraut JM; Schmalfeldt B; Schwaab I; Siddiqui N; Sieh W; Sobiczewski P; Song H; Terry KL; Van Nieuwenhuysen E; Vanderstichele A; Vergote I; Walsh CS; Webb PM; Wentzensen N; Whittemore AS; Wu AH; Ziogas A; Odunsi K; Chang-Claude J; Goode EL; Moysich KB, 2017, 'No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival', Cancer Epidemiology Biomarkers and Prevention, 26, pp. 420 - 424,

Journal articles | 2016

Cuellar-Partida G; Lu Y; Dixon SC; Australian Ovarian Cancer Study ; Fasching PA; Hein A; Burghaus S; Beckmann MW; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Vanderstichele A; Doherty JA; Rossing MA; Chang-Claude J; Rudolph A; Wang-Gohrke S; Goodman MT; Bogdanova N; Dörk T; Dürst M; Hillemanns P; Runnebaum IB; Antonenkova N; Butzow R; Leminen A; Nevanlinna H; Pelttari LM; Edwards RP; Kelley JL; Modugno F; Moysich KB; Ness RB; Cannioto R; Høgdall E; Høgdall C; Jensen A; Giles GG; Bruinsma F; Kjaer SK; Hildebrandt MAT; Liang D; Lu KH; Wu X; Bisogna M; Dao F; Levine DA; Cramer DW; Terry KL; Tworoger SS; Stampfer M; Missmer S; Bjorge L; Salvesen HB; Kopperud RK; Bischof K; Aben KKH; Kiemeney LA; Massuger LFAG; Brooks-Wilson A; Olson SH; McGuire V; Rothstein JH; Sieh W; Whittemore AS; Cook LS; Le ND; Blake Gilks C; Gronwald J; Jakubowska A; Lubiński J; Kluz T; Song H; Tyrer JP; Wentzensen N; Brinton L; Trabert B; Lissowska J; McLaughlin JR; Narod SA; Phelan C; Anton-Culver H; Ziogas A; Eccles D; Campbell I; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Wu AH; Dansonka-Mieszkowska A; Kupryjanczyk J; Timorek A; Szafron L; Cunningham JM; Fridley BL; Winham SJ; Bandera EV; Poole EM; Morgan TK, 2016, 'Assessing the genetic architecture of epithelial ovarian cancer histological subtypes', Human Genetics, 135, pp. 741 - 756,

Journal articles | 2016

Dixon SC; Nagle CM; Thrift AP; Pharoah PDP; Pearce CL; Zheng W; Painter JN; Chenevix-Trench G; Fasching PA; Beckmann MW; Lambrechts D; Vergote I; Lambrechts S; Van Nieuwenhuysen E; Rossing MA; Doherty JA; GWicklund K; Chang-Claude J; Rudolph A; Moysich KB; Odunsi K; Goodman MT; Wilkens LR; Thompson PJ; Shvetsov YB; Dörk T; Park-Simon TW; Hillemanns P; Bogdanova N; Butzow R; Nevanlinna H; Pelttari LM; Leminen A; Modugno F; Ness RB; Edwards RP; Kelley JL; Heitz F; Karlan BY; Kjær SK; Høgdall E; Jensen A; Goode EL; Fridley BL; Cunningham JM; Winham SJ; Giles GG; Bruinsma F; Milne RL; Southey MC; Hildebrandt MAT; Wu X; Lu KH; Liang D; Levine DA; Bisogna M; Schildkraut JM; Berchuck A; Cramer DW; Terry KL; Bandera EV; Olson SH; Salvesen HB; Thomsen LC; Kopperud RK; Bjorge L; Kiemeney LA; Massuger LFAG; Pejovic T; Cook LS; Le ND; Swenerton KD; Brooks-Wilson A; Kelemen LE; Lubiński J; Huzarski T; Gronwald J; Menkiszak J; Wentzensen N; Brinton L; Yang H; Lissowska J; Høgdall CK; Lundvall L; Song H; Tyrer JP; Campbell I; Eccles D; Paul J; Glasspool R; Siddiqui N; Whittemore AS; Sieh W; McGuire V; Rothstein JH; Narod SA; Phelan C; Risch HA; McLaughlin JR; Anton-Culver H, 2016, 'Adult body mass index and risk of ovarian cancer by subtype: A Mendelian randomization study', International Journal of Epidemiology, 45, pp. 884 - 895,

Journal articles | 2016

Hampras SS; Sucheston-Campbell LE; Cannioto R; Chang-Claude J; Modugno F; Dörk T; Hillemanns P; Preus L; Knutson KL; Wallace PK; Hong CC; Friel G; Davis W; Nesline M; Pearce CL; Kelemen LE; Goodman MT; Bandera EV; Terry KL; Schoof N; Eng KH; Clay A; Singh PK; Joseph JM; Aben KKH; Anton-Culver H; Antonenkova N; Baker H; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Cook LS; Cramer DW; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Despierre E; Dicks E; Doherty JA; du Bois A; Dürst M; Easton D; Eccles D; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MAT; Hogdall C; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kellar M; Kelley JL; Kiemeney LA; Klapdor R; Kolomeyevskaya N; Krakstad C; Kjaer SK; Kruszka B; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Liu S; Lu K; Lubinski J; Lundvall L; Massuger LFAG; Matsuo K; McGuire V, 2016, 'Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer', Oncotarget, 7, pp. 69097 - 69110,

Journal articles | 2016

Hollestelle A; Van Der Baan FH; Berchuck A; Johnatty SE; Aben KK; Agnarsson BA; Aittomäki K; Alducci E; Andrulis IL; Anton-Culver H; Antonenkova NN; Antoniou AC; Apicella C; Arndt V; Arnold N; Arun BK; Arver B; Ashworth A; Baglietto L; Balleine R; Bandera EV; Barrowdale D; Bean YT; Beckmann L; Beckmann MW; Benitez J; Berger A; Berger R; Beuselinck B; Bisogna M; Bjorge L; Blomqvist C; Bogdanova NV; Bojesen A; Bojesen SE; Bolla MK; Bonanni B; Brand JS; Brauch H; Brenner H; Brinton L; Brooks-Wilson A; Bruinsma F; Brunet J; Brüning T; Budzilowska A; Bunker CH; Burwinkel B; Butzow R; Buys SS; Caligo MA; Campbell I; Carter J; Chang-Claude J; Chanock SJ; Claes KBM; Collée JM; Cook LS; Couch FJ; Cox A; Cramer D; Cross SS; Cunningham JM; Cybulski C; Czene K; Damiola F; Dansonka-Mieszkowska A; Darabi H; De La Hoya M; Defazio A; Dennis J; Devilee P; Dicks EM; Diez O; Doherty JA; Domchek SM; Dorfling CM; Dörk T; Silva IDS; Du Bois A; Dumont M; Dunning AM; Duran M; Easton DF; Eccles D; Edwards RP; Ehrencrona H; Ejlertsen B; Ekici AB; Ellis SD; Engel C; Eriksson M; Fasching PA; Feliubadalo L; Figueroa J; Flesch-Janys D; Fletcher O; Fontaine A; Fortuzzi S; Fostira F, 2016, 'No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer', Gynecologic Oncology, 141, pp. 386 - 401,

Journal articles | 2016

Jatoi A; Vierkant RA; Hawthorne KM; Block MS; Ramus SJ; Larson NB; Fridley BL; Goode EL, 2016, 'Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer', Oncology (Switzerland), 90, pp. 59 - 68,

Journal articles | 2016

Kar SP; Beesley J; Al Olama AA; Michailidou K; Tyrer J; Kote-Jarai ZA; Lawrenson K; Lindstrom S; Ramus SJ; Thompson DJ; Kibel AS; Dansonka-Mieszkowska A; Michael A; Dieffenbach AK; Gentry-Maharaj A; Whittemore AS; Wolk A; Monteiro A; Peixoto A; Kierzek A; Cox A; Rudolph A; Gonzalez-Neira A; Wu AH; Lindblom A; Swerdlow A; Ziogas A; Ekici AB; Burwinkel B; Karlan BY; Nordestgaard BG; Blomqvist C; Phelan C; McLean C; Pearce CL; Vachon C; Cybulski C; Slavov C; Stegmaier C; Maier C; Ambrosone CB; Hogdall CK; Teerlink CC; Kang D; Tessier DC; Schaid DJ; Stram DO; Cramer DW; Neal DE; Eccles D; Flesch-Janys D; Velez Edwards DR; Wokozorczyk D; Levine DA; Yannoukakos D; Sawyer EJ; Bandera EV; Poole EM; Goode EL; Khusnutdinova E; Hogdall E; Song F; Bruinsma F; Heitz F; Modugno F; Hamdy FC; Wiklund F; Giles GG; Olsson H; Wildiers H; Ulmer HU; Pandha H; Risch HA; Darabi H; Salvesen HB; Nevanlinna H; Gronberg H; Brenner H; Brauch H; Anton-Culver H; Song H; Lim HY; McNeish I; Campbell I; Vergote I; Gronwald J; Lubiński J; Stanford JL; Benitez J; Doherty JA; Permuth JB; Chang-Claude J; Donovan JL; Dennis J; Schildkraut JM; Schleutker J; Hopper JL; Kupryjanczyk J; Park JY; Figueroa J, 2016, 'Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types', Cancer Discovery, 6, pp. 1052 - 1067,

Journal articles | 2016

Karami S; Han Y; Pande M; Cheng I; Rudd J; Pierce BL; Nutter EL; Schumacher FR; Kote-Jarai Z; Lindstrom S; Witte JS; Fang S; Han J; Kraft P; Hunter DJ; Song F; Hung RJ; McKay J; Gruber SB; Chanock SJ; Risch A; Shen H; Haiman CA; Boardman L; Ulrich CM; Casey G; Peters U; Amin Al Olama A; Berchuck A; Berndt SI; Bezieau S; Brennan P; Brenner H; Brinton L; Caporaso N; Chan AT; Chang-Claude J; Christiani DC; Cunningham JM; Easton D; Eeles RA; Eisen T; Gala M; Gallinger SJ; Gayther SA; Goode EL; Grönberg H; Henderson BE; Houlston R; Joshi AD; Küry S; Landi MT; Le Marchand L; Muir K; Newcomb PA; Permuth-Wey J; Pharoah P; Phelan C; Potter JD; Ramus SJ; Risch H; Schildkraut J; Slattery ML; Song H; Wentzensen N; White E; Wiklund F; Zanke BW; Sellers TA; Zheng W; Chatterjee N; Amos CI; Doherty JA, 2016, 'Telomere structure and maintenance gene variants and risk of five cancer types', International Journal of Cancer, 139, pp. 2655 - 2670,

Journal articles | 2016

Köbel M; Rahimi K; Rambau PF; Naugler C; Le Page C; Meunier L; De Ladurantaye M; Lee S; Leung S; Goode EL; Ramus SJ; Carlson JW; Li X; Ewanowich CA; Kelemen LE; Vanderhyden B; Provencher D; Huntsman D; Lee CH; Gilks CB; Mes Masson AM, 2016, 'An Immunohistochemical Algorithm for Ovarian Carcinoma Typing', International Journal of Gynecological Pathology, 35, pp. 430 - 441,

Journal articles | 2016

Lawrenson K; Kar S; McCue K; Kuchenbaeker K; Michailidou K; Tyrer J; Beesley J; Ramus SJ; Li Q; Delgado MK; Lee JM; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Arun BK; Arver B; Bandera EV; Barile M; Barkardottir RB; Barrowdale D; Beckmann MW; Benitez J; Berchuck A; Bisogna M; Bjorge L; Blomqvist C; Blot W; Bogdanova N; Bojesen A; Bojesen SE; Bolla MK; Bonanni B; Børresen-Dale AL; Brauch H; Brennan P; Brenner H; Bruinsma F; Brunet J; Buhari SA; Burwinkel B; Butzow R; Buys SS; Cai Q; Caldes T; Campbell I; Canniotto R; Chang-Claude J; Chiquette J; Choi JY; Claes KBM; Cook LS; Cox A; Cramer DW; Cross SS; Cybulski C; Czene K; Daly MB; Damiola F; Dansonka-Mieszkowska A; Darabi H; Dennis J; Devilee P; Diez O; Doherty JA; Domchek SM; Dorfling CM; Dörk T; Dumont M; Ehrencrona H; Ejlertsen B; Ellis S; Engel C; Lee E; Evans DG; Fasching PA; Feliubadalo L; Figueroa J; Flesch-Janys D; Fletcher O; Flyger H; Foretova L; Fostira F; Foulkes WD; Fridley BL; Friedman E; Frost D; Gambino G; Ganz PA; Garber J; García-Closas M; Gentry-Maharaj A; Ghoussaini M; Giles GG; Glasspool R; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Goode EL, 2016, 'Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus', Nature Communications, 7,

Journal articles | 2016

Lee AW; Bomkamp A; Bandera EV; Jensen A; Ramus SJ; Goodman MT; Rossing MA; Modugno F; Moysich KB; Chang-Claude J; Rudolph A; Gentry-Maharaj A; Terry KL; Gayther SA; Cramer DW; Doherty JA; Schildkraut JM; Kjaer SK; Ness RB; Menon U; Berchuck A; Mukherjee B; Roman L; Pharoah PD; Chenevix-Trench G; Olson S; Hogdall E; Wu AH; Pike MC; Stram DO; Pearce CL, 2016, 'A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer', International Journal of Cancer, 139, pp. 2646 - 2654,

Journal articles | 2016

Lee AW; Ness RB; Roman LD; Terry KL; Schildkraut JM; Chang-Claude J; Doherty JA; Menon U; Cramer DW; Gayther SA; Risch H; Gentry-Maharaj A; Goodman MT; Modugno F; Eilbe U; Moysich KB; Berchuck A; Rossing MA; Jensen A; Wicklund KG; Cushing-Haugen KL; Hogdall E; Rudolph A; Thompson PJ; Wilkens LR; Kjaer SK; Carney ME; Stram DO; Ramus SJ; Wu AH; Pike MC; Pearce CL, 2016, 'Association between menopausal estrogen-only therapy and ovarian carcinoma risk', Obstetrics and Gynecology, 127, pp. 828 - 836,

Journal articles | 2016

Lee AW; Templeman C; Stram DA; Beesley J; Tyrer J; Berchuck A; Pharoah PP; Chenevix-Trench G; Pearce CL; Ness RB; Dansonka-Mieszkowska A; Gentry-Maharaj A; Hein A; Whittemore AS; Jensen A; Du Bois A; Brooks-Wilson A; Rudolph A; Jakubowska A; Wu AH; Ziogas A; Ekici AB; Leminen A; Rosen B; Spiewankiewicz B; Karlan BY; Trabert B; Fridley BL; Gilks CB; Krakstad C; Phelan CM; Cybulski C; Walsh C; Hogdall C; Cramer DW; Huntsman DG; Eccles D; Lambrechts D; Liang D; Levine DA; Iversen ES; Bandera EV; Poole EM; Goode EL; Van Nieuwenhuysen E; Hogdall E; Bruinsma F; Heitz F; Modugno F; Giles GG; Risch HA; Baker H; Salvesen HB; Nevanlinna H; Anton-Culver H; Song H; McNeish I; Campbell IG; Vergote I; Runnebaum IB; Tangen IL; Schwaab I; Gronwald J; Paul J; Lubinski J; Doherty JA; Chang-Claude J; Lester J; Schildkraut JM; McLaughlin JR; Lissowska J; Kupryjanczyk J; Kelley JL; Rothstein JH; Cunningham JM; Lu K; Carty K; Terry KL; Aben KKH; Moysich KB; Wicklund KG; Odunsi K; Kiemeney LA; Sucheston-Campbell L; Lundvall L; Massuger LFAG; Pelttari LM; Kelemen LE; Cook LS; Bjorge L; Nedergaard L; Brinton LA; Wilkens LR; Pike MC; Goodman MT; Bisogna M; Rossing MA; Beckmann MW; Dürst M; Southey MC, 2016, 'Evidence of a genetic link between endometriosis and ovarian cancer', Fertility and Sterility, 105, pp. 35 - 43.e10,

Journal articles | 2016

Meeks HD; Song H; Michailidou K; Bolla MK; Dennis J; Wang Q; Barrowdale D; Frost D; McGuffog L; Ellis S; Feng B; Buys SS; Hopper JL; Southey MC; Tesoriero A; James PA; Bruinsma F; Campbell IG; Broeks A; Schmidt MK; Hogervorst FBL; Beckman MW; Fasching PA; Fletcher O; Johnson N; Sawyer EJ; Riboli E; Banerjee S; Menon U; Tomlinson I; Burwinkel B; Hamann U; Marme F; Rudolph A; Janavicius R; Tihomirova L; Tung N; Garber J; Cramer D; Terry KL; Poole EM; Tworoger SS; Dorfling CM; Van Rensburg EJ; Godwin AK; Guénel P; Truong T; Stoppa-Lyonnet D; Damiola F; Mazoyer S; Sinilnikova OM; Isaacs C; Maugard C; Bojesen SE; Flyger H; Gerdes AM; Hansen TVO; Jensen A; Kjaer SK; Hogdall C; Hogdall E; Pedersen IS; Thomassen M; Benitez J; González-Neira A; Osorio A; Hoya MDL; Segura PP; Diez O; Lazaro C; Brunet J; Anton-Culver H; Eunjung L; John EM; Neuhausen SL; Ding YC; Castillo D; Weitzel JN; Ganz PA; Nussbaum RL; Chan SB; Karlan BY; Lester J; Wu A; Gayther S; Ramus SJ; Sieh W; Whittermore AS; Monteiro ANA; Phelan CM; Terry MB; Piedmonte M; Offit K; Robson M; Levine D; Moysich KB; Cannioto R; Olson SH; Daly MB; Nathanson KL, 2016, 'BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers', Journal of the National Cancer Institute, 108,

Journal articles | 2016

Ong JS; Cuellar-Partida G; Lu Y; Fasching PA; Hein A; Burghaus S; Beckmann MW; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Vanderstichele A; Doherty JA; Rossing MA; Chang-Claude J; Eilber U; Rudolph A; Wang-Gohrke S; Goodman MT; Bogdanova N; Dörk T; Dürst M; Hillemanns P; Runnebaum IB; Antonenkova N; Butzow R; Leminen A; Nevanlinna H; Pelttari LM; Edwards RP; Kelley JL; Modugno F; Moysich KB; Ness RB; Cannioto R; Høgdall E; Høgdall CK; Jensen A; Giles GG; Bruinsma F; Kjaer SK; Hildebrandt MAT; Liang D; Lu KH; Wu X; Bisogna M; Dao F; Levine DA; Cramer DW; Terry KL; Tworoger SS; Stampfer M; Missmer S; Bjorge L; Salvesen HB; Kopperud RK; Bischof K; Aben KKH; Kiemeney LA; Massuger LFAG; Brooks-Wilson A; Olson SH; McGuire V; Rothstein JH; Sieh W; Whittemore AS; Cook LS; Le ND; Blake Gilks C; Gronwald J; Jakubowska A; Lubiński J; Kluz T; Song H; Tyrer JP; Wentzensen N; Brinton L; Trabert B; Lissowska J; McLaughlin JR; Narod SA; Phelan C; Anton-Culver H; Ziogas A; Eccles D; Campbell I; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Wu AH; Dansonka-Mieszkowska A; Kupryjanczyk J; Timorek A; Szafron L; Cunningham JM; Fridley BL; Winham SJ; Bandera EV; Poole EM; Morgan TK, 2016, 'Association of vitamin D levels and risk of ovarian cancer: A Mendelian randomization study', International Journal of Epidemiology, 45, pp. 1619 - 1630,

Journal articles | 2016

Permuth JB; Pirie A; Chen YA; Lin HY; Reid BM; Chen Z; Monteiro A; Dennis J; Mendoza-Fandino G; Anton-Culver H; Bandera EV; Bisogna M; Brinton L; Brooks-Wilson A; Carney ME; Chenevix-Trench G; Cook LS; Cramer DW; Cunningham JM; Cybulski C; D'Aloisio AA; Doherty JA; Earp M; Edwards RP; Fridley BL; Gayther SA; Gentry-Maharaj A; Goodman MT; Gronwald J; Hogdall E; Iversen ES; Jakubowska A; Jensen A; Karlan BY; Kelemen LE; Kjaer SK; Kraft P; Le ND; Levine DA; Lissowska J; Lubinski J; Matsuo K; Menon U; Modugno R; Moysich KB; Nakanishi T; Ness RB; Olson S; Orlow I; Pearce CL; Pejovic T; Poole EM; Ramus SJ; Rossing MA; Sandler DP; Shu XO; Song H; Taylor JA; Teo SH; Terry KL; Thompson PJ; Tworoger SS; Webb PM; Wentzensen N; Wilkens LR; Winham S; Woo YL; Wu AH; Yang H; Zheng W; Ziogas A; Phelan CM; Schildkraut JM; Berchuck A; Goode EL; Pharoah PDP; Sellers TA, 2016, 'Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk', Human Molecular Genetics, 25, pp. 3600 - 3612,

Journal articles | 2016

Permuth JB; Reid B; Earp M; Chen YA; Monteiro ANA; Chen Z; Chenevix-Trench G; Fasching PA; Beckmann MW; Lambrechts D; Vanderstichele A; Van Niewenhuyse E; Vergote I; Rossing MA; Doherty JA; Chang-Claude J; Moysich K; Odunsi K; Goodman MT; Shvetsov YB; Wilkens LR; Thompson PJ; Dörk T; Bogdanova N; Butzow R; Nevanlinna H; Pelttari L; Leminen A; Modugno F; Edwards RP; Ness RB; Kelley J; Heitz F; Karlan B; Lester J; Kjaer SK; Jensen A; Giles G; Hildebrandt M; Liang D; Lu KH; Wu X; Levine DA; Bisogna M; Berchuck A; Cramer DW; Terry KL; Tworoger SS; Poole EM; Bandera EV; Fridley B; Cunningham J; Winham SJ; Olson SH; Orlow I; Bjorge L; Kiemeney LA; Massuger L; Pejovic T; Moffitt M; Le N; Cook LS; Brooks-Wilson A; Kelemen LE; Gronwald J; Lubinski J; Wentzensen N; Brinton LA; Lissowska J; Yang H; Hogdall E; Hogdall C; Lundvall L; Pharoah PDP; Song H; Campbell I; Eccles D; McNeish I; Whittemore A; McGuire V; Sieh W; Rothstein J; Phelan CM; Risch H; Narod S; McLaughlin J; Anton-Culver H; Ziogas A; Menon U; Gayther S; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Kupryjanczyk J; Dansonka-Mieszkowska A; Schildkraut JM; Cheng JQ; Goode EL; Sellers TA, 2016, 'Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: Results from a large-scale collaboration', Oncotarget, 7, pp. 72381 - 72394,

Journal articles | 2016

Pharoah PDP; Song H; Dicks E; Intermaggio MP; Harrington P; Baynes C; Alsop K; Bogdanova N; Cicek MS; Cunningham JM; Fridley BL; Gentry-Maharaj A; Hillemanns P; Lele S; Lester J; McGuire V; Moysich KB; Poblete S; Sieh W; Sucheston-Campbell L; Widschwendter M; Whittemore AS; Dörk T; Menon U; Odunsi K; Goode EL; Karlan BY; Bowtell DD; Gayther SA; Ramus SJ; Wozniak E; Ryan A; Ford J; Balogun N; Mack M; Luccarini C, 2016, 'PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations', Journal of the National Cancer Institute, 108,

Journal articles | 2016

Præstegaard C; Kjaer SK; Nielsen TSS; Jensen SM; Webb PM; Nagle CM; Høgdall E; Risch HA; Rossing MA; Doherty JA; Wicklund KG; Goodman MT; Modugno F; Moysich K; Ness RB; Edwards RP; Goode EL; Winham SJ; Fridley BL; Cramer DW; Terry KL; Schildkraut JM; Berchuck A; Bandera EV; Paddock L; Kiemeney LA; Massuger LF; Wentzensen N; Pharoah P; Song H; Whittemore AS; McGuire V; Sieh W; Rothstein J; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pearce CL; Pike MC; Lee AW; Chang-Claude J; Jensen A, 2016, 'The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies', Cancer Epidemiology, 41, pp. 71 - 79,

Journal articles | 2016

Rebbeck TR; Friebel TM; Mitra N; Wan F; Chen S; Andrulis IL; Apostolou P; Arnold N; Arun BK; Barrowdale D; Benitez J; Berger R; Berthet P; Borg A; Buys SS; Caldes T; Carter J; Chiquette J; Claes KBM; Couch FJ; Cybulski C; Daly MB; de la Hoya M; Diez O; Domchek SM; Nathanson KL; Durda K; Ellis S; Evans DG; Foretova L; Friedman E; Frost D; Ganz PA; Garber J; Glendon G; Godwin AK; Greene MH; Gronwald J; Hahnen E; Hallberg E; Hamann U; Hansen TVO; Imyanitov EN; Isaacs C; Jakubowska A; Janavicius R; Jaworska-Bieniek K; John EM; Karlan BY; Kaufman B; Kwong A; Laitman Y; Lasset C; Lazaro C; Lester J; Loman N; Lubinski J; Manoukian S; Mitchell G; Montagna M; Neuhausen SL; Nevanlinna H; Niederacher D; Nussbaum RL; Offit K; Olah E; Olopade OI; Park SK; Piedmonte M; Radice P; Rappaport-Fuerhauser C; Rookus MA; Seynaeve C; Simard J; Singer CF; Soucy P; Southey M; Stoppa-Lyonnet D; Sukiennicki G; Szabo CI; Tancredi M; Teixeira MR; Teo SH; Terry MB; Thomassen M; Tihomirova L; Tischkowitz M; Toland AE; Toloczko-Grabarek A; Tung N; van Rensburg EJ; Villano D; Wang-Gohrke S; Wappenschmidt B; Weitzel JN; Zidan J; Zorn KK; McGuffog L; Easton D; Chenevix-Trench G, 2016, 'Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women', Breast Cancer Research, 18,

Journal articles | 2016

Silvestri V; Barrowdale D; Mulligan AM; Neuhausen SL; Fox S; Karlan BY; Mitchell G; James P; Thull DL; Zorn KK; Carter NJ; Nathanson KL; Domchek SM; Rebbeck TR; Ramus SJ; Nussbaum RL; Olopade OI; Rantala J; Yoon SY; Caligo MA; Spugnesi L; Bojesen A; Pedersen IS; Thomassen M; Jensen UB; Toland AE; Senter L; Andrulis IL; Glendon G; Hulick PJ; Imyanitov EN; Greene MH; Mai PL; Singer CF; Rappaport-Fuerhauser C; Kramer G; Vijai J; Offit K; Robson M; Lincoln A; Jacobs L; Machackova E; Foretova L; Navratilova M; Vasickova P; Couch FJ; Hallberg E; Ruddy KJ; Sharma P; Kim SW; Teixeira MR; Pinto P; Montagna M; Matricardi L; Arason A; Johannsson OT; Barkardottir RB; Jakubowska A; Lubinski J; Izquierdo A; Pujana MA; Balmaña J; Diez O; Ivady G; Papp J; Olah E; Kwong A; Nevanlinna H; Aittomäki K; Perez Segura P; Caldes T; Van Maerken T; Poppe B; Claes KBM; Isaacs C; Elan C; Lasset C; Stoppa-Lyonnet D; Barjhoux L; Belotti M; Meindl A; Gehrig A; Sutter C; Engel C; Niederacher D; Steinemann D; Hahnen E; Kast K; Arnold N; Varon-Mateeva R; Wand D; Godwin AK; Evans DG; Frost D; Perkins J; Adlard J; Izatt L; Platte R; Eeles R; Ellis S, 2016, 'Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2', Breast Cancer Research, 18, pp. 15,

Journal articles | 2016

Southey MC; Goldgar DE; Winqvist R; Pylkäs K; Couch F; Tischkowitz M; Foulkes WD; Dennis J; Michailidou K; van Rensburg EJ; Heikkinen T; Nevanlinna H; Hopper JL; Dörk T; Claes KBM; Reis-Filho J; Teo ZL; Radice P; Catucci I; Peterlongo P; Tsimiklis H; Odefrey FA; Dowty JG; Schmidt MK; Broeks A; Hogervorst FB; Verhoef S; Carpenter J; Clarke C; Scott RJ; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Peto J; dos-Santos-Silva I; Fletcher O; Johnson N; Bolla MK; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Marme F; Burwinkel B; Yang R; Guénel P; Truong T; Menegaux F; Sanchez M; Bojesen S; Nielsen SF; Flyger H; Benitez J; Zamora MP; Perez JIA; Menéndez P; Anton-Culver H; Neuhausen S; Ziogas A; Clarke CA; Brenner H; Arndt V; Stegmaier C; Brauch H; Brüning T; Ko YD; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova NV; Antonenkova NN; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Spurdle AB; Wauters E; Smeets D; Beuselinck B; Floris G; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Olson JE; Vachon C; Pankratz VS; McLean C; Haiman CA; Henderson BE; Schumacher F; Marchand LL; Kristensen V; Alnæs GG; Zheng W; Hunter DJ; Lindstrom S, 2016, 'PALB2, CHEK2 and ATM rare variants and cancer risk: Data from COGS', Journal of Medical Genetics, 53, pp. 800 - 811,

Journal articles | 2016

Talhouk A; Kommoss S; Mackenzie R; Cheung M; Leung S; Chiu DS; Kalloger SE; Huntsman DG; Chen S; Intermaggio M; Gronwald J; Chan FC; Ramus SJ; Steidl C; Scott DW; Anglesio MS, 2016, 'Single-patient molecular testing with nanostring ncounter data using a reference-based strategy for batch effect correction', PLoS ONE, 11, pp. e0153844,

Journal articles | 2016

Usset JL; Raghavan R; Tyrer JP; McGuire V; Sieh W; Webb P; Chang-Claude J; Rudolph A; Anton-Culver H; Berchuck A; Brinton L; Cunningham JM; DeFazio A; Doherty JA; Edwards RP; Gayther SA; Gentry-Maharaj A; Goodman MT; Høgdall E; Jensen A; Johnatty SE; Kiemeney LA; Kjaer SK; Larson MC; Lurie G; Massuger L; Menon U; Modugno F; Moysich KB; Ness RB; Pike MC; Ramus SJ; Rossing MA; Rothstein J; Song H; Thompson PJ; Van Den Berg DJ; Vierkant RA; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wilkens LR; Wu AH; Yang H; Pearce CL; Schildkraut JM; Pharoah P; Goode EL; Fridley BL, 2016, 'Assessment of multifactor gene?environment interactions and ovarian cancer risk: Candidate genes, obesity, and hormone-related risk factors', Cancer Epidemiology Biomarkers and Prevention, 25, pp. 780 - 790,

Journal articles | 2016

Vigorito E; Kuchenbaecker KB; Beesley J; Adlard J; Agnarsson BA; Andrulis IL; Arun BK; Barjhoux L; Belotti M; Benitez J; Berger A; Bojesen A; Bonanni B; Brewer C; Caldes T; Caligo MA; Campbell I; Chan SB; Claes KBM; Cohn DE; Cook J; Daly MB; Damiola F; Davidson R; de Pauw A; Delnatte C; Diez O; Domchek SM; Dumont M; Durda K; Dworniczak B; Easton DF; Eccles D; Ardnor CE; Eeles R; Ejlertsen B; Ellis S; Evans DG; Feliubadalo L; Fostira F; Foulkes WD; Friedman E; Frost D; Gaddam P; Ganz PA; Garber J; Garcia-Barberan V; Gauthier-Villars M; Gehrig A; Gerdes AM; Giraud S; Godwin AK; Goldgar DE; Hake CR; Hansen TVO; Healey S; Hodgson S; Hogervorst FBL; Houdayer C; Hulick PJ; Imyanitov EN; Isaacs C; Izatt L; Izquierdo A; Jacobs L; Jakubowska A; Janavicius R; Jaworska-Bieniek K; Jensen UB; John EM; Vijai J; Karlan BY; Kast K; Khan S; Kwong A; Laitman Y; Lester J; Lesueur F; Liljegren A; Lubinski J; Mai PL; Manoukian S; Mazoyer S; Meindl A; Mensenkamp AR; Montagna M; Nathanson KL; Neuhausen SL; Nevanlinna H; Niederacher D; Olah E; Olopade OI; Ong KR; Osorio A; Park SK; Paulsson-Karlsson Y; Pedersen IS; Peissel B; Peterlongo P; Pfeiler G, 2016, 'Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers', PLoS ONE, 11, pp. e0158801,

Journal articles | 2016

Winham SJ; Pirie A; Chen YA; Larson MC; Fogarty ZC; Earp MA; Anton-Culver H; Bandera EV; Cramer D; Doherty JA; Goodman MT; Gronwald J; Karlan BY; Kjaer SK; Levine DA; Menon U; Ness RB; Pearce CL; Pejovic T; Rossing MA; Wentzensen N; Bean YT; Bisogna M; Brinton LA; Carney ME; Cunningham JM; Cybulski C; DeFazio A; Dicks EM; Edwards RP; Gayther SA; Gentry-Maharaj A; Gore M; Iversen ES; Jensen A; Johnatty SE; Lester J; Lin HY; Lissowska J; Lubinski J; Menkiszak J; Modugno F; Moysich KB; Orlow I; Pike MC; Ramus SJ; Song H; Terry KL; Thompson PJ; Tyrer JP; Van Den Berg DJ; Vierkant RA; Vitonis AF; Walsh C; Wilkens LR; Wu AH; Yang H; Ziogas A; Berchuck A; Chenevix-Trench G; Schildkraut JM; Permuth-Wey J; Phelan CM; Pharoah PDP; Fridley BL; Sellers TA; Goode EL; Bowtell D; Gertig D; Green A; Webb P; Parsons P; Hayward N; Whiteman D, 2016, 'Investigation of exomic variants associated with overall survival in ovarian cancer', Cancer Epidemiology Biomarkers and Prevention, 25, pp. 446 - 454,

Journal articles | 2016

Zeng C; Guo X; Long J; Kuchenbaecker KB; Droit A; Michailidou K; Ghoussaini M; Kar S; Freeman A; Hopper JL; Milne RL; Bolla MK; Wang Q; Dennis J; Agata S; Ahmed S; Aittomäki K; Andrulis IL; Anton-Culver H; Antonenkova NN; Arason A; Arndt V; Arun BK; Arver B; Bacot F; Barrowdale D; Baynes C; Beeghly-Fadiel A; Benitez J; Bermisheva M; Blomqvist C; Blot WJ; Bogdanova NV; Bojesen SE; Bonanni B; Borresen-Dale AL; Brand JS; Brauch H; Brennan P; Brenner H; Broeks A; Brüning T; Burwinkel B; Buys SS; Cai Q; Caldes T; Campbell I; Carpenter J; Chang-Claude J; Choi JY; Claes KBM; Clarke C; Cox A; Cross SS; Czene K; Daly MB; de la Hoya M; De Leeneer K; Devilee P; Diez O; Domchek SM; Doody M; Dorfling CM; Dörk T; dos-Santos-Silva I; Dumont M; Dwek M; Dworniczak B; Egan K; Eilber U; Einbeigi Z; Ejlertsen B; Ellis S; Frost D; Lalloo F; Fasching PA; Figueroa J; Flyger H; Friedlander M; Friedman E; Gambino G; Gao YT; Garber J; García-Closas M; Gehrig A; Damiola F; Lesueur F; Mazoyer S; Stoppa-Lyonnet D; Giles GG; Godwin AK; Goldgar DE; González-Neira A; Greene MH; Guénel P; Haeberle L; Haiman CA; Hallberg E; Hamann U; Hansen TVO, 2016, 'Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus', Breast Cancer Research, 18,

Journal articles | 2015

, 2015, 'An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers', Breast Cancer Research,

Journal articles | 2015

Amankwah EK; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Chornokur G; Aben KKH; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chen Z; Chen YA; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Jim H; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LFAG; Matsuo K; Mcguire V; Mclaughlin JR; Mcneish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP, 2015, 'Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk', Genetic Epidemiology, 39, pp. 689 - 697,

Journal articles | 2015

Candido-dos-Reis FJ; Song H; Goode EL; Cunningham JM; Fridley BL; Larson MC; Alsop K; Dicks E; Harrington P; Ramus SJ; De Fazio A; Mitchell G; Fereday S; Bolton KL; Gourley C; Michie C; Karlan B; Lester J; Walsh C; Cass I; Olsson H; Gore M; Benitez JJ; Garcia MJ; Andrulis I; Mulligan AM; Glendon G; Blanco I; Lazaro C; Whittemore AS; McGuire V; Sieh W; Montagna M; Alducci E; Sadetzki S; Chetrit A; Kwong A; Kjaer SK; Jensen A; Høgdall E; Neuhausen S; Nussbaum R; Daly M; Greene MH; Mai PL; Moysich K; Toland AE; Lambrechts D; Ellis S; Frost D; Brenton JD; Tischkowitz M; Easton DF; Antoniou A; Chenevix-Trench G; Gayther SA; Bowtell D; Pharoah PDP, 2015, 'Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer', Clinical Cancer Research, 21, pp. 652 - 657,

Journal articles | 2015

Chornokur G; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Amankwah EK; Qu X; Tsai YY; Jim HSL; Chen Z; Chen AY; Permuth-Wey J; Aben KKH; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; Du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kelemen LE; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LFAG; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I, 2015, 'Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk', PLoS ONE, 10, pp. e0128106 - e0128106,

Journal articles | 2015

Coetzee SG; Shen HC; Hazelett DJ; Lawrenson K; Kuchenbaecker K; Tyrer J; Rhie SK; Levanon K; Karst A; Drapkin R; Ramus SJ; Couch FJ; Offit K; Chenevix-Trench G; Monteiro ANA; Antoniou A; Freedman M; Coetzee GA; Pharoah PDP; Noushmehr H; Gayther SA; Anton-Culver H; Antonenkova N; Baker H; Bandera EV; Bean Y; Beckmann MW; Berchuck A; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Chang-Claude J; Chen A; Chen Z; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Dicks E; Doherty JA; Dörk T; Bois AD; Dürst M; Eccles D; Easton DF; Edwards RP; Eilber U; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Grownwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Hogdall E; Hogdall C; Hosono S; Iversen ES; Jakubowska A; James P; Jensen A; Ji BT; Karlan BY; Kjaer SK; Kelemen LE; Kellar M; Kelley JL; Kiemeney LA; Krakstad C; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L, 2015, 'Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci', Human Molecular Genetics, 24, pp. 3595 - 3607,

Journal articles | 2015

Davis SJ; Sheppard KE; Anglesio MS; George J; Traficante N; Fereday S; Intermaggio MP; Menon U; Gentry-Maharaj A; Lubinski J; Gronwald J; Pearce CL; Pike MC; Wu A; Kommoss S; Pfisterer J; Bois AD; Hilpert F; Ramus SJ; Bowtell DDL; Huntsman DG; Pearson RB; Simpson KJ; Campbell IG; Gorringe KL, 2015, 'Enhanced GAB2 expression is associated with improved survival in high-grade serous ovarian cancer and sensitivity to PI3K inhibition', Molecular Cancer Therapeutics, 14, pp. 1495 - 1503,

Journal articles | 2015

Hung RJ; Ulrich CM; Goode EL; Brhane Y; Muir K; Chan AT; Le Marchand L; Schildkraut J; Witte JS; Eeles R; Boffetta P; Spitz MR; Poirier JG; Rider DN; Fridley BL; Chen Z; Haiman C; Schumacher F; Easton DF; Landi MT; Brennan P; Houlston R; Christiani DC; Field JK; Bickeboeller H; Risch A; Kote-Jarai Z; Wiklund F; Gronberg H; Chanock S; Berndt SI; Kraft P; Lindstrom S; Al Olama AA; Song H; Phelan C; Wentzensen N; Peters U; Slattery ML; Sellers TA; Casey G; Gruber SB; Hunter DJ; Amos CI; Henderson B, 2015, 'Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer', JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 107,

Journal articles | 2015

Jim HSL; Lin H-Y; Tyrer JP; Lawrenson K; Dennis J; Chornokur G; Chen Z; Chen AY; Permuth-Wey J; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Sieh W; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao Y-T; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji B-T; Karlan BY; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Vierkant RA; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LFAG; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Thomsen L; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Palmieri Weber R; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Schernhammer E; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schwaab I; Shu X-O; Shvetsov YB; Siddiqui N; Song H; Southey MC; Spiewankiewicz B; Sucheston-Campbell L; Teo S-H; Terry KL; Thompson PJ; Tangen IL; Tworoger SS; van Altena AM; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo Y-L; Yang H; Zheng W; Ziogas A; Amankwah E; Berchuck A; Georgia Chenevix-Trench on behalf of the AOCS management group 95,96 ; Schildkraut JM; Kelemen LE; Ramus SJ; Monteiro ANA; Goode EL; Narod SA; Gayther SA; Pharoah PDP; Sellers TA; Phelan CM, 2015, 'Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).', J Genet Genome Res, 2,

Journal articles | 2015

Johnatty SE; Tyrer JP; Kar S; Beesley J; Lu Y; Gao B; Fasching PA; Hein A; Ekici AB; Beckmann MW; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Lambrechts S; Rossing MA; Doherty JA; Chang-Claude J; Modugno F; Ness RB; Moysich KB; Levine DA; Kiemeney LA; Massuger LFAG; Gronwald J; Lubiński J; Jakubowska A; Cybulski C; Brinton L; Lissowska J; Wentzensen N; Song H; Rhenius V; Campbell I; Eccles D; Sieh W; Whittemore AS; McGuire V; Rothstein JH; Sutphen R; Anton-Culver H; Ziogas A; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Pearce CL; Pike MC; Stram DO; Wu AH; Kupryjanczyk J; Dansonka-Mieszkowska A; Rzepecka IK; Spiewankiewicz B; Goodman MT; Wilkens LR; Carney ME; Thompson PJ; Heitz F; Du Bois A; Schwaab I; Harter P; Pisterer J; Hillemanns P; Karlan BY; Walsh C; Lester J; Orsulic S; Winham SJ; Earp M; Larson MC; Fogarty ZC; Høgdall E; Jensen A; Kjaer SK; Fridley BL; Cunningham JM; Vierkant RA; Schildkraut JM; Iversen ES; Terry KL; Cramer DW; Bandera EV; Orlow I; Pejovic T; Bean Y; Høgdall C; Lundvall L; McNeish I; Paul J; Carty K; Siddiqui N; Glasspool R; Sellers T; Kennedy C; Chiew YE; Berchuck A; MacGregor S; Pharoah PDP; Goode EL; DeFazio A, 2015, 'Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium', Clinical Cancer Research, 21, pp. 5264 - 5276,

Journal articles | 2015

Kar SP; Tyrer JP; Li Q; Lawrenson K; Aben KKH; Anton-Culver H; Antonenkova N; Chenevix-Trench G; Baker H; Bandera EV; Bean YT; Beckmann MW; Berchuck A; Bisogna M; Bjørge L; Bogdanova N; Brinton L; Brooks-Wilson A; Butzow R; Campbell I; Carty K; Chang-Claude J; Chen YA; Chen Z; Cook LS; Cramer D; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Dicks E; Doherty JA; Dörk T; Du Bois A; Dürst M; Eccles D; Easton DF; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Grownwald J; Harrington P; Harter P; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Hogdall E; Hogdall CK; Hosono S; Iversen ES; Jakubowska A; Paul J; Jensen A; Ji BT; Karlan BY; Kjaer SK; Kelemen LE; Kellar M; Kelley J; Kiemeney LA; Krakstad C; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger L; Matsuo K; McGuire V; McLaughlin JR; McNeish IA; Menon U; Modugno F; Moysich KB; Narod SA; Nedergaard L; Ness RB; Nevanlinna H; Kunleodunsi ; Olson SH; Orlow I; Orsulic S; Weber RP, 2015, 'Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk', Cancer Epidemiology Biomarkers and Prevention, 24, pp. 1574 - 1584,

Journal articles | 2015

Kelemen LE; Lawrenson K; Tyrer J; Li Q; Lee JM; Seo JH; Phelan CM; Beesley J; Chen X; Spindler TJ; Aben KKH; Anton-Culver H; Antonenkova N; Baker H; Bandera EV; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Chang-Claude J; Chen YA; Chen Z; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Dicks E; Doherty JA; Dörk T; Bois AD; Dürst M; Eccles D; Easton DT; Edwards RP; Eilber U; Ekici AB; Engelholm SA; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Grownwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Hogdall E; Hogdall C; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kellar M; Kelley JL; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LFAG; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Modugno F; Moes-Sosnowska J; Moysich KB; Narod SA; Nedergaard L, 2015, 'Genome-wide significant risk associations for mucinous ovarian carcinoma', Nature Genetics, 47, pp. 888 - 897,

Journal articles | 2015

Kuchenbaecker KB; Ramus SJ; Tyrer J; Lee A; Shen HC; Beesley J; Lawrenson K; McGuffog L; Healey S; Lee JM; Spindler TJ; Lin YG; Pejovic T; Bean Y; Li Q; Coetzee S; Hazelett D; Miron A; Southey M; Terry MB; Goldgar DE; Buys SS; Janavicius R; Dorfling CM; Van Rensburg EJ; Neuhausen SL; Ding YC; Hansen TVO; Jønson L; Gerdes AM; Ejlertsen B; Barrowdale D; Dennis J; Benitez J; Osorio A; Garcia MJ; Komenaka I; Weitzel JN; Ganschow P; Peterlongo P; Bernard L; Viel A; Bonanni B; Peissel B; Manoukian S; Radice P; Papi L; Ottini L; Fostira F; Konstantopoulou I; Garber J; Frost D; Perkins J; Platte R; Ellis S; Godwin AK; Schmutzler RK; Meindl A; Engel C; Sutter C; Sinilnikova OM; Damiola F; Mazoyer S; Stoppa-Lyonnet D; Claes K; De Leeneer K; Kirk J; Rodriguez GC; Piedmonte M; O'Malley DM; De La Hoya M; Caldes T; Aittomäki K; Nevanlinna H; Margriet JC; Rookus MA; Oosterwijk JC; Tihomirova L; Tung N; Hamann U; Isaccs C; Tischkowitz M; Imyanitov EN; Caligo MA; Campbell IG; Hogervorst FBL; Olah E; Diez O; Blanco I; Brunet J; Lazaro C; Pujana MA; Jakubowska A; Gronwald J; Lubinski J; Sukiennicki G; Barkardottir RB; Plante M; Simard J; Soucy P, 2015, 'Identification of six new susceptibility loci for invasive epithelial ovarian cancer', Nature Genetics, 47, pp. 164 - 171,

Journal articles | 2015

Lawrenson K; Iversen ES; Tyrer J; Weber RP; Concannon P; Hazelett DJ; Li Q; Marks JR; Berchuck A; Lee JM; Aben KKH; Anton-Culver H; Antonenkova N; Bandera EV; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Chang-Claude J; Chenevix-Trench G; Chen A; Chen Z; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Plisiecka-Halasa J; Dennis J; Dicks E; Doherty JA; Dörk T; du Bois A; Eccles D; Easton DT; Edwards RP; Eilber U; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Gronwald J; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Hogdall E; Hogdall C; Hosono S; Jakubowska A; Paul J; Jensen A; Karlan BY; Kjaer SK; Kelemen LE; Kellar M; Kelley JL; Kiemeney LA; Krakstad C; Lambrechts D; Lambrechts S; Le ND; Lee AW; Cannioto R; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LFAG; Matsuo K; McGuire V; McLaughlin JR; Nevanlinna H; McNeish I; Menon U; Modugno F; Moysich KB; Narod SA; Nedergaard L; Ness RB; Noor Azmi MA; Odunsi K; Olson SH, 2015, 'Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer', Carcinogenesis, 36, pp. 1341 - 1353,

Journal articles | 2015

Lawrenson K; Li Q; Kar S; Seo JH; Tyrer J; Spindler TJ; Lee J; Chen Y; Karst A; Drapkin R; Aben KKH; Anton-Culver H; Antonenkova N; Baker H; Bandera EV; Bean Y; Beckmann MW; Berchuck A; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Chang-Claude J; Chenevix-Trench G; Chen A; Chen Z; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Dicks E; Doherty JA; Dörk T; Du Bois A; Dürst M; Eccles D; Easton DT; Edwards RP; Eilber U; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Grownwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Hogdall E; Hogdall C; Hosono S; Iversen ES; Jakubowska A; James P; Jensen A; Ji BT; Karlan BY; Kjaer SK; Kelemen LE; Kellar M; Kelley JL; Kiemeney LA; Krakstad C; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LFAG; Matsuo K; McGuire V; McLaughlin JR; Nevanlinna H; McNeish I; Menon U; Modugno F, 2015, 'Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer', Nature Communications, 6,

Journal articles | 2015

Lee AW; Tyrer JP; Doherty JA; Stram DA; Kupryjanczyk J; Dansonka-Mieszkowska A; Plisiecka-Halasa J; Spiewankiewicz B; Myers EJ; Chenevix-Trench G; Fasching PA; Beckmann MW; Ekici AB; Hein A; Vergote I; Van Nieuwenhuysen E; Lambrechts D; Wicklund KG; Eilber U; Wang-Gohrke S; Chang-Claude J; Rudolph A; Sucheston-Campbell L; Odunsi K; Moysich KB; Shvetsov YB; Thompson PJ; Goodman MT; Wilkens LR; Dörk T; Hillemanns P; Dürst M; Runnebaum IB; Bogdanova N; Pelttari LM; Nevanlinna H; Leminen A; Edwards RP; Kelley JL; Harter P; Schwaab I; Heitz F; Du Bois A; Orsulic S; Lester J; Walsh C; Karlan BY; Hogdall E; Kjaer SK; Jensen A; Vierkant RA; Cunningham JM; Goode EL; Fridley BL; Southey MC; Giles GG; Bruinsma F; Wu X; Hildebrandt MAT; Lu K; Liang D; Bisogna M; Levine DA; Weber RP; Schildkraut JM; Iversen ES; Berchuck A; Terry KL; Cramer DW; Tworoger SS; Poole EM; Olson SH; Orlow I; Bandera EV; Bjorge L; Tangen IL; Salvesen HB; Krakstad C; Massuger LFAG; Kiemeney LA; Aben KKH; Van Altena AM; Bean Y; Pejovic T; Kellar M; Le ND; Cook LS; Kelemen LE; Brooks-Wilson A; Lubinski J; Gronwald J; Cybulski C; Jakubowska A; Wentzensen N; Brinton LA; Lissowska J; Yang H; Nedergaard L; Lundvall L; Hogdall C, 2015, 'Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study', Gynecologic Oncology, 136, pp. 542 - 548,

Journal articles | 2015

Leong HS; Galletta L; Etemadmoghadam D; George J; Köbel M; Ramus SJ; Bowtell D, 2015, 'Efficient molecular subtype classification of high-grade serous ovarian cancer', Journal of Pathology, 236, pp. 272 - 277,

Journal articles | 2015

Lu Y; Cuellar-Partida G; Painter JN; Nyholt DR; Morris AP; Fasching PA; Hein A; Burghaus S; Beckmann MW; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Vanderstichele A; Doherty JA; Rossing MA; Wicklund KG; Chang-Claude J; Eilber U; Rudolph A; Wang-Gohrke S; Goodman MT; Bogdanova N; Dörk T; Dürst M; Hillemanns P; Runnebaum IB; Antonenkova N; Butzow R; Leminen A; Nevanlinna H; Pelttari LM; Edwards RP; Kelley JL; Modugno F; Moysich KB; Ness RB; Cannioto R; Høgdall E; Jensen A; Giles GG; Bruinsma F; Kjaer SK; Hildebrandt MAT; Liang D; Lu KH; Wu X; Bisogna M; Dao F; Levine DA; Cramer DW; Terry KL; Tworoger SS; Missmer S; Bjorge L; Salvesen HB; Kopperud RK; Bischof K; Aben KKH; Kiemeney LA; Massuger LFAG; Brooks-Wilson A; Olson SH; McGuire V; Rothstein JH; Sieh W; Whittemore AS; Cook LS; Le ND; BlakeGilks C; Gronwald J; Jakubowska A; Lubiński J; Gawełko J; Song H; Tyrer JP; Wentzensen N; Brinton L; Trabert B; Lissowska J; Mclaughlin JR; Narod SA; Phelan C; Anton-Culver H; Ziogas A; Eccles D; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Wu AH; Dansonka-Mieszkowska A; Kupryjanczyk J; Timorek A; Szafron L; Cunningham JM; Fridley BL; Winham SJ; Bandera EV; Poole EM; Morgan TK, 2015, 'Shared genetics underlying epidemiological association between endometriosis and ovarian cancer', Human Molecular Genetics, 24, pp. 5955 - 5964,

Journal articles | 2015

Ramus SJ; Song H; Dicks E; Tyrer JP; Rosenthal AN; Intermaggio MP; Fraser L; Gentry-Maharaj A; Hayward J; Philpott S; Anderson C; Edlund CK; Conti D; Harrington P; Barrowdale D; Bowtell DD; Alsop K; Mitchell G; Cicek MS; Cunningham JM; Fridley BL; Alsop J; Jimenez-Linan M; Poblete S; Lele S; Sucheston-Campbell L; Moysich KB; Sieh W; McGuire V; Lester J; Bogdanova N; Dürst M; Hillemanns P; Odunsi K; Whittemore AS; Karlan BY; Dörk T; Goode EL; Menon U; Jacobs IJ; Antoniou AC; Pharoah PDP; Gayther SA, 2015, 'Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer', Journal of the National Cancer Institute, 107,

Journal articles | 2015

Song H; Dicks E; Ramus SJ; Tyrer JP; Intermaggio MP; Hayward J; Edlund CK; Conti D; Harrington P; Fraser L; Philpott S; Anderson C; Rosenthal A; Gentry-Maharaj A; Bowtell DD; Alsop K; Cicek MS; Cunningham JM; Fridley BL; Alsop J; Jimenez-Linan M; Høgdall E; Høgdall CK; Jensen A; Kjaer SK; Lubiński J; Huzarski T; Jakubowska A; Gronwald J; Poblete S; Lele S; Sucheston-Campbell L; Moysich KB; Odunsi K; Goode EL; Menon U; Jacobs IJ; Gayther SA; Pharoah PDP, 2015, 'Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population', Journal of Clinical Oncology, 33, pp. 2901 - 2907,

Journal articles | 2014

Block MS; Charbonneau B; Vierkant RA; Fogarty Z; Bamlet WR; Pharoah PDP; Chenevix-Trench G; Rossing MA; Cramer D; Pearce CL; Schildkraut J; Menon U; Kjaer SK; Levine DA; Gronwald J; Culver HA; Whittemore AS; Karlan BY; Lambrechts D; Wentzensen N; Kupryjanczyk J; Chang-Claude J; Bandera EV; Hogdall E; Heitz F; Kaye SB; Fasching PA; Campbell I; Goodman MT; Pejovic T; Bean YT; Hays LE; Lurie G; Eccles D; Hein A; Beckmann MW; Ekici AB; Paul J; Brown R; Flanagan JM; Harter P; Du Bois A; Schwaab I; Hogdall CK; Lundvall L; Olson SH; Orlow I; Paddock LE; Rudolph A; Eilber U; Dansonka-Mieszkowska A; Rzepecka IK; Ziolkowska-Seta I; Brinton LA; Yang H; Garcia-Closas M; Despierre E; Lambrechts S; Vergote I; Walsh CS; Lester J; Sieh W; McGuire V; Rothstein JH; Ziogas A; Lubinski J; Cybulski C; Menkiszak J; Jensen A; Gayther SA; Ramus SJ; Gentry-Maharaj A; Berchuck A; Wu AH; Pike MC; Van Den Berg D; Terry KL; Vitonis AF; Ramirez SM; Rider DN; Knutson KL; Sellers TA; Phelan CM; Doherty JA; Johnatty SE; De Fazio A; Song H; Tyrer J; Kalli KR; Fridley BL; Cunningham JM; Goode EL, 2014, 'Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer', Cancer Epidemiology Biomarkers and Prevention, 23, pp. 1421 - 1427,

Journal articles | 2014

Charbonneau B; Block MS; Bamlet WR; Vierkant RA; Kalli KR; Fogarty Z; Rider DN; Sellers TA; Tworoger SS; Poole E; Risch HA; Salvesen HB; Kiemeney LA; Baglietto L; Giles GG; Severi G; Trabert B; Wentzensen N; Chenevix-Trench G; Whittemore AS; Sieh W; Chang-Claude J; Bandera EV; Orlow I; Terry K; Goodman MT; Thompson PJ; Cook LS; Rossing MA; Ness RB; Narod SA; Kupryjanczyk J; Lu K; Butzow R; Dork T; Pejovic T; Campbell I; Le ND; Bunker CH; Bogdanova N; Runnebaum IB; Eccles D; Paul J; Wu AH; Gayther SA; Hogdall E; Heitz F; Kaye SB; Karlan BY; Anton-Culver H; Gronwald J; Hogdall CK; Lambrechts D; Fasching PA; Menon U; Schildkraut J; Pearce CL; Levine DA; Kjaer SK; Cramer D; Flanagan JM; Phelan CM; Brown R; Massuger LFAG; Song H; Doherty JA; Krakstad C; Liang D; Odunsi K; Berchuck A; Jensen A; Lubinski J; Nevanlinna H; Bean YT; Lurie G; Ziogas A; Walsh C; Despierre E; Brinton L; Hein A; Rudolph A; Dansonka-Mieszkowska A; Olson SH; Harter P; Tyrer J; Vitonis AF; Brooks-Wilson A; Aben KK; Pike MC; Ramus SJ; Wik E; Cybulski C; Lin J; Sucheston L; Edwards R; McGuire V; Lester J; Du Bois A; Lundvall L; Wang-Gohrke S, 2014, 'Risk of ovarian cancer and the NF-kB pathway: Genetic association with IL1A and TNFSF10', Cancer Research, 74, pp. 852 - 861,

Journal articles | 2014

Charbonneau B; Moysich KB; Kalli KR; Oberg AL; Vierkant RA; Fogarty ZC; Block MS; Maurer MJ; Goergen KM; Fridley BL; Cunningham JM; Rider DN; Preston C; Hartmann LC; Lawrenson K; Wang C; Tyrer J; Song H; De Fazio A; Johnatty SE; Doherty JA; Phelan CM; Sellers TA; Ramirez SM; Vitonis AF; Terry KL; Van Den Berg D; Pike MC; Wu AH; Berchuck A; Gentry-Maharaj A; Ramus SJ; Diergaarde B; Shen H; Jensen A; Menkiszak J; Cybulski C; Lubinski J; Ziogas A; Rothstein JH; McGuire V; Sieh W; Lester J; Walsh C; Vergote I; Lambrechts S; Despierre E; Garcia-Closas M; Yang H; Brinton LA; Spiewankiewicz B; Rzepecka IK; Dansonka-Mieszkowska A; Seibold P; Rudolph A; Paddock LE; Orlow I; Lundvall L; Olson SH; Hogdall CK; Schwaab I; Du Bois A; Harter P; Flanagan JM; Brown R; Paul J; Ekici AB; Beckmann MW; Hein A; Eccles D; Lurie G; Hays LE; Bean YT; Pejovic T; Goodman MT; Campbell I; Fasching PA; Konecny G; Kaye SB; Heitz F; Hogdall E; Bandera EV; Chang-Claude J; Kupryjanczyk J; Wentzensen N; Lambrechts D; Karlan BY; Whittemore AS; Culver HA; Gronwald J; Levine DA; Kjaer SK; Menon U; Schildkraut JM; Pearce CL; Cramer DW; Rossing MA; Chenevix-Trench G; Pharoah PDP; Gayther SA, 2014, 'Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome', Cancer Immunology Research, 2, pp. 332 - 340,

Journal articles | 2014

Earp MA; Kelemen LE; Magliocco AM; Swenerton KD; Chenevix-Trench G; Lu Y; Hein A; Ekici AB; Beckmann MW; Fasching PA; Lambrechts D; Despierre E; Vergote I; Lambrechts S; Doherty JA; Rossing MA; Chang-Claude J; Rudolph A; Friel G; Moysich KB; Odunsi K; Sucheston-Campbell L; Lurie G; Goodman MT; Carney ME; Thompson PJ; Runnebaum IB; Dürst M; Hillemanns P; Dörk T; Antonenkova N; Bogdanova N; Leminen A; Nevanlinna H; Pelttari LM; Butzow R; Bunker CH; Modugno F; Edwards RP; Ness RB; Du Bois A; Heitz F; Schwaab I; Harter P; Karlan BY; Walsh C; Lester J; Jensen A; Kjær SK; Høgdall CK; Høgdall E; Lundvall L; Sellers TA; Fridley BL; Goode EL; Cunningham JM; Vierkant RA; Giles GG; Baglietto L; Severi G; Southey MC; Liang D; Wu X; Lu K; Hildebrandt MAT; Levine DA; Bisogna M; Schildkraut JM; Iversen ES; Weber RP; Berchuck A; Cramer DW; Terry KL; Poole EM; Tworoger SS; Bandera EV; Chandran U; Orlow I; Olson SH; Wik E; Salvesen HB; Bjorge L; Halle MK; Van Altena AM; Aben KKH; Kiemeney LA; Massuger LFAG; Pejovic T; Bean YT; Cybulski C; Gronwald J; Lubinski J; Wentzensen N; Brinton LA; Lissowska J; Garcia-Closas M; Dicks E; Dennis J; Easton DF; Song H, 2014, 'Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA', Human Genetics, 133, pp. 481 - 497,

Journal articles | 2014

Kelemen LE; Terry KL; Goodman MT; Webb PM; Bandera EV; McGuire V; Anne Rossing M; Wang Q; Dicks E; Tyrer JP; Song H; Kupryjanczyk J; Dansonka-Mieszkowska A; Plisiecka-Halasa J; Timorek A; Menon U; Gentry-Maharaj A; Gayther SA; Ramus SJ; Narod SA; Risch HA; McLaughlin JR; Siddiqui N; Glasspool R; Paul J; Carty K; Gronwald J; Lubiński J; Jakubowska A; Cybulski C; Kiemeney LA; Massuger LFAG; van Altena AM; Aben KKH; Olson SH; Orlow I; Cramer DW; Levine DA; Bisogna M; Giles GG; Southey MC; Bruinsma F; Kjær SK; Høgdall E; Jensen A; Høgdall CK; Lundvall L; Engelholm SA; Heitz F; du Bois A; Harter P; Schwaab I; Butzow R; Nevanlinna H; Pelttari LM; Leminen A; Thompson PJ; Lurie G; Wilkens LR; Lambrechts D; Van Nieuwenhuysen E; Lambrechts S; Vergote I; Beesley J; Fasching PA; Beckmann MW; Hein A; Ekici AB; Doherty JA; Wu AH; Pearce CL; Pike MC; Stram D; Chang-Claude J; Rudolph A; Dörk T; Dürst M; Hillemanns P; Runnebaum IB; Bogdanova N; Antonenkova N; Odunsi K; Edwards RP; Kelley JL; Modugno F; Ness RB; Karlan BY; Walsh C; Lester J; Orsulic S; Fridley BL; Vierkant RA; Cunningham JM; Wu X; Lu K; Liang D; Hildebrandt MAT; Palmieri Weber R; Iversen ES, 2014, 'Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk', Molecular Nutrition and Food Research, 58, pp. 2023 - 2035,

Journal articles | 2014

Kuchenbaecker KB; Neuhausen SL; Robson M; Barrowdale D; McGuffog L; Mulligan AM; Andrulis IL; Spurdle AB; Schmidt MK; Schmutzler RK; Engel C; Wappenschmidt B; Nevanlinna H; Thomassen M; Southey M; Radice P; Ramus SJ; Domchek SM; Nathanson KL; Lee A; Healey S; Nussbaum RL; Rebbeck TR; Arun BK; James P; Karlan BY; Lester J; Cass I; Terry MB; Daly MB; Goldgar DE; Buys SS; Janavicius R; Tihomirova L; Tung N; Dorfling CM; van Rensburg EJ; Steele L; v O Hansen T; Ejlertsen B; Gerdes AM; Nielsen FC; Dennis J; Cunningham J; Hart S; Slager S; Osorio A; Benitez J; Duran M; Weitzel JN; Tafur I; Hander M; Peterlongo P; Manoukian S; Peissel B; Roversi G; Scuvera G; Bonanni B; Mariani P; Volorio S; Dolcetti R; Varesco L; Papi L; Tibiletti MG; Giannini G; Fostira F; Konstantopoulou I; Garber J; Hamann U; Donaldson A; Brewer C; Foo C; Evans DG; Frost D; Eccles D; Douglas F; Brady A; Cook J; Tischkowitz M; Adlard J; Barwell J; Ong KR; Walker L; Izatt L; Side LE; Kennedy MJ; Rogers MT; Porteous ME; Morrison PJ; Platte R; Eeles R; Davidson R; Hodgson S; Ellis S; Godwin AK; Rhiem K; Meindl A; Ditsch N; Arnold N; Plendl H, 2014, 'Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers', Breast Cancer Research, 16,

Journal articles | 2014

Köbel M; Madore J; Ramus SJ; Clarke BA; Pharoah PDP; Deen S; Bowtell DD; Odunsi K; Menon U; Morrison C; Lele S; Bshara W; Sucheston L; Beckmann MW; Hein A; Thiel FC; Hartmann A; Wachter DL; Anglesio MS; Høgdall E; Jensen A; Høgdall C; Kalli KR; Fridley BL; Keeney GL; Fogarty ZC; Vierkant RA; Liu S; Cho S; Nelson G; Ghatage P; Gentry-Maharaj A; Gayther SA; Benjamin E; Widschwendter M; Intermaggio MP; Rosen B; Bernardini MQ; MacKay H; Oza A; Shaw P; Jimenez-Linan M; Driver KE; Alsop J; MacK M; Koziak JM; Steed H; Ewanowich C; Defazio A; Chenevix-Trench G; Fereday S; Gao B; Johnatty SE; George J; Galletta L; Goode EL; Kjær SK; Huntsman DG; Fasching PA; Moysich KB; Brenton JD; Kelemen LE, 2014, 'Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: Implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study', British Journal of Cancer, 111, pp. 2297 - 2307,

Journal articles | 2014

Lu Y; Ek WE; Whiteman D; Vaughan TL; Spurdle AB; Easton DF; Pharoah PD; Thompson DJ; Dunning AM; Hayward NK; Chenevix-Trench G; Macgregor S, 2014, 'Most common 'sporadic' cancers have a significant germline genetic component', Human Molecular Genetics, 23, pp. 6112 - 6118,

Journal articles | 2014

Song H; Cicek MS; Dicks E; Harrington P; Ramus SJ; Cunningham JM; Fridley BL; Tyrer JP; Alsop J; Jimenez-Linan M; Gayther SA; Goode EL; Pharoah PDP, 2014, 'The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population', Human Molecular Genetics, 23, pp. 4703 - 4709,

Journal articles | 2014

Trabert B; Ness RB; Lo-Ciganic WH; Murphy MA; Goode EL; Poole EM; Brinton LA; Webb PM; Nagle CM; Jordan SJ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Lurie G; Kjær SK; Hogdall E; Jensen A; Cramer DW; Terry KL; Vitonis A; Bandera EV; Olson S; King MG; Chandran U; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pearce CL; Pike MC; Berchuck A; Schildkraut JM; Wentzensen N, 2014, 'Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: A pooled analysis in the ovarian cancer association consortium', Journal of the National Cancer Institute, 106,

Journal articles | 2013

Bojesen SE; Pooley KA; Johnatty SE; Beesley J; Michailidou K; Tyrer JP; Edwards SL; Pickett HA; Shen HC; Smart CE; Hillman KM; Mai PL; Lawrenson K; Stutz MD; Lu Y; Karevan R; Woods N; Johnston RL; French JD; Chen X; Weischer M; Nielsen SF; Maranian MJ; Ghoussaini M; Ahmed S; Baynes C; Bolla MK; Wang Q; Dennis J; McGuffog L; Barrowdale D; Lee A; Healey S; Lush M; Tessier DC; Vincent D; Bacot F; Vergote I; Lambrechts S; Despierre E; Risch HA; González-Neira A; Rossing MA; Pita G; Doherty JA; Álvarez N; Larson MC; Fridley BL; Schoof N; Chang-Claude J; Cicek MS; Peto J; Kalli KR; Broeks A; Armasu SM; Schmidt MK; Braaf LM; Winterhoff B; Nevanlinna H; Konecny GE; Lambrechts D; Rogmann L; Guénel P; Teoman A; Milne RL; Garcia JJ; Cox A; Shridhar V; Burwinkel B; Marme F; Hein R; Sawyer EJ; Haiman CA; Wang-Gohrke S; Andrulis IL; Moysich KB; Hopper JL; Odunsi K; Lindblom A; Giles GG; Brenner H; Simard J; Lurie G; Fasching PA; Carney ME; Radice P; Wilkens LR; Swerdlow A; Goodman MT; Brauch H; Garcia-Closas M; Hillemanns P; Winqvist R; Dürst M; Devilee P; Runnebaum I; Jakubowska A; Lubinski J; Mannermaa A; Butzow R, 2013, 'Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer', Nature Genetics, 45, pp. 371 - 384,

Journal articles | 2013

Couch FJ; Wang X; McGuffog L; Lee A; Olswold C; Kuchenbaecker KB; Soucy P; Fredericksen Z; Barrowdale D; Dennis J; Gaudet MM; Dicks E; Kosel M; Healey S; Sinilnikova OM; Lee A; Bacot F; Vincent D; Hogervorst FBL; Peock S; Stoppa-Lyonnet D; Jakubowska A; Radice P; Schmutzler RK; Domchek SM; Piedmonte M; Singer CF; Friedman E; Thomassen M; Hansen TVO; Neuhausen SL; Szabo CI; Blanco I; Greene MH; Karlan BY; Garber J; Phelan CM; Weitzel JN; Montagna M; Olah E; Andrulis IL; Godwin AK; Yannoukakos D; Goldgar DE; Caldes T; Nevanlinna H; Osorio A; Terry MB; Daly MB; van Rensburg EJ; Hamann U; Ramus SJ; Ewart Toland A; Caligo MA; Olopade OI; Tung N; Claes K; Beattie MS; Southey MC; Imyanitov EN; Tischkowitz M; Janavicius R; John EM; Kwong A; Diez O; Balmaña J; Barkardottir RB; Arun BK; Rennert G; Teo SH; Ganz PA; Campbell I; van der Hout AH; van Deurzen CHM; Seynaeve C; Gómez Garcia EB; van Leeuwen FE; Meijers-Heijboer HEJ; Gille JJP; Ausems MGEM; Blok MJ; Ligtenberg MJL; Rookus MA; Devilee P; Verhoef S; van Os TAM; Wijnen JT; Frost D; Ellis S; Fineberg E; Platte R; Evans DG; Izatt L; Eeles RA; Adlard J; Eccles DM; Cook J; Brewer C; Douglas F; Hodgson S, 2013, 'Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk', PLoS Genetics, 9,

Journal articles | 2013

Faber MT; Kjær SK; Dehlendorff C; Chang-Claude J; Andersen KK; Høgdall E; Webb PM; Jordan SJ; Rossing MA; Doherty JA; Lurie G; Thompson PJ; Carney ME; Goodman MT; Ness RB; Modugno F; Edwards RP; Bunker CH; Goode EL; Fridley BL; Vierkant RA; Larson MC; Schildkraut J; Cramer DW; Terry KL; Vitonis AF; Bandera EV; Olson SH; King M; Chandran U; Kiemeney LA; Massuger LFAG; Van Altena AM; Vermeulen SH; Brinton L; Wentzensen N; Lissowska J; Yang HP; Moysich KB; Odunsi K; Kasza K; Odunsi-Akanji O; Song H; Pharaoh P; Shah M; Whittemore AS; McGuire V; Sieh W; Sutphen R; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Pike MC; Risch HA; Jensen A, 2013, 'Cigarette smoking and risk of ovarian cancer: A pooled analysis of 21 case-control studies', Cancer Causes and Control, 24, pp. 989 - 1004,

Journal articles | 2013

Goode EL; DeRycke M; Kalli KR; Oberg AL; Cunningham JM; Maurer MJ; Fridley BL; Armasu SM; Serie DJ; Ramar P; Goergen K; Vierkant RA; Rider DN; Sicotte H; Wang C; Winterhoff B; Phelan CM; Schildkraut JM; Weber RP; Iversen E; Berchuck A; Sutphen R; Birrer MJ; Hampras S; Preus L; Gayther SA; Ramus SJ; Wentzensen N; Yang HP; Garcia-Closas M; Song H; Tyrer J; Pharoah PPD; Konecny G; Sellers TA; Ness RB; Sucheston LE; Odunsi K; Hartmann LC; Moysich KB; Knutson KL, 2013, 'Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer', PLoS ONE, 8, pp. e53903,

Journal articles | 2013

Köbel M; Kalloger SE; Lee S; Duggan MA; Kelemen LE; Prentice L; Kalli KR; Fridley BL; Visscher DW; Keeney GL; Vierkant RA; Cunningham JM; Chow C; Ness RB; Moysich K; Edwards R; Modugno F; Bunker C; Wozniak EL; Benjamin E; Gayther SA; Gentry-Maharaj A; Menon U; Gilks CB; Huntsman DG; Ramus SJ; Goode EL, 2013, 'Biomarker-based ovarian carcinoma typing: A histologic investigation in the ovarian tumor tissue analysis consortium', Cancer Epidemiology Biomarkers and Prevention, 22, pp. 1677 - 1686,

Journal articles | 2013

Olsen CM; Nagle CM; Whiteman DC; Ness R; Pearce CL; Pike MC; Rossing MA; Terry KL; Wu AH; Group S; Risch HA; Yu H; Doherty JA; Chang-Claude J; Hein R; Nickels S; Wang-Gohrke S; Goodman MT; Carney ME; Matsuno RK; Lurie G; Moysich K; Kjaer SK; Jensen A; Hogdall E; Goode EL; Fridley BL; Vierkant RA; Larson MC; Schildkraut J; Hoyo C; Moorman P; Weber RP; Cramer DW; Vitonis AF; Bandera EV; Olson SH; Rodriguez-Rodriguez L; King M; Brinton LA; Yang H; Garcia-Closas M; Lissowska J; Anton-Culver H; Ziogas A; Gayther SA; Ramus SJ; Menon U; Gentry-Maharaj A; Webb PM, 2013, 'Obesity and risk of ovarian cancer subtypes: Evidence from the Ovarian Cancer Association Consortium', Endocrine-Related Cancer, 20, pp. 251 - 262,

Journal articles | 2013

Pearce CL; Rossing MA; Lee AW; Ness RB; Webb PM; Chenevix-Trench G; Jordan SM; Stram DA; Chang-Claude J; Hein R; Nickels S; Lurie G; Thompson PJ; Carney ME; Goodman MT; Moysich K; Hogdall E; Jensen A; Goode EL; Fridley BL; Cunningham JM; Vierkant RA; Weber RP; Ziogas A; Anton-Culver H; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Brinton L; Wentzensen N; Lissowska J; Garcia-Closas M; Massuger LFAG; Kiemeney LALM; Van Altena AM; Aben KKH; Berchuck A; Doherty JA; Iversen E; Mcguire V; Moorman PG; Pharoah P; Pike MC; Risch H; Sieh W; Stram DO; Terry KL; Whittemore A; Wu AH; Schildkraut JM; Kjaer SK, 2013, 'Combined and interactive effects of environmental and gwas-identified risk factors in ovarian cancer', Cancer Epidemiology Biomarkers and Prevention, 22, pp. 880 - 890,

Journal articles | 2013

Permuth-Wey J; Lawrenson K; Shen HC; Velkova A; Tyrer JP; Chen Z; Lin HY; Ann Chen Y; Tsai YY; Qu X; Ramus SJ; Karevan R; Lee J; Lee N; Larson MC; Aben KK; Anton-Culver H; Antonenkova N; Antoniou AC; Armasu SM; Bacot F; Baglietto L; Bandera EV; Barnholtz-Sloan J; Beckmann MW; Birrer MJ; Bloom G; Bogdanova N; Brinton LA; Brooks-Wilson A; Brown R; Butzow R; Cai Q; Campbell I; Chang-Claude J; Chanock S; Chenevix-Trench G; Cheng JQ; Cicek MS; Coetzee GA; Cook LS; Couch FJ; Cramer DW; Cunningham JM; Dansonka-Mieszkowska A; Despierre E; Doherty JA; Dörk T; Du Bois A; Dürst M; Easton DF; Eccles D; Edwards R; Ekici AB; Fasching PA; Fenstermacher DA; Flanagan JM; Garcia-Closas M; Gentry-Maharaj A; Giles GG; Glasspool RM; Gonzalez-Bosquet J; Goodman MT; Gore M; Górski B; Gronwald J; Hall P; Halle MK; Harter P; Heitz F; Hillemanns P; Hoatlin M; Høgdall CK; Høgdall E; Hosono S; Jakubowska A; Jensen A; Jim H; Kalli KR; Karlan BY; Kaye SB; Kelemen LE; Kiemeney LA; Kikkawa F; Konecny GE; Krakstad C; Krüger Kjaer S; Kupryjanczyk J; Lambrechts D; Lambrechts S; Lancaster JM; Le ND; Leminen A; Levine DA; Liang D; Kiong Lim B; Lin J; Lissowska J; Lu KH; Lubiński J, 2013, 'Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31', Nature Communications, 4,

Journal articles | 2013

Pharoah PDP; Tsai YY; Ramus SJ; Phelan CM; Goode EL; Lawrenson K; Buckley M; Fridley BL; Tyrer JP; Shen H; Weber R; Karevan R; Larson MC; Song H; Tessier DC; Bacot F; Vincent D; Cunningham JM; Dennis J; Dicks E; Aben KK; Anton-Culver H; Antonenkova N; Armasu SM; Baglietto L; Bandera EV; Beckmann MW; Birrer MJ; Bloom G; Bogdanova N; Brenton JD; Brinton LA; Brooks-Wilson A; Brown R; Butzow R; Campbell I; Carney ME; Carvalho RS; Chang-Claude J; Chen YA; Chen Z; Chow WH; Cicek MS; Coetzee G; Cook LS; Cramer DW; Cybulski C; Dansonka-Mieszkowska A; Despierre E; Doherty JA; Dörk T; Du Bois A; Dürst M; Eccles D; Edwards R; Ekici AB; Fasching PA; Fenstermacher D; Flanagan J; Gao YT; Garcia-Closas M; Gentry-Maharaj A; Giles G; Gjyshi A; Gore M; Gronwald J; Guo Q; Halle MK; Harter P; Hein A; Heitz F; Hillemanns P; Hoatlin M; Høgdall E; Høgdall CK; Hosono S; Jakubowska A; Jensen A; Kalli KR; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Konecny GE; Krakstad C; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee N; Lee J; Leminen A; Lim BK; Lissowska J; Lubiński J; Lundvall L; Lurie G; Massuger LFAG; Matsuo K; McGuire V, 2013, 'GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer', Nature Genetics, 45, pp. 362 - 370,

Journal articles | 2013

Shen H; Fridley BL; Song H; Lawrenson K; Cunningham JM; Ramus SJ; Cicek MS; Tyrer J; Stram D; Larson MC; Köbel M; Ziogas A; Zheng W; Yang HP; Wu AH; Wozniak EL; Ling Woo Y; Winterhoff B; Wik E; Whittemore AS; Wentzensen N; Palmieri Weber R; Vitonis AF; Vincent D; Vierkant RA; Vergote I; Van Den Berg D; Van Altena AM; Tworoger SS; Thompson PJ; Tessier DC; Terry KL; Teo SH; Templeman C; Stram DO; Southey MC; Sieh W; Siddiqui N; Shvetsov YB; Shu XO; Shridhar V; Wang-Gohrke S; Severi G; Schwaab I; Salvesen HB; Rzepecka IK; Runnebaum IB; Anne Rossing M; Rodriguez-Rodriguez L; Risch HA; Renner SP; Poole EM; Pike MC; Phelan CM; Pelttari LM; Pejovic T; Paul J; Orlow I; Zawiah Omar S; Olson SH; Odunsi K; Nickels S; Nevanlinna H; Ness RB; Narod SA; Nakanishi T; Moysich KB; Monteiro ANA; Moes-Sosnowska J; Modugno F; Menon U; McLaughlin JR; McGuire V; Matsuo K; Mat Adenan NA; Massuger LFAG; Lurie G; Lundvall L; Lubiński J; Lissowska J; Levine DA; Leminen A; Lee AW; Le ND; Lambrechts S; Lambrechts D; Kupryjanczyk J; Krakstad C; Konecny GE; Krüger Kjaer S; Kiemeney LA; Kelemen LE; Keeney GL; Karlan BY; Karevan R; Kalli KR; Kajiyama H; Ji BT; Jensen A; Jakubowska A, 2013, 'Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer', Nature Communications, 4,

Journal articles | 2013

Sieh W; Köbel M; Longacre TA; Bowtell DD; deFazio A; Goodman MT; Høgdall E; Deen S; Wentzensen N; Moysich KB; Brenton JD; Clarke BA; Menon U; Gilks CB; Kim A; Madore J; Fereday S; George J; Galletta L; Lurie G; Wilkens LR; Carney ME; Thompson PJ; Matsuno RK; Kjær SK; Jensen A; Høgdall C; Kalli KR; Fridley BL; Keeney GL; Vierkant RA; Cunningham JM; Brinton LA; Yang HP; Sherman ME; García-Closas M; Lissowska J; Odunsi K; Morrison C; Lele S; Bshara W; Sucheston L; Jimenez-Linan M; Driver K; Alsop J; Mack M; McGuire V; Rothstein JH; Rosen BP; Bernardini MQ; Mackay H; Oza A; Wozniak EL; Benjamin E; Gentry-Maharaj A; Gayther SA; Tinker AV; Prentice LM; Chow C; Anglesio MS; Johnatty SE; Chenevix-Trench G; Whittemore AS; Pharoah PDP; Goode EL; Huntsman DG; Ramus SJ, 2013, 'Hormone-receptor expression and ovarian cancer survival: An Ovarian Tumor Tissue Analysis consortium study', The Lancet Oncology, 14, pp. 853 - 862,

Journal articles | 2013

Southey MC; Park DJ; Nguyen-Dumont T; Campbell I; Thompson E; Trainer AH; Chenevix-Trench G; Simard J; Dumont M; Soucy P; Thomassen M; Jønson L; Pedersen IS; Hansen TVO; Nevanlinna H; Khan S; Sinilnikova O; Mazoyer S; Lesueur F; Damiola F; Schmutzler R; Meindl A; Hahnen E; Dufault MR; Chris Chan TL; Kwong A; Barkardóttir R; Radice P; Peterlongo P; Devilee P; Hilbers F; Benitez J; Kvist A; Törngren T; Easton D; Hunter D; Lindstrom S; Kraft P; Zheng W; Gao YT; Long J; Ramus S; Feng BJ; Weitzel JN; Nathanson K; Offit K; Joseph V; Robson M; Schrader K; Wang SM; Kim YC; Lynch H; Snyder C; Tavtigian S; Neuhausen S; Couch FJ; Goldgar DE, 2013, 'COMPLEXO: Identifying the missing heritability of breast cancer via next generation collaboration', Breast Cancer Research, 15,

Journal articles | 2013

White KL; Vierkant RA; Fogarty ZC; Charbonneau B; Block MS; Pharoah PDP; Chenevix-Trench G; Rossing MA; Cramer DW; Pearce CL; Schildkraut JM; Menon U; Kjaer SK; Levine DA; Gronwald J; Culver HA; Whittemore AS; Karlan BY; Lambrechts D; Wentzensen N; Kupryjanczyk J; Chang-Claude J; Bandera EV; Hogdall E; Heitz F; Kaye SB; Fasching PA; Campbell I; Goodman MT; Pejovic T; Bean Y; Lurie G; Eccles D; Hein A; Beckmann MW; Ekici AB; Paul J; Brown R; Flanagan JM; Harter P; Du Bois A; Schwaab I; Hogdall CK; Lundvall L; Olson SH; Orlow I; Paddock LE; Rudolph A; Eilber U; Dansonka-Mieszkowska A; Rzepecka IK; Ziolkowska-Seta I; Brinton L; Yang H; Garcia-Closas M; Despierre E; Lambrechts S; Vergote I; Walsh C; Lester J; Sieh W; McGuire V; Rothstein JH; Ziogas A; Lubiński J; Cybulski C; Menkiszak J; Jensen A; Gayther SA; Ramus SJ; Gentry-Maharaj A; Berchuck A; Wu AH; Pike MC; Van DenBerg D; Terry KL; Vitonis AF; Doherty JA; Johnatty SE; DeFazio A; Song H; Tyrer J; Sellers TA; Phelan CM; Kalli KR; Cunningham JM; Fridley BL; Goode EL, 2013, 'Analysis of over 10,000 cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome', Cancer Epidemiology Biomarkers and Prevention, 22, pp. 987 - 992,

Journal articles | 2013

Widschwendter M; Rosenthal AN; Philpott S; Rizzuto I; Fraser L; Hayward J; Intermaggio MP; Edlund CK; Ramus SJ; Gayther SA; Dubeau L; Fourkala EO; Zaikin A; Menon U; Jacobs IJ, 2013, 'The sex hormone system in carriers of BRCA1/2 mutations: A case-control study', The Lancet Oncology, 14, pp. 1226 - 1232,

Journal articles | 2012

Bolton KL; Chenevix-Trench G; Goh C; Sadetzki S; Ramus SJ; Karlan BY; Lambrechts D; Despierre E; Barrowdale D; McGuffog L; Healey S; Easton DF; Sinilnikova O; Benítez J; García MJ; Neuhausen S; Gail MH; Hartge P; Peock S; Frost D; Evans DG; Eeles R; Godwin AK; Daly MB; Kwong A; Ma ESK; Lázaro C; Blanco I; Montagna M; D'Andrea E; Nicoletto MO; Johnatty SE; Kjær SK; Jensen A; Høgdall E; Goode EL; Fridley BL; Loud JT; Greene MH; Mai PL; Chetrit A; Lubin F; Hirsh-Yechezkel G; Glendon G; Andrulis IL; Toland AE; Senter L; Gore ME; Gourley C; Michie CO; Song H; Tyrer J; Whittemore AS; McGuire V; Sieh W; Kristoffersson U; Olsson H; Borg A; Levine DA; Steele L; Beattie MS; Chan S; Nussbaum RL; Moysich KB; Gross J; Cass I; Walsh C; Li AJ; Leuchter R; Gordon O; Garcia-Closas M; Gayther SA; Chanock SJ; Antoniou AC; Pharoah PDP, 2012, 'Association between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer', JAMA, 307, pp. 382 - 390,

Journal articles | 2012

Couch FJ; Gaudet MM; Antoniou AC; Ramus SJ; Kuchenbaecker KB; Soucy P; Beesley J; Chen X; Wang X; Kirchhoff T; McGuffog L; Barrowdale D; Lee A; Healey S; Sinilnikova OM; Andrulis IL; Ozcelik H; Mulligan AM; Thomassen M; Gerdes AM; Jensen UB; Skytte AB; Kruse TA; Caligo MA; Von Wachenfeldt A; Barbany-Bustinza G; Loman N; Soller M; Ehrencrona H; Karlsson P; Nathanson K; Rebbeck TR; Domchek SM; Jakubowska A; Lubinski J; Jaworska K; Durda K; Zołwocka E; Huzarski T; Byrski T; Gronwald J; Cybulski C; Goŕski B; Osorio A; Durań M; Tejada MI; Benitez J; Hamann U; Hogervorst FBL; Van Os TA; Van Leeuwen FE; Meijers-Heijboer HEJ; Wijnen J; Blok MJ; Kets M; Hooning MJ; Oldenburg RA; Ausems MGEM; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Jacobs C; Eeles RA; Adlard J; Davidson R; Eccles DM; Cole T; Cook J; Paterson J; Brewer C; Douglas F; Hodgson SV; Morrison PJ; Walker L; Porteous ME; Kennedy MJ; Side LE; Bove B; Godwin AK; Stoppa-Lyonnet D; Fassy-Colcombet M; Castera L; Cornelis F; Mazoyer S; Leóne M; Boutry-Kryza N; Bressac-de Paillerets B; Caron O; Pujol P; Coupier I; Delnatte C; Akloul L; Lynch HT; Snyder CL; Buys SS; Daly MB; Terry MB, 2012, 'Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers', Cancer Epidemiology Biomarkers and Prevention, 21, pp. 645 - 657,

Journal articles | 2012

Ding YC; McGuffog L; Healey S; Friedman E; Laitman Y; Shimon SP; Kaufman B; Liljegren A; Lindblom A; Olsson H; Kristoffersson U; Stenmark-Askmalm M; Melin B; Domchek SM; Nathanson KL; Rebbeck TR; Jakubowska A; Lubinski J; Jaworska K; Durda K; Gronwald J; Huzarski T; Cybulski C; Byrski T; Osorio A; Cajal TR; Stavropoulou AV; Benítez J; Hamann U; Rookus M; Aalfs CM; De Lange JL; Meijers-Heijboer HEJ; Oosterwijk JC; Van Asperen CJ; Gómez García EB; Hoogerbrugge N; Jager A; Van Der Luijt RB; Easton DF; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Lalloo F; Izatt L; Eeles R; Adlard J; Davidson R; Eccles D; Cole T; Cook J; Brewer C; Tischkowitz M; Godwin AK; Pathak H; Stoppa-Lyonnet D; Sinilnikova OM; Mazoyer S; Barjhoux L; Léoné M; Gauthier-Villars M; Caux-Moncoutier V; De Pauw A; Hardouin A; Berthet P; Dreyfus H; Ferrer SF; Collonge-Rame MA; Sokolowska J; Buys S; Daly M; Miron A; Terry MB; Chung W; John EM; Southey M; Goldgar D; Singer CF; Tea MKM; Gschwantler-Kaulich D; Fink-Retter A; Hansen TVO; Ejlertsen B; Johannsson OT; Offi K; Sarrel K; Gaudet MM; Vijai J; Robson M; Piedmonte MR; Andrews L; Cohn D; DeMars LR; DiSilvestro P; Rodriguez G; Toland AE; Montagna M, 2012, 'A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers', Cancer Epidemiology Biomarkers and Prevention, 21, pp. 1362 - 1370,

Journal articles | 2012

Fridley BL; Jenkins GD; Tsai YY; Song H; Bolton KL; Fenstermacher D; Tyrer J; Ramus SJ; Cunningham JM; Vierkant RA; Chen Z; Chen YA; Iversen E; Menon U; Gentry-Maharaj A; Schildkraut J; Sutphen R; Gayther SA; Hartmann LC; Pharoah PDP; Sellers TA; Goode EL, 2012, 'Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes', Cancer Epidemiology Biomarkers and Prevention, 21, pp. 529 - 536,

Journal articles | 2012

Hopper JL; Jenkins MA; Dowty JG; Dite GS; Apicella C; Keogh L; Win AK; Young JP; Buchanan D; Walsh MD; Rosty C; Baglietto L; Severi G; Phillips KA; Wong EM; Dobrovic A; Waring P; Winship I; Ramus SJ; Giles GG; Southey MC, 2012, 'Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers', Pathology, 44, pp. 89 - 98,

Journal articles | 2012

Lu Y; Chen X; Beesley J; Johnatty SE; Defazio A; Lambrechts S; Lambrechts D; Despierre E; Vergotes I; Chang-Claude J; Hein R; Nickels S; Wang-Gohrke S; Dörk T; Dürst M; Antonenkova N; Bogdanova N; Goodman MT; Lurie G; Wilkens LR; Carney ME; Butzow R; Nevanlinna H; Heikkinen T; Leminen A; Kiemeney LA; Massuger LFAG; Van Altena AM; Aben KK; Kjaer SK; Hogdall E; Jensen A; Brooks-Wilson A; Le N; Cook L; Earp M; Kelemen L; Easton D; Pharoah P; Song H; Tyrer J; Ramus S; Menon U; Gentry-Maharaj A; Gayther SA; Bandera EV; Olson SH; Orlow I; Rodriguez-Rodriguez L; Macgregor S; Chenevix-Trench G, 2012, 'Genome-wide association study for ovarian cancer susceptibility using pooled DNA', Twin Research and Human Genetics, 15, pp. 615 - 623,

Journal articles | 2012

Mavaddat N; Barrowdale D; Andrulis IL; Domchek SM; Eccles D; Nevanlinna H; Ramus SJ; Spurdle A; Robson M; Sherman M; Mulligan AM; Couch FJ; Engel C; McGuffog L; Healey S; Sinilnikova OM; Southey MC; Terry MB; Goldgar D; O'Malley F; John EM; Janavicius R; Tihomirova L; Hansen TVO; Nielsen FC; Osorio A; Stavropoulou A; Benítez J; Manoukian S; Peissel B; Barile M; Volorio S; Pasini B; Dolcetti R; Putignano AL; Ottini L; Radice P; Hamann U; Rashid MU; Hogervorst FB; Kriege M; Van Der Luijt RB; Peock S; Frost D; Evans DG; Brewer C; Walker L; Rogers MT; Side LE; Houghton C; Weaver JE; Godwin AK; Schmutzler RK; Wappenschmidt B; Meindl A; Kast K; Arnold N; Niederacher D; Sutter C; Deissler H; Gadzicki D; Preisler-Adams S; Varon-Mateeva R; Schönbuchner I; Gevensleben H; Stoppa-Lyonnet D; Belotti M; Barjhoux L; Isaacs C; Peshkin BN; Caldes T; De Al Hoya M; Cañadas C; Heikkinen T; Heikkilä P; Aittomäki K; Blanco I; Lazaro C; Brunet J; Agnarsson BA; Arason A; Barkardottir RB; Dumont M; Simard J; Montagna M; Agata S; D'Andrea E; Yan M; Fox S; Rebbeck TR; Rubinstein W; Tung N; Garber JE; Wang X; Fredericksen Z; Pankratz VS; Lindor NM; Szabo C; Offit K; Sakr R, 2012, 'Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA)', Cancer Epidemiology Biomarkers and Prevention, 21, pp. 134 - 147,

Journal articles | 2012

Pearce CL; Templeman C; Rossing MA; Lee A; Near AM; Webb PM; Nagle CM; Doherty JA; Cushing-Haugen KL; Wicklund KG; Chang-Claude J; Hein R; Lurie G; Wilkens LR; Carney ME; Goodman MT; Moysich K; Kjaer SK; Hogdall E; Jensen A; Goode EL; Fridley BL; Larson MC; Schildkraut JM; Palmieri RT; Cramer DW; Terry KL; Vitonis AF; Titus LJ; Ziogas A; Brewster W; Anton-Culver H; Gentry-Maharaj A; Ramus SJ; Anderson AR; Brueggmann D; Fasching PA; Gayther SA; Huntsman DG; Menon U; Ness RB; Pike MC; Risch H; Wu AH; Berchuck A, 2012, 'Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies', The Lancet Oncology, 13, pp. 385 - 394,

Journal articles | 2012

Poole EM; Gates MA; High BA; Chanock SJ; Cramer DW; Cunningham JM; Fridley BL; Gayther SA; Goode EL; Iversen ES; Lissowska J; Weber RTP; Pharoah PDP; Phelan CM; Ramus SJ; Schildkraut JM; Sutphen R; Tsai YY; Tyrer J; Vierkant RA; Wentzensen N; Yang HP; Terry KL; Tworoger SS, 2012, 'ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium', Cancer Causes and Control, 23, pp. 1805 - 1810,

Journal articles | 2012

Ramus SJ; Antoniou AC; Kuchenbaecker KB; Soucy P; Beesley J; Chen X; McGuffog L; Sinilnikova OM; Healey S; Barrowdale D; Lee A; Thomassen M; Gerdes AM; Kruse TA; Jensen UB; Skytte AB; Caligo MA; Liljegren A; Lindblom A; Olsson H; Kristoffersson U; Stenmark-Askmalm M; Melin B; Domchek SM; Nathanson KL; Rebbeck TR; Jakubowska A; Lubinski J; Jaworska K; Durda K; Złowocka E; Gronwald J; Huzarski T; Byrski T; Cybulski C; Toloczko-Grabarek A; Osorio A; Benitez J; Duran M; Tejada MI; Hamann U; Rookus M; van Leeuwen FE; Aalfs CM; Meijers-Heijboer HEJ; van Asperen CJ; van Roozendaal KEP; Hoogerbrugge N; Collée JM; Kriege M; van der Luijt RB; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Lalloo F; Jacobs C; Eeles R; Adlard J; Davidson R; Eccles D; Cole T; Cook J; Paterson J; Douglas F; Brewer C; Hodgson S; Morrison PJ; Walker L; Porteous ME; Kennedy MJ; Pathak H; Godwin AK; Stoppa-Lyonnet D; Caux-Moncoutier V; de Pauw A; Gauthier-Villars M; Mazoyer S; Léoné M; Calender A; Lasset C; Bonadona V; Hardouin A; Berthet P; Bignon YJ; Uhrhammer N; Faivre L; Loustalot C; Buys S; Daly M; Miron A; Terry MB; Chung WK; John EM; Southey M; Goldgar D; Singer CF; Tea MK, 2012, 'Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers', Human Mutation, 33, pp. 690 - 702,

Journal articles | 2012

Vachon CM; Scott CG; Fasching PA; Hall P; Tamimi RM; Li J; Stone J; Apicella C; Odefrey F; Gierach GL; Jud SM; Heusinger K; Beckmann MW; Pollan M; Fernańdez-Navarro P; Gonzalez-Neira A; Benitez J; Van Gils CH; Lokate M; Onland-Moret NC; Peeters PHM; Brown J; Leyland J; Varghese JS; Easton DF; Thompson DJ; Luben RN; Warren RML; Wareham NJ; Loos RJF; Khaw KT; Ursin G; Lee E; Gayther SA; Ramus SJ; Eeles RA; Leach MO; Kwan-Lim G; Couch FJ; Giles GG; Baglietto L; Krishnan K; Southey MC; Le Marchand L; Kolonel LN; Woolcott C; Maskarinec G; Haiman CA; Walker K; Johnson N; McCormack VA; Biong M; Alnaes GIG; Gram IT; Kristensen VN; Brøresen-Dale AL; Lindstrom̈ S; Hankinson SE; Hunter DJ; Andrulis IL; Knight JA; Boyd NF; Figuero JD; Lissowska J; Wesolowska E; Peplonska B; Bukowska A; Reszka E; Liu JJ; Eriksson L; Czene K; Audley T; Wu AH; Pankratz VS; Hopper JL; Dos-Santos-Silva I, 2012, 'Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk', Cancer Epidemiology Biomarkers and Prevention, 21, pp. 1156 - 1166,

Journal articles | 2012

White KL; Schildkraut JM; Palmieri RT; Iversen ES; Berchuck A; Vierkant RA; Rider DN; Charbonneau B; Cicek MS; Sutphen R; Birrer MJ; Pharoah PPD; Song H; Tyrer J; Gayther SA; Ramus SJ; Wentzensen N; Yang HP; Garcia-Closas M; Phelan CM; Cunningham JM; Fridley BL; Sellers TA; Goode EL, 2012, 'Ovarian cancer risk associated with inherited inflammation- related variants', Cancer Research, 72, pp. 1064 - 1069,

Journal articles | 2011

Amankwah EK; Kelemen LE; Wang Q; Song H; Chenevix-Trench G; Beesley J; Webb PM; Pearce CL; Wu AH; Pike MC; Stram DO; Chang-Claude J; Wang-Gohrke S; Ness RB; Goode EL; Cunningham JM; Fridley BL; Vierkant RA; Tworoger SS; Whittemore AS; McGuire V; Sieh W; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Rossing MA; Doherty JA; Goodman MT; Carney ME; Lurie G; Wilkens LR; Kjær SK; Høgdall E; Cramer DW; Terry KL; Garcia-Closas M; Yang H; Lissowska J; Anton-Culver H; Ziogas A; Schildkraut JM; Berchuck A; Pharoah PDP, 2011, 'Prostate cancer susceptibility polymorphism rs2660753 s not associated with invasive ovarian cancer', Cancer Epidemiology Biomarkers and Prevention, 20, pp. 1028 - 1031,

Journal articles | 2011

Amankwah EK; Wang Q; Schildkraut JM; Tsai YY; Ramus SJ; Fridley BL; Beesley J; Johnatty SE; Webb PM; Chenevix-Trench G; Australian Ovarian Cancer Study Group ; Dale LC; Lambrechts D; Amant F; Despierre E; Vergote I; Gayther SA; Gentry-Maharaj A; Menon U; Chang-Claude J; Wang-Gohrke S; Anton-Culver H; Ziogas A; Dörk T; Dürst M; Antonenkova N; Bogdanova N; Brown R; Flanagan JM; Kaye SB; Paul J; Bützow R; Nevanlinna H; Campbell I; Eccles DM; Karlan BY; Gross J; Walsh C; Pharoah PDP; Song H; Kjær S; Høgdall E; Høgdall C; Lundvall L; Nedergaard L; Kiemeney LALM; Massuger LFAG; van Altena AM; Vermeulen SHHM; Le ND; Brooks-Wilson A; Cook LS; Phelan CM; Cunningham JM; Vachon CM; Vierkant RA; Iversen ES; Berchuck A; Goode EL; Sellers TA; Kelemen LE, 2011, 'Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: A report from the ovarian cancer association consortium', PLoS ONE, 6,

Journal articles | 2011

Balogun N; Gentry-Maharaj A; Wozniak EL; Lim A; Ryan A; Ramus SJ; Ford J; Burnell M; Widschwendter M; Gessler SF; Gayther SA; Jacobs IJ; Menon U, 2011, 'Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study', Journal of Clinical Epidemiology, 64, pp. 525 - 530,

Journal articles | 2011

Batra J; Nagle CM; O'Mara T; Higgins M; Dong Y; Tan OL; Lose F; Skeie LM; Srinivasan S; Bolton KL; Song H; Ramus SJ; Gayther SA; Pharoah PDP; Kedda MA; Spurdle AB; Clements JA, 2011, 'A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival', BMC Cancer, 11,

Journal articles | 2011

Beesley J; Pickett HA; Johnatty SE; Dunning AM; Chen X; Li J; Michailidou K; Lu Y; Rider DN; Palmieri RT; Stutz MD; Lambrechts D; Despierre E; Lambrechts S; Vergote I; Chang-Claude J; Nickels S; Vrieling A; Flesch-Janys D; Wang-Gohrke S; Eilber U; Bogdanova N; Antonenkova N; Runnebaum IB; Dörk T; Goodman MT; Lurie G; Wilkens LR; Matsuno RK; Kiemeney LA; Aben KKH; Marees T; Massuger LFAG; Fridley BL; Vierkant RA; Bandera EV; Olson SH; Orlow I; Rodriguez-Rodriguez L; Cook LS; Le ND; Brooks-Wilson A; Kelemen LE; Campbell I; Gayther SA; Ramus SJ; Gentry-Maharaj A; Menon U; Ahmed S; Baynes C; Pharoah PD; Muir K; Lophatananon A; Chaiwerawattana A; Wiangnon S; Macgregor S; Easton DF; Reddel RR; Goode EL; Chenevix-Trench G, 2011, 'Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers', PLoS ONE, 6,

Journal articles | 2011

Cox DG; Simard J; Sinnett D; Hamdi Y; Soucy P; Ouimet M; Barjhoux L; Verny-Pierre C; McGuffog L; Healey S; Szabo C; Greene MH; Mai PL; Andrulis IL; Ontario Cancer Genetics Network ; Thomassen M; Gerdes A-M; Caligo MA; Friedman E; Laitman Y; Kaufman B; Paluch SS; Borg Å; Karlsson P; Askmalm MS; Bustinza GB; SWE-BRCA Collaborators ; Nathanson KL; Domchek SM; Rebbeck TR; Benítez J; Hamann U; Rookus MA; van den Ouweland AMW; Ausems MGEM; Aalfs CM; van Asperen CJ; Devilee P; Gille HJJP; HEBON ; EMBRACE ; Peock S; Frost D; Evans DG; Eeles R; Izatt L; Adlard J; Paterson J; Eason J; Godwin AK; Remon M-A; Moncoutier V; Gauthier-Villars M; Lasset C; Giraud S; Hardouin A; Berthet P; Sobol H; Eisinger F; Bressac de Paillerets B; Caron O; Delnatte C; GEMO Study Collaborators ; Goldgar D; Miron A; Ozcelik H; Buys S; Southey MC; Terry MB; Breast Cancer Family Registry ; Singer CF; Dressler A-C; Tea M-K; Hansen TVO; Johannsson O; Piedmonte M; Rodriguez GC; Basil JB; Blank S; Toland AE; Montagna M; Isaacs C; Blanco I; Gayther SA; Moysich KB; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Sutter C; Gadzicki D; Fiebig B; Caldes T; Laframboise R; Nevanlinna H; Chen X; Beesley J; Spurdle AB; Neuhausen SL; Ding YC; Couch FJ; Wang X; Peterlongo P; Manoukian S; Bernard L; Radice P; Easton DF; Chenevix-Trench G; Antoniou AC; Stoppa-Lyonnet D; Mazoyer S; Sinilnikova OM; Consortium of Investigators of Modifiers of BRCA1/2 , 2011, 'Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.', Hum Mol Genet, 20, pp. 4732 - 4747,

Journal articles | 2011

Lurie G; Wilkens LR; Thompson PJ; Carney ME; Palmieri RT; Pharoah PDP; Song H; Hogdall E; Kjaer SK; Dicioccio RA; McGuire V; Whittemore AS; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Goodman MT, 2011, 'Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: Pooled analysis in five studies within the Ovarian Cancer Association Consortium', International Journal of Cancer, 128, pp. 936 - 943,

Journal articles | 2011

Lurie G; Wilkens LR; Thompson PJ; Shvetsov YB; Matsuno RK; Carney ME; Palmieri RT; Wu AH; Pike MC; Pearce CL; Menon U; Gentry-Maharaj A; Gayther SA; Ramus SJ; Whittemore AS; McGuire V; Sieh W; Pharoah PDP; Song H; Gronwald J; Jakubowska A; Cybulski C; Lubinski J; Schildkraut JM; Berchuck A; Kjær S; Høgdall E; Fasching PA; Beckmann MW; Ekici AB; Hein A; Chenevix-Trench G; Webb PM; Beesley J; The Australian Ovarian Cancer Study ; Goodman MT; The Ovarian Cancer Association Consortium , 2011, 'Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: Pooled analysis within the ovarian cancer association consortium', PLoS ONE, 6,

Journal articles | 2011

Mulligan AM; Couch FJ; Barrowdale D; Domchek SM; Eccles D; Nevanlinna H; Ramus SJ; Robson M; Sherman M; Spurdle AB; Wappenschmidt B; Lee A; McGuffog L; Healey S; Sinilnikova OM; Janavicius R; Hansen TV; Nielsen FC; Ejlertsen B; Osorio A; Muñoz-Repeto I; Durán M; Godino J; Pertesi M; Benítez J; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Cattaneo E; Bonanni B; Viel A; Pasini B; Papi L; Ottini L; Savarese A; Bernard L; Radice P; Hamann U; Verheus M; Meijers-Heijboer HEJ; Wijnen J; Gómez García EB; Nelen MR; Kets CM; Seynaeve C; Tilanus-Linthorst MMA; van der Luijt RB; Os TV; Rookus M; Frost D; Jones JL; Evans DG; Lalloo F; Eeles R; Izatt L; Adlard J; Davidson R; Cook J; Donaldson A; Dorkins H; Gregory H; Eason J; Houghton C; Barwell J; Side LE; McCann E; Murray A; Peock S; Godwin AK; Schmutzler RK; Rhiem K; Engel C; Meindl A; Ruehl I; Arnold N; Niederacher D; Sutter C; Deissler H; Gadzicki D; Kast K; Preisler-Adams S; Varon-Mateeva R; Schoenbuchner I; Fiebig B; Heinritz W; Schäfer D; Gevensleben H; Caux-Moncoutier V; Fassy-Colcombet M; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Hardouin A; Berthet P; Muller D; Fricker JP; Mortemousque I; Pujol P, 2011, 'Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2', Breast Cancer Research, 13, pp. R110,

Journal articles | 2011

Near AM; Wu AH; Templeman C; Van Den Berg DJ; Doherty JA; Rossing MA; Goode EL; Cunningham JM; Vierkant RA; Fridley BL; Chenevix-Trench G; Webb PM; Kjær SK; Hogdall E; Gayther SA; Ramus SJ; Menon U; Gentry-Maharaj A; Schildkraut JM; Moorman PG; Palmieri RT; Ness RB; Moysich K; Cramer DW; Terry KL; Vitonis AF; Pike MC; Berchuck A; Pearce CL, 2011, 'Progesterone receptor gene polymorphisms and risk of endometriosis: Results from an international collaborative effort', Fertility and Sterility, 95, pp. 40 - 45,

Journal articles | 2011

Notaridou M; Quaye L; Dafou D; Jones C; Song H; Høgdall E; Kjaer SK; Christensen L; Høgdall C; Blaakaer J; McGuire V; Wu AH; Van Den Berg DJ; Pike MC; Gentry-Maharaj A; Wozniak E; Sher T; Jacobs IJ; Tyrer J; Schildkraut JM; Moorman PG; Iversen ES; Jakubowska A; Mȩdrek K; Lubiński J; Ness RB; Moysich KB; Wilkens LR; Carney ME; Wang-Gohrke S; Doherty JA; Rossing MA; Beckmann MW; Thiel FC; Ekici AB; Chen X; Beesley J; Gronwald J; Fasching PA; Chang-Claude J; Goodman MT; Chenevix-Trench G; Berchuck A; Pearce CL; Whittemore AS; Menon U; Pharoah PDP; Gayther SA; Ramus SJ, 2011, 'Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer', International Journal of Cancer, 128, pp. 2063 - 2074,

Journal articles | 2011

Pearce CL; Doherty JA; Van Den Berg DJ; Moysich K; Hsu C; Cushing-Haugen KL; Conti DV; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Pharoah PDP; Song H; Kjaer SK; Hogdall E; Hogdall C; Whittemore AS; McGuire V; Sieh W; Gronwald J; Medrek K; Jakubowska A; Lubinski J; Chenevix-Trench G; Beesley J; Webb PM; Berchuck A; Schildkraut JM; Iversen ES; Moorman PG; Edlund CK; Stram DO; Pike MC; Ness RB; Rossing MA; Wu AH, 2011, 'Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk', Human Molecular Genetics, 20, pp. 2263 - 2272,

Journal articles | 2011

Permuth-Wey J; Chen Z; Tsai YY; Lin HY; Chen YA; Barnholtz-Sloan J; Birrer MJ; Chanock SJ; Cramer DW; Cunningham JM; Fenstermacher D; Fridley BL; Garcia-Closas M; Gayther SA; Gentry-Maharaj A; Gonzalez-Bosquet J; Iversen E; Jim H; McLaughlin J; Menon U; Narod SA; Phelan CM; Ramus SJ; Risch H; Song H; Sutphen R; Terry KL; Tyrer J; Vierkant RA; Wentzensen N; Lancaster JM; Cheng JQ; Berchuck A; Pharoah PDP; Schildkraut JM; Goode EL; Sellers TA, 2011, 'MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium', Cancer Epidemiology Biomarkers and Prevention, 20, pp. 1793 - 1797,

Journal articles | 2011

Permuth-Wey J; Kim D; Tsai YY; Lin HY; Chen YA; Barnholtz-Sloan J; Birrer MJ; Bloom G; Chanock SJ; Chen Z; Cramer DW; Cunningham JM; Dagne G; Ebbert-Syfrett J; Fenstermacher D; Fridley BL; Garcia-Closas M; Gayther SA; Ge W; Gentry-Maharaj A; Gonzalez-Bosquet J; Goode EL; Iversen E; Jim H; Kong W; McLaughlin J; Menon U; Monteiro ANA; Narod SA; Pharoah PDP; Phelan CM; Qu X; Ramus SJ; Risch H; Schildkraut JM; Song H; Stockwell H; Sutphen R; Terry KL; Tyrer J; Vierkant RA; Wentzensen N; Lancaster JM; Cheng JQ; Sellers TA, 2011, 'LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer', Cancer Research, 71, pp. 3896 - 3903,

Journal articles | 2011

Pharoah PDP; Palmieri RT; Ramus SJ; Gayther SA; Andrulis IL; Anton-Culver H; Antonenkova N; Antoniou AC; Goldgar D; Beattie MS; Beckmann MW; Birrer MJ; Bogdanova N; Bolton KL; Brewster W; Brooks-Wilson A; Brown R; Butzow R; Caldes T; Caligo MA; Campbell I; Chang-Claude J; Chen YA; Cook LS; Couch FJ; Cramer DW; Cunningham JM; Despierre E; Doherty JA; Dörk T; Dürst M; Eccles DM; Ekici AB; Easton D; Fasching PA; De Fazio A; Fenstermacher DA; Flanagan JM; Fridley BL; Friedman E; Gao B; Sinilnikova O; Gentry-Maharaj A; Godwin AK; Goode EL; Goodman MT; Gross J; Hansen TVO; Harnett P; Rookus M; Heikkinen T; Hein R; Høgdall C; Høgdall E; Iversen ES; Jakubowska A; Johnatty SE; Karlan BY; Kauff ND; Kaye SB; Chenevix-Trench G; Kelemen LE; Kiemeney LA; Kjaer SK; Lambrechts D; LaPolla JP; Lázaro C; Le ND; Leminen A; Leunen K; Levine DA; Lu Y; Lundvall L; Macgregor S; Marees T; Massuger LF; McLaughlin JR; Menon U; Montagna M; Moysich KB; Narod SA; Nathanson KL; Nedergaard L; Ness RB; Nevanlinna H; Nickels S; Osorio A; Paul J; Pearce CL; Phelan CM; Pike MC; Radice P; Rossing MA; Schildkraut JM; Sellers TA; Singer CF; Song H; Stram DO; Sutphen R; Lindblom A, 2011, 'The role of KRAS rs61764370 in invasive epithelial ovarian cancer: Implications for clinical testing', Clinical Cancer Research, 17, pp. 3742 - 3750,

Journal articles | 2011

Ramus SJ; Kartsonaki C; Gayther SA; Pharoah PDP; Sinilnikova OM; Beesley J; Chen X; McGuffog L; Healey S; Couch FJ; Wang X; Fredericksen Z; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Allavena A; Ottini L; Papi L; Gismondi V; Capra F; Radice P; Greene MH; Mai PL; Andrulis IL; Glendon G; Ozcelik H; Thomassen M; Gerdes AM; Kruse TA; Cruger D; Jensen UB; Caligo MA; Olsson H; Kristoffersson U; Lindblom A; Arver B; Karlsson P; Stenmark Askmalm M; Borg A; Neuhausen SL; Ding YC; Nathanson KL; Domchek SM; Jakubowska A; Lubiński J; Huzarski T; Byrski T; Gronwald J; Górski B; Cybulski C; Dbniak T; Osorio A; Durán M; Tejada MI; Benítez J; Hamann U; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Bodmer D; Ausems MGEM; Van Os TA; Asperen CJ; Blok MJ; Meijers-Heijboer HEJ; Peock S; Cook M; Oliver C; Frost D; Dunning AM; Evans DG; Eeles R; Pichert G; Cole T; Hodgson S; Brewer C; Morrison PJ; Porteous M; Kennedy MJ; Rogers MT; Side LE; Donaldson A; Gregory H; Godwin A; Stoppa-Lyonnet D; Moncoutier V; Castera L; Mazoyer S; Barjhoux L; Bonadona V; Leroux D; Faivre L; Lidereau R; Nogues C; Bignon YJ, 2011, 'Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers', Journal of the National Cancer Institute, 103, pp. 105 - 116,

Journal articles | 2011

Smith LD; Tesoriero AA; Wong EM; Ramus SJ; O'Malley FP; Mulligan AM; Terry MB; Senie RT; Santella RM; John EM; Andrulis IL; Ozcelik H; Daly MB; Godwin AK; Buys SS; Fox S; Goldgar DE; Giles GG; Hopper JL; Southey MC, 2011, 'Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: A report from The Breast Cancer Family Registry', Breast Cancer Research, 13,

Journal articles | 2011

Southey MC; Ramus SJ; Dowty JG; Smith LD; Tesoriero AA; Wong EEM; Dite GS; Jenkins MA; Byrnes GB; Winship I; Phillips KA; Giles GG; Hopper JL, 2011, 'Morphological predictors of BRCA1 germline mutations in young women with breast cancer', British Journal of Cancer, 104, pp. 903 - 909,

Journal articles | 2010

Antoniou AC; Beesley J; McGuffog L; Sinilnikova OM; Healey S; Neuhausen SL; Ding YC; Rebbeck TR; Weitzel JN; Lynch HT; Isaacs C; Ganz PA; Tomlinson G; Olopade OI; Couch FJ; Wang X; Lindor NM; Pankratz VS; Radice P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Viel A; Allavena A; Dall'Olio V; Peterlongo P; Szabo CI; Zikan M; Claes K; Poppe B; Foretova L; Mai PL; Greene MH; Rennert G; Lejbkowicz F; Glendon G; Ozcelik H; Andrulis IL; Thomassen M; Gerdes AM; Sunde L; Cruger D; Jensen UB; Caligo M; Friedman E; Kaufman B; Laitman Y; Milgrom R; Dubrovsky M; Cohen S; Borg A; Jernström H; Lindblom A; Rantala J; Stenmark-Askmalm M; Melin B; Nathanson K; Domchek S; Jakubowska A; Lubinski J; Huzarski T; Osorio A; Lasa A; Durán M; Tejada MI; Godino J; Benitez J; Hamann U; Kriege M; Hoogerbrugge N; Van Der Luijt RB; Van Asperen CJ; Devilee P; Meijers-Heijboer EJ; Blok MJ; Aalfs CM; Hogervorst F; Rookus M; Cook M; Oliver C; Frost D; Conroy D; Evans DG; Lalloo F; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Hodgson S; Morrison PJ; Porteous ME; Walker L; Kennedy MJ; Dorkins H; Peock S; Godwin AK; Stoppa-Lyonnet D; De Pauw A, 2010, 'Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction', Cancer Research, 70, pp. 9742 - 9754,

Journal articles | 2010

Antoniou AC; Wang X; Fredericksen ZS; McGuffog L; Tarrell R; Sinilnikova OM; Healey S; Morrison J; Kartsonaki C; Lesnick T; Ghoussaini M; Barrowdale D; Peock S; Cook M; Oliver C; Frost D; Eccles D; Evans DG; Eeles R; Izatt L; Chu C; Douglas F; Paterson J; Stoppa-Lyonnet D; Houdayer C; Mazoyer S; Giraud S; Lasset C; Remenieras A; Caron O; Hardouin A; Berthet P; Hogervorst FBL; Rookus MA; Jager A; Van Den Ouweland A; Hoogerbrugge N; Van Der Luijt RB; Meijers-Heijboer H; G'mez García EB; Devilee P; Vreeswijk MPG; Lubinski J; Jakubowska A; Gronwald J; Huzarski T; Byrski T; G'rski B; Cybulski C; Spurdle AB; Holland H; Goldgar DE; John EM; Hopper JL; Southey M; Buys SS; Daly MB; Terry MB; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Preisler-Adams S; Arnold N; Niederacher D; Sutter C; Domchek SM; Nathanson KL; Rebbeck T; Blum JL; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Blank SV; Friedman E; Kaufman B; Laitman Y; Milgrom R; Andrulis IL; Glendon G; Ozcelik H; Kirchhoff T; Vijai J; Gaudet MM; Altshuler D; Guiducci C; Loman N; Harbst K; Rantala J; Ehrencrona H; Gerdes AM; Thomassen M; Sunde L; Peterlongo P; Manoukian S; Bonanni B; Viel A; Radice P, 2010, 'A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population', Nature Genetics, 42, pp. 885 - 892,

Journal articles | 2010

Bolton KL; Tyrer J; Song H; Ramus SJ; Notaridou M; Jones C; Sher T; Gentry-Maharaj A; Wozniak E; Tsai YY; Weidhaas J; Paik D; Van Den Berg DJ; Stram DO; Pearce CL; Wu AH; Brewster W; Anton-Culver H; Ziogas A; Narod SA; Levine DA; Kaye SB; Brown R; Paul J; Flanagan J; Sieh W; McGuire V; Whittemore AS; Campbell I; Gore ME; Lissowska J; Yang HP; Medrek K; Gronwald J; Lubinski J; Jakubowska A; Le ND; Cook LS; Kelemen LE; Brook-Wilson A; Massuger LFAG; Kiemeney LA; Aben KKH; Van Altena AM; Houlston R; Tomlinson I; Palmieri RT; Moorman PG; Schildkraut J; Iversen ES; Phelan C; Vierkant RA; Cunningham JM; Goode EL; Fridley BL; Kruger-Kjaer S; Blaeker J; Hogdall E; Hogdall C; Gross J; Karlan BY; Ness RB; Edwards RP; Odunsi K; Moyisch KB; Baker JA; Modugno F; Heikkinenen T; Butzow R; Nevanlinna H; Leminen A; Bogdanova N; Antonenkova N; Doerk T; Hillemanns P; Dürst M; Runnebaum I; Thompson PJ; Carney ME; Goodman MT; Lurie G; Wang-Gohrke S; Hein R; Chang-Claude J; Rossing MA; Cushing-Haugen KL; Doherty J; Chen C; Rafnar T; Besenbacher S; Sulem P; Stefansson K; Birrer MJ; Terry KL; Hernandez D; Cramer DW; Vergote I; Amant F; Lambrechts D; Despierre E, 2010, 'Common variants at 19p13 are associated with susceptibility to ovarian cancer', Nature Genetics, 42, pp. 880 - 884,

Journal articles | 2010

Dafou D; Grun B; Sinclair J; Lawrenson K; Benjamin EC; Hogdall E; Kruger-Kjaer S; Christensen L; Sowter HM; Al-Attar A; Edmondson R; Darby S; Berchuck A; Laird PW; Pearce CL; Ramus SJ; Jacobs IJ; Gayther SA, 2010, 'Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers', Neoplasia, 12, pp. 579 - 589,

Journal articles | 2010

Doherty JA; Rossing MA; Cushing-Haugen KL; Chen C; Van Den Berg DJ; Wu AH; Pike MC; Ness RB; Moysich K; Chenevix-Trench G; Beesley J; Webb PM; Chang-Claude J; Wang-Gohrke S; Goodman MT; Lurie G; Thompson PJ; Carney ME; Hogdall E; Kjaer SK; Hogdall C; Goode EL; Cunningham JM; Fridley BL; Vierkant RA; Berchuck A; Moorman PG; Schildkraut JM; Palmieri RT; Cramer DW; Terry KL; Yang HP; Garcia-Closas M; Chanock S; Lissowska J; Song H; Pharoah PDP; Shah M; Perkins B; McGuire V; Whittemore AS; Di Cioccio RA; Gentry-Maharaj A; Menon U; Gayther SA; Ramus SJ; Ziogas A; Brewster W; Anton-Culver H; Pearce CL, 2010, 'ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study', Cancer Epidemiology Biomarkers and Prevention, 19, pp. 245 - 250,

Journal articles | 2010

Gaudet MM; Kirchhoff T; Green T; Vijai J; Korn JM; Guiducci C; Segrè AV; McGee K; McGuffog L; Kartsonaki C; Morrison J; Healey S; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Gauthier-Villars M; Sobol H; Longy M; Frenay M; Hogervorst FBL; Rookus MA; Collée JM; Hoogerbrugge N; van Roozendaal KEP; Piedmonte M; Rubinstein W; Nerenstone S; Van Le L; Blank SV; Caldés T; De la Hoya M; Nevanlinna H; Aittomäki K; Lazaro C; Blanco I; Arason A; Johannsson OT; Barkardottir RB; Devilee P; Olopade OI; Neuhausen SL; Wang X; Fredericksen ZS; Peterlongo P; Manoukian S; Barile M; Viel A; Radice P; Phelan CM; Narod S; Rennert G; Lejbkowicz F; Flugelman A; Andrulis IL; Glendon G; Ozcelik H; Toland AE; Montagna M; D'Andrea E; Friedman E; Laitman Y; Borg A; Beattie M; Ramus SJ; Domchek SM; Nathanson KL; Rebbeck T; Spurdle AB; Chen X; Holland H; John EM; Hopper JL; Buys SS; Daly MB; Southey MC; Terry MB; Tung N; Hansen TVO; Nielsen FC; Greene MI; Mai PL; Osorio A; Durán M; Andres R; Benítez J; Weitzel JN; Garber J; Hamann U; Peock S; Cook M; Oliver C; Frost D; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Walker L; Eason J; Barwell J, 2010, 'Common genetic variants and modification of penetrance of BRCA2-associated breast cancer', PLoS Genetics, 6, pp. 1 - 12,

Journal articles | 2010

Goode EL; Chenevix-Trench G; Song H; Ramus SJ; Notaridou M; Lawrenson K; Widschwendter M; Vierkant RA; Larson MC; Kjaer SK; Birrer MJ; Berchuck A; Schildkraut J; Tomlinson I; Kiemeney LA; Cook LS; Gronwald J; Garcia-Closas M; Gore ME; Campbell I; Whittemore AS; Sutphen R; Phelan C; Anton-Culver H; Pearce CL; Lambrechts D; Rossing MA; Chang-Claude J; Moysich KB; Goodman MT; Dörk T; Nevanlinna H; Ness RB; Rafnar T; Hogdall C; Hogdall E; Fridley BL; Cunningham JM; Sieh W; McGuire V; Godwin AK; Cramer DW; Hernandez D; Levine D; Lu K; Iversen ES; Palmieri RT; Houlston R; Van Altena AM; Aben KKH; Massuger LFAG; Brooks-Wilson A; Kelemen LE; Le ND; Jakubowska A; Lubinski J; Medrek K; Stafford A; Easton DF; Tyrer J; Bolton KL; Harrington P; Eccles D; Chen A; Molina AN; Davila BN; Arango H; Tsai YY; Chen Z; Risch HA; McLaughlin J; Narod SA; Ziogas A; Brewster W; Gentry-Maharaj A; Menon U; Wu AH; Stram DO; Pike MC; Beesley J; Webb PM; Chen X; Ekici AB; Thiel FC; Beckmann MW; Yang H; Wentzensen N; Lissowska J; Fasching PA; Despierre E; Amant F; Vergote I; Doherty J; Hein R; Wang-Gohrke S; Lurie G; Carney ME; Thompson PJ; Runnebaum I; Hillemanns P, 2010, 'A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24', Nature Genetics, 42, pp. 874 - 879,

Journal articles | 2010

Johnatty SE; Beesley J; Chen X; Macgregor S; Duffy DL; Spurdle AB; de Fazio A; Gava N; Webb PM; Rossing MA; Doherty JA; Goodman MT; Lurie G; Thompson PJ; Wilkens LR; Ness RB; Moysich KB; Chang-Claude J; Wang-Gohrke S; Cramer DW; Terry KL; Hankinson SE; Tworoger SS; Garcia-Closas M; Yang H; Lissowska J; Chanock SJ; Pharoah PD; Song H; Whitemore AS; Pearce CL; Stram DO; Wu AH; Pike MC; Gayther SA; Ramus SJ; Menon U; Gentry-Maharaj A; Anton-Culver H; Ziogas A; Hogdall E; Kjaer SK; Hogdall C; Berchuck A; Schildkraut JM; Iversen ES; Moorman PG; Phelan CM; Sellers TA; Cunningham JM; Vierkant RA; Rider DN; Goode EL; Haviv I; Chenevix-Trench G, 2010, 'Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "Hot-Spot"', PLoS Genetics, 6, pp. 1 - 10,

Journal articles | 2010

Kelemen LE; Goodman MT; McGuire V; Rossing MA; Webb PM; Köbel M; Anton-Culver H; Beesley J; Berchuck A; Brar S; Carney ME; Chang-Claude J; Chenevix-Trench G; Cramer DW; Cunningham JM; DiCioccio RA; Doherty JA; Easton DF; Fredericksen ZS; Fridley BL; Gates MA; Gayther SA; Gentry-Maharaj A; Høgdall E; Kjær SK; Lurie G; Menon U; Moorman PG; Moysich K; Ness RB; Palmieri RT; Pearce CL; Pharoah PDP; Ramus SJ; Song H; Stram DO; Tworoger SS; Van Den Berg D; Vierkant RA; Wang-Gohrke S; Whittemore AS; Wilkens LR; Wu AH; Schildkraut JM; Sellers TA; Goode EL, 2010, 'Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium', Cancer Epidemiology Biomarkers and Prevention, 19, pp. 1822 - 1830,

Journal articles | 2010

Lose F; Nagle CM; O'Mara T; Batra J; Bolton KL; Song H; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Pharoah PDP; Kedda MA; Spurdle AB, 2010, 'Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival', Gynecologic Oncology, 119, pp. 479 - 483,

Journal articles | 2010

Phelan CM; Tsai YY; Goode EL; Vierkant RA; Fridley BL; Beesley J; Chen XQ; Webb PM; Chanock S; Cramer DW; Moysich K; Edwards RP; Chang-Claude J; Garcia-Closas M; Yang H; Wang-Gohrke S; Hein R; Green AC; Lissowska J; Carney ME; Lurie G; Wilkens LR; Ness RB; Pearce CL; Wu AH; Van Den Berg DJ; Stram DO; Terry KL; Whiteman DC; Whittemore AS; DiCioccio RA; McGuire V; Doherty JA; Rossing MA; Anton-Culver H; Ziogas A; Hogdall C; Hogdall E; Kjaer SK; Blaakaer J; Quaye L; Ramus SJ; Jacobs I; Song H; Pharoah PDP; Iversen ES; Marks JR; Pike MC; Gayther SA; Cunningham JM; Goodman MT; Schildkraut JM; Chenevix-Trench G; Berchuck A; Sellers TA, 2010, 'Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-hispanic white women: The Ovarian Cancer Association Consortium', Cancer Epidemiology Biomarkers and Prevention, 19, pp. 600 - 604,

Journal articles | 2010

Terry KL; Vitonis AF; Hernandez D; Lurie G; Song H; Ramus SJ; Titus-Ernstoff L; Carney ME; Wilkens LR; Gentry-Maharaj A; Menon U; Gayther SA; Pharaoh PD; Goodman MT; Cramer DW; Birrer MJ, 2010, 'A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies', International Journal of Molecular Epidemiology and Genetics, 1, pp. 272 - 277

Journal articles | 2010

Teschendorff AE; Menon U; Gentry-Maharaj A; Ramus SJ; Weisenberger DJ; Shen H; Campan M; Noushmehr H; Bell CG; Maxwell AP; Savage DA; Mueller-Holzner E; Marth C; Kocjan G; Gayther SA; Jones A; Beck S; Wagner W; Laird PW; Jacobs IJ; Widschwendter M, 2010, 'Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer', Genome Research, 20, pp. 440 - 446,

Journal articles | 2010

2010, 'Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer', PLoS genetics, 6,

Journal articles | 2010

2010, 'Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer', PLoS genetics, 6,

Journal articles | 2009

Cunningham JM; Vierkant RA; Sellers TA; Phelan C; Rider DN; Liebow M; Schildkraut J; Berchuck A; Couch FJ; Wang X; Fridley BL; Gentry-Maharaj A; Menon U; Hogdall E; Kjaer S; Whittemore A; Dicioccio R; Song H; Gayther SA; Ramus SJ; Pharaoh PDP; Goode EL, 2009, 'Cell cycle genes and ovarian cancer susceptibility: A tagSNP analysis', British Journal of Cancer, 101, pp. 1461 - 1468,

Journal articles | 2009

Dafou D; Ramus SJ; Choi K; Grun B; Trott DA; Newbold RF; Jacobs IJ; Jones C; Gayther SA, 2009, 'Chromosomes 6 and 18 induce neoplastic suppression in epithelial ovarian cancer cells', International Journal of Cancer, 124, pp. 1037 - 1044,

Journal articles | 2009

Evans DGR; Lennard F; Pointon LJ; Ramus SJ; Gayther SA; Sodha N; Kwan-Lim GE; Leach MO; Warren R; Thompson D; Easton DF; Eeles R, 2009, 'Eligibility for magnetic resonance imaging screening in the United Kingdom: Effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS study', Cancer Epidemiology Biomarkers and Prevention, 18, pp. 2123 - 2131,

Journal articles | 2009

Fasching PA; Gayther S; Pearce L; Schildkraut JM; Goode E; Thiel F; Chenevix-Trench G; Chang-Claude J; Wang-Gohrke S; Ramus S; Pharoah P; Berchuck A, 2009, 'Role of genetic polymorphisms and ovarian cancer susceptibility', Molecular Oncology, 3, pp. 171 - 181,

Journal articles | 2009

Gareth Evans D; Easton D; Eeles R; Ramus S; Kwan-Lim G; Lennard F, 2009, 'Eligibility for MRI screening in the UK: Effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS study', European Journal of Surgical Oncology (EJSO), 35, pp. 1204 - 1204,

Journal articles | 2009

Goode EL; Fridley BL; Vierkant RA; Cunningham JM; Phelan CM; Anderson S; Rider DN; White KL; Pankratz VS; Song H; Hogdall E; Kjaer SK; Whittemore AS; DiCioccio R; Ramus SJ; Gayther SA; Schildkraut JM; Pharaoh PPD; Sellers TA, 2009, 'Candidate gene analysis using imputed genotypes: Cell cycle single-nucleotide polymorphisms and ovarian cancer risk', Cancer Epidemiology Biomarkers and Prevention, 18, pp. 935 - 944,

Journal articles | 2009

Khalique L; Ayhan A; Whittaker JC; Singh N; Jacobs IJ; Gayther SA; Ramus SJ, 2009, 'The clonal evolution of metastases from primary serous epithelial ovarian cancers', International Journal of Cancer, 124, pp. 1579 - 1586,

Journal articles | 2009

Pearce CL; Near AM; Van Den Berg DJ; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Anderson AR; Edlund CK; Wu AH; Chen X; Beesley J; Webb PM; Holt SK; Chen C; Doherty JA; Rossing MA; Whittemore AS; McGuire V; DiCioccio RA; Goodman MT; Lurie G; Carney ME; Wilkens LR; Ness RB; Moysich KB; Edwards R; Jennison E; Kjaer SK; Hogdall E; Hogdall CK; Goode EL; Sellers TA; Vierkant RA; Cunningham JC; Schildkraut JM; Berchuck A; Moorman PG; Iversen ES; Cramer DW; Terry KL; Vitonis AF; Titus-Ernstoff L; Song H; Pharoah PDP; Spurdle AB; Anton-Culver H; Ziogas A; Brewster W; Galitovskiy V; Chenevix-Trench G; Gertig D; Vanden Bergh T; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D; Robertson G; DeFazio A; Hung J; Chiew YE; Stenlake A; Sullivan H; Brand A; Jaworski R; Harnett P; Wain G; Green A; Moore S; Harrap K; Sadkowsky T; Purdie D; Whiteman D; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Martin K; Ranieri B; White J; Mamers P; Healy D; Jobling T; Maniolitas T; McNealage J; Rogers P; Susil B; Veitch A; Constable J; Ping Tong S; Robinson I; Simpson I; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S, 2009, 'Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium', British Journal of Cancer, 100, pp. 412 - 420,

Journal articles | 2009

Quaye L; Dafou D; Ramus SJ; Song H; Maharaj AG; Notaridou M; Hogdall E; Kjaer SK; Christensen L; Hogdall C; Easton DF; Jacobs I; Menon U; Pharoah PDP; Gayther SA, 2009, 'Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival', Human Molecular Genetics, 18, pp. 1869 - 1878,

Journal articles | 2009

Quaye L; Song H; Ramus SJ; Gentry-Maharaj A; Høgdall E; DiCioccio RA; McGuire V; Wu AH; Van Den Berg DJ; Pike MC; Wozniak E; Doherty JA; Rossing MA; Ness RB; Moysich KB; Høgdall C; Blaakaer J; Easton DF; Ponder BAJ; Jacobs IJ; Menon U; Whittemore AS; Krüger-Kjaer S; Pearce CL; Pharoah PDP; Gayther SA, 2009, 'Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer', British Journal of Cancer, 100, pp. 993 - 1001,

Journal articles | 2009

Quaye L; Tyrer J; Ramus SJ; Song H; Wozniak E; DiCioccio RA; McGuire V; Høhdall E; Høhdall C; Blaakaer J; Goode EL; Schildkraut JM; Easton DF; Krüger-Kjaer S; Whittemore AS; Gayther SA; Pharoah PDP, 2009, 'Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer', PLoS ONE, 4,

Journal articles | 2009

Ramus SJ; Gayther SA, 2009, 'The Contribution of BRCA1 and BRCA2 to Ovarian Cancer', Molecular Oncology, 3, pp. 138 - 150,

Journal articles | 2009

Schildkraut JM; Goode EL; Clyde MA; Iversen ES; Moorman PG; Berchuck A; Marks JR; Lissowska J; Brinton L; Peplonska B; Cunningham JM; Vierkant RA; Rider DN; Chenevix-Trench G; Webb PM; Beesley J; Chen X; Phelan C; Sutphen R; Sellers TA; Pearce L; Wu AH; Van Berg DD; Conti D; Elund CK; Anderson R; Goodman MT; Lurie G; Carney ME; Thompson PJ; Gayther SA; Ramus SJ; Jacobs I; Kjaer SK; Hogdall E; Blaakaer J; Hogdall C; Easton DF; Song H; Pharoah PDP; Whittemore AS; McGuire V; Quaye L; Anton-Culver H; Ziogas A; Terry KL; Cramer DW; Hankinson SE; Tworoger SS; Calingaert B; Chanock S; Sherman M; Garcia-Closas M, 2009, 'Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer', Cancer Research, 69, pp. 2349 - 2357,

Journal articles | 2009

Soegaard M; Frederiksen K; Jensen A; Høgdall E; Høgdall C; Blaakaer J; Ramus SJ; Gayther SA; Kjaer SK, 2009, 'Risk of ovarian cancer in women with first-degree relatives with cancer', Acta Obstetricia et Gynecologica Scandinavica, 88, pp. 449 - 456,

Journal articles | 2009

Song H; Ramus SJ; Kjaer SK; DiCioccio RA; Chenevix-Trench G; Pearce CL; Hogdall E; Whittemore AS; McGuire V; Hogdall C; Blaakaer J; Wu AH; Van Den Berg DJ; Stram DO; Menon U; Gentry-Maharaj A; Jacobs IJ; Webb PM; Beesley J; Chen X; Rossing MA; Doherty JA; Chang-Claude J; Wang-Gohrke S; Goodman MT; Lurie G; Thompson PJ; Carney ME; Ness RB; Moysich K; Goode EL; Vierkant RA; Cunningham JM; Anderson S; Schildkraut JM; Berchuck A; Iversen ES; Moorman PG; Garcia-Closas M; Chanock S; Lissowska J; Brinton L; Anton-Culver H; Ziogas A; Brewster WR; Ponder BAJ; Easton DF; Gayther SA; Pharoah PDP, 2009, 'Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study', Human Molecular Genetics, 18, pp. 2297 - 2304,

Journal articles | 2009

Song H; Ramus SJ; Tyrer J; Bolton KL; Gentry-Maharaj A; Wozniak E; Anton-Culver H; Chang-Claude J; Cramer DW; DiCioccio R; Dörk T; Goode EL; Goodman MT; Schildkraut JM; Sellers T; Baglietto L; Beckmann MW; Beesley J; Blaakaer J; Carney ME; Chanock S; Chen Z; Cunningham JM; Dicks E; Doherty JA; Dürst M; Ekici AB; Fenstermacher D; Fridley BL; Giles G; Gore ME; De Vivo I; Hillemanns P; Hogdall C; Hogdall E; Iversen ES; Jacobs IJ; Jakubowska A; Li D; Lissowska J; Lubiński J; Lurie G; McGuire V; McLaughlin J; Mȩdrek K; Moorman PG; Moysich K; Narod S; Phelan C; Pye C; Risch H; Runnebaum IB; Severi G; Southey M; Stram DO; Thiel FC; Terry KL; Tsai YY; Tworoger SS; Van Den Berg DJ; Vierkant RA; Wang-Gohrke S; Webb PM; Wilkens LR; Wu AH; Yang H; Brewster W; Ziogas A; Houlston R; Tomlinson I; Whittemore AS; Rossing MA; Ponder BAJ; Pearce CL; Ness RB; Menon U; Kjaer SK; Gronwald J; Garcia-Closas M; Fasching PA; Easton DF; Chenevix-Trench G; Berchuck A; Pharoah PDP; Gayther SA, 2009, 'A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2', Nature Genetics, 41, pp. 996 - 1000,

Journal articles | 2009

Teschendorff AE; Menon U; Gentry-Maharaj A; Ramus SJ; Gayther SA; Apostolidou S; Jones A; Lechner M; Beck S; Jacobs IJ; Widschwendter M, 2009, 'An epigenetic signature in peripheral blood predicts active ovarian cancer', PLoS ONE, 4,

Journal articles | 2009

Thompson DJ; Leach MO; Kwan-Lim G; Gayther SA; Ramus SJ; Warsi I; Lennard F; Khazen M; Bryant E; Reed S; Boggis CRM; Evans DG; Eeles RA; Easton DF; Warren RML, 2009, 'Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: The UK MARIBS study', Breast Cancer Research, 11,

Journal articles | 2008

Ghoussaini M; Song H; Koessler T; Al Olama AA; Kote-Jarai Z; Driver KE; Pooley KA; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; Whittemore AS; Gayther SA; Giles GG; Guy M; Edwards SM; Morrison J; Donovan JL; Hamdy FC; Dearnaley DP; Ardern-Jones AT; Hall AL; O'Brien LT; Gehr-Swain BN; Wilkinson RA; Brown PM; Hopper JL; Neal DE; Pharoah PDP; Ponder BAJ; Eeles RA; Easton DF; Dunning AM, 2008, 'Multiple loci with different cancer specificities within the 8q24 gene desert', Journal of the National Cancer Institute, 100, pp. 962 - 966,

Journal articles | 2008

Mann A; Hogdall E; Ramus SJ; DiCioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Ponder BAJ; Kjaer SK; Gayther SA; Thompson DJ; Pharoah PDP; Song H, 2008, 'Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients', European Journal of Cancer, 44, pp. 2259 - 2265,

Journal articles | 2008

Palmieri RT; Wilson MA; Iversen ES; Clyde MA; Calingaert B; Moorman PG; Poole C; Anderson AR; Anderson S; Anton-Culver H; Beesley J; Hogdall E; Brewster W; Carney ME; Chen X; Chenevix-Trench G; Chang-Claude J; Cunningham JM; DiCioccio RA; Doherty JA; Easton DF; Edlund CK; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Kjaer SK; Hogdall CK; Hopkins MP; Jenison EL; Blaakaer J; Lurie G; McGuire V; Menon U; Moysich KB; Ness RB; Pearce CL; Pharoah PDP; Pike MC; Ramus SJ; Rossing MA; Song H; Terada KY; VanDenBerg D; Vierkant RA; Wang-Gohrke S; Webb PM; Whittemore AS; Wu AH; Ziogas A; Berchuck A; Schildkraut JM, 2008, 'Polymorphism in the IL18 gene and epithelial ovarian cancer in non-hispanic white women', Cancer Epidemiology Biomarkers and Prevention, 17, pp. 3567 - 3572,

Journal articles | 2008

Pearce CL; Wu AH; Gayther SA; Bale AE; Beck PA; Beesley J; Chanock S; Cramer DW; DiCioccio R; Edwards R; Fredericksen ZS; Garcia-Closas M; Goode EL; Green AC; Hartmann LC; Hogdall E; Kjær SK; Lissowska J; McGuire V; Modugno F; Moysich K; Ness RB; Ramus SJ; Risch HA; Sellers TA; Song H; Stram DO; Terry KL; Webb PM; Whiteman DC; Whittemore AS; Zheng W; Pharoah PDP; Chenevix-Trench G; Pike MC; Schildkraut J; Berchuck A, 2008, 'Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: Results from the ovarian cancer association consortium pooled analysis', British Journal of Cancer, 98, pp. 282 - 288,

Journal articles | 2008

Quaye L; Gayther SA; Ramus SJ; Di Cioccio R; McGuire V; Hogdall E; Hogdall C; Blaakr J; Easton DF; Ponder BAJ; Jacobs I; Kjaer SK; Whittemore AS; Pearce CL; Pharoah PDP; Song H, 2008, 'The effects of common genetic variants in oncogenes on ovarian cancer survival', Clinical Cancer Research, 14, pp. 5833 - 5839,

Journal articles | 2008

Ramus SJ; Elmasry K; Luo Z; Gammerman A; Lu K; Ayhan A; Singh N; Glenn McCluggage W; Jacobs IJ; Whittaker JC; Gayther SA, 2008, 'Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer', Clinical Cancer Research, 14, pp. 5840 - 5848,

Journal articles | 2008

Ramus SJ; Vierkant RA; Johnatty SE; Pike MC; Van Den Berg DJ; Wu AH; Pearce CL; Menon U; Gentry-Maharaj A; Gayther SA; DiCioccio RA; McGuire V; Whittemore AS; Song H; Easton DF; Pharoah PDP; Garcia-Closas M; Chanock S; Lissowska J; Brinton L; Terry KL; Cramer DW; Tworoger SS; Hankinson SE; Berchuck A; Moorman PG; Schildkraut JM; Cunningham JM; Liebow M; Kjaer SK; Hogdall E; Hogdall C; Blaakaer J; Ness RB; Moysich KB; Edwards RP; Carney ME; Lurie G; Goodman MT; Wang-Gohrke S; Kropp S; Chang-Claude J; Webb PM; Chen X; Beesley J; Chenevix-Trench G; Goode EL; Bowtell D; Green A; DeFazio A; Gertig D; Traficante N; Moore S; Hung J; Fereday S; Harrap K; Sadkowsky T; Mellon A; Robertson R; Vanden Bergh T; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Martin K; Ranieri B; White J; Jayde V; Bowes VL; Mamers P; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S; Glavinas L; Proietto A; Braye S; Otton G; Bonaventura T; Stewart J; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D, 2008, 'Consortium analysis of 7 candidate SNPs for ovarian cancer', International Journal of Cancer, 123, pp. 380 - 388,

Journal articles | 2008

Soegaard M; Kjaer SK; Cox M; Wozniak E; Høgdall E; Høgdall C; Blaakaer J; Jacobs IJ; Gayther SA; Ramus SJ, 2008, 'BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark', Clinical Cancer Research, 14, pp. 3761 - 3767,

Journal articles | 2008

Song H; Hogdall E; Ramus SJ; DiCioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PDP; Gayther SA, 2008, 'Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival', Clinical Cancer Research, 14, pp. 1090 - 1095,

Journal articles | 2008

Song H; Koessler T; Ahmed S; Ramus SJ; Kjaer SK; DiCioccio RA; Wozniak E; Hogdall E; Whittemore AS; McGuire V; Ponder BAJ; Turnbull C; Hines S; Rahman N; Eeles RA; Easton DF; Gayther SA; Dunning AM; Pharoah PDP, 2008, 'Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer', Cancer Research, 68, pp. 8837 - 8842,

Journal articles | 2007

Beesley J; Jordan SJ; Spurdle AB; Song H; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Pharoah PDP; Webb PM; Chenevix-Trench G; Bowtell D; Green A; DeFazio A; Gertig D; Traficante N; Moore S; Hung J; Fereday S; Harrap K; Sadkowsky T; Mellon A; Robertson R; Vanden Bergh T; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Martin K; Ranieri B; White J; Jayde V; Bowes L; Mamers P; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S; Glavinas L; Proietto A; Braye S; Otton G; Bonaventura T; Stewart J; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D; Robertson G; Beale P; Beith J; Carter J; Dalrymple C; Hamilton A; Houghton R; Russell P; Brand A; Jaworski R; Harnett P; Wain G; Crandon A; Cummings M; Horwood K; Obermair A; Wyld D; Nicklin J; Perrin L; Ward B; Davy M; Hall C; Dodd T; Healy T; Pittman K; Henderson D; Hyde S; Miller J; Pierdes J; Blomfield P; Challis D; McIntosh R; Parker A, 2007, 'Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: Results from two Australian studies and an additional validation set', Cancer Epidemiology Biomarkers and Prevention, 16, pp. 2557 - 2565,

Journal articles | 2007

Gayther SA; Song H; Ramus SJ; Kjaer SK; Whittemore AS; Quaye L; Tyrer J; Shadforth D; Hogdall E; Hogdall C; Blaeker J; DiCioccio R; McGuire V; Webb PM; Beesley J; Green AC; Whiteman DC; Goodman MT; Lurie G; Carney ME; Modugno F; Ness RB; Edwards RP; Moysich KB; Goode EL; Couch FJ; Cunningham JM; Sellers TA; Wu AH; Pike MC; Iversen ES; Marks JR; Garcia-Closas M; Brinton L; Lissowska J; Peplonska B; Easton DF; Jacobs I; Ponder BAJ; Schildkraut J; Pearce CL; Chenevix-Trench G; Berchuck A; Pharoah PDP, 2007, 'Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer', Cancer Research, 67, pp. 3027 - 3035,

Journal articles | 2007

Khalique L; Ayhan A; Weale ME; Jacobs IJ; Ramus SJ; Gayther SA, 2007, 'Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours', Journal of Pathology, 211, pp. 286 - 295,

Journal articles | 2007

Leach MO; Eeles R; Evans G; Easton D; Warren R; Gayther S; Ramus S; Boggis C; Lennard F; Bryant E; Warsi I; Khazen M; Pointon L; Thompson D; Amin A; Kwan-Lim G, 2007, 'O-58 The UK MARIBS study of MRI breast screening: progress on genetic and density projects', European Journal of Cancer Supplements, 5, pp. 18 - 18,

Journal articles | 2007

Ramus SJ; Harrington PA; Pye C; DiCioccio RA; Cox MJ; Garlinghouse-Jones K; Oakley-Girvan I; Jacobs IJ; Hardy RM; Whittemore AS; Ponder BAJ; Piver MS; Pharoah PDP; Gayther SA, 2007, 'Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer', Human Mutation, 28, pp. 1207 - 1215,

Journal articles | 2007

Ramus SJ; Harrington PA; Pye C; Peock S; Cook MR; Cox MJ; Jacobs IJ; DiCioccio RA; Whittemore AS; Piver MS; EMBRACE ; Easton DF; Ponder BAJ; Pharoah PDP; Gayther SA, 2007, 'Screening for the BRCA1-ins6kbEx13 mutation: potential for misdiagnosis. Mutation in brief #964. Online.', Human mutation, 28, pp. 525 - 526,

Journal articles | 2007

Smith LD; Tesoriero AA; Ramus SJ; Dite G; Royce SG; Giles GG; McCredie MRE; Hopper JL; Southey MC, 2007, 'BRCA1 promoter deletions in young women with breast cancer and a strong family history: A population-based study', European Journal of Cancer, 43, pp. 823 - 827,

Journal articles | 2007

Song H; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BAJ; Dunning AM; Gayther SA; Pharoah PDP, 2007, 'Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibilty to breast and ovarian cancer', PLoS ONE, 2,

Journal articles | 2006

Dafou D; Ramus S; Timms J; Sinclair J; Jones C; New-Bold RF; Jacobs I; Gayther S; Trott DA; Kelly G, 2006, '0022: Identification of Tumour Suppressor Genes in Epithelial Ovarian Cancer Using Microcell Mediated Chromosome Transfer', International Journal of Gynecologic Cancer, 16, pp. 605.1 - 605,

Journal articles | 2006

Khalique L; Jacobs I; Ramus S; Gayther S; Ayhan A; Weale ME, 2006, '0025: Intra Tumour Genetic Heterogeneity in Epithelial Ovarian Cancer: the Implications for Clinical Diagnostics', International Journal of Gynecologic Cancer, 16, pp. 606.1 - 606,

Journal articles | 2006

Price GR; Armes JE; Ramus SJ; Provenzano E; Kumar B; Cowie TF; Ciciulla J; Hutchins AM; Thomas M; Venter DJ, 2006, 'Phenotype-directed analysis of genotype in early-onset, familial breast cancers', Pathology, 38, pp. 520 - 527,

Journal articles | 2006

Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BAJ; Kjaer SK; Pharoah PDP; Gayther SA, 2006, 'Common variants in mismatch repair genes and risk of invasive ovarian cancer', Carcinogenesis, 27, pp. 2235 - 2242,

Journal articles | 2006

Song H; Ramus SJ; Shadforth D; Quaye L; Kjaer SK; DiCioccio RA; Dunning AM; Hogdall E; Hogdall C; Whittemore AS; McGuire V; Lesueur F; Easton DF; Jacobs IJ; Ponder BAJ; Gayther SA; Pharoah PDP, 2006, 'Common variants in RB1 gene and risk of invasive ovarian cancer', Cancer Research, 66, pp. 10220 - 10226,

Journal articles | 2005

Venter DJ; Ramus SJ; Hammet FMA; De Silva M; Hutchins AM; Petrovic V; Price G; Armes JE, 2005, 'Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines', Cancer Genetics and Cytogenetics, 160, pp. 134 - 140,

Journal articles | 2004

Armes JE; Hammet F; De Silva M; Ciciulla J; Ramus SJ; Soo WK; Mahoney A; Yarovaya N; Henderson MA; Gish K; Hutchins AM; Price GR; Venter DJ, 2004, 'Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers', Oncogene, 23, pp. 5697 - 5702,

Journal articles | 2004

Rae JM; Ramus SJ; Waltham M; Armes JE; Campbell IG; Clarke R; Barndt RJ; Johnson MD; Thompson EW, 2004, 'Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties', Clinical and Experimental Metastasis, 21, pp. 543 - 552,

Journal articles | 2004

Thompson EW; Waltham M; Ramus SJ; Hutchins AM; Armes JE; Campbell IG; Williams ED; Thompson PR; Rae JM; Johnson MD; Clarke R, 2004, 'LCC15-MB cells are MDA-MB-435: A review of misidentified breast and prostate cell lines', Clinical and Experimental Metastasis, 21, pp. 535 - 541,

Journal articles | 2004

Werness BA; Ramus SJ; DiCioccio RA; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; Tsukada Y; Harrington P; Gayther SA; Ponder BAJ; Piver MS, 2004, 'Histopathology, FIGO Stage, and BRCA Mutation Status of Ovarian Cancers from the Gilda Radner Familial Ovarian Cancer Registry', International Journal of Gynecological Pathology, 23, pp. 29 - 34,

Journal articles | 2004

Whittemore AS; Balise RR; Pharoah PDP; DiCioccio RA; Oakley-Girvan I; Ramus SJ; Daly M; Usinowicz MB; Garlinghouse-Jones K; Ponder BAJ; Buys S; Senie R; Andrulis I; John E; Hopper JL; Piver MS, 2004, 'Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations', British Journal of Cancer, 91, pp. 1911 - 1915,

Journal articles | 2003

Ramus SJ; Pharoah PDP; Harrington P; Pye C; Werness B; Bobrow L; Ayhan A; Wells D; Fishman A; Gore M; DiCioccio RA; Piver MS; Whittemore AS; Ponder BAJ; Gayther SA, 2003, 'BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases', Cancer Research, 63, pp. 417 - 423

Journal articles | 2001

Esteller M; Fraga MF; Guo M; Garcia-Foncillas J; Hedenfalk I; Godwin AK; Trojan J; Vaurs-Barrière C; Bignon YJ; Ramus S; Benitez J; Caldes T; Akiyama Y; Yuasa Y; Launonen V; Canal MJ; Rodriguez R; Capella G; Peinado MA; Borg A; Aaltonen LA; Ponder BA; Baylin SB; Herman JG, 2001, 'DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis', Human Molecular Genetics, 10, pp. 3001 - 3007,

Journal articles | 2001

Ramus SJ; Fishman A; Pharoah PDP; Yarkoni S; Altaras M; Ponder BAJ, 2001, 'Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations', European Journal of Surgical Oncology, 27, pp. 278 - 281,

Journal articles | 2000

Knowles CH; Chir B; Gayther SA; Scott M; Ramus S; Anand P; Williams NS; Ponder BA, 2000, 'Idiopathic slow-transit constipation is not associated with mutations of the RET proto-oncogene or GDNF', Diseases of the Colon and Rectum, 43, pp. 851 - 857,

Journal articles | 2000

Russell PA; Pharoah PDP; De Foy K; Ramus SJ; Symmonds I; Wilson A; Scott I; Ponder BAJ; Gayther SA, 2000, 'Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers', International Journal of Cancer, 87, pp. 317 - 321, http://dx.doi.org/10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B

Journal articles | 2000

Werness BA; Parvatiyar P; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Wiest J; Tsukada Y; Ponder BAJ; Piver MS, 2000, 'Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53', Journal of the National Cancer Institute, 92, pp. 1088 - 1091,

Journal articles | 2000

Werness BA; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Tsukada Y; Ponder BAJ; Piver MS, 2000, 'Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation', International Journal of Gynecological Pathology, 19, pp. 390 - 394,

Journal articles | 2000

Werness BA; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; Dicioccio RA; Tsukada Y; Ponder A.J. B; Piver MS, 2000, 'Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations', Human Pathology, 31, pp. 1420 - 1424,

Journal articles | 1999

Csokay B; Udvarhelyi N; Sulyok Z; Besznyak I; Ramus S; Ponder B; Olah E, 1999, 'High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history', Cancer Research, 59, pp. 995 - 998,

Journal articles | 1999

Ramus SJ; Bobrow LG; Pharoah PDP; Finnigan DS; Fishman A; Altaras M; Harrington PA; Gayther SA; Ponder BAJ; Friedman LS, 1999, 'Increased frequency of TP53 mutations in BRCAI and BRCA2 ovarian tumours', Genes Chromosomes and Cancer, 25, pp. 91 - 96, http://dx.doi.org/10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5

Journal articles | 1999

Ramus SJ; Forrest SM; Pitt DD; Cotton RGH, 1999, 'Genotype and intellectual phenotype in untreated phenylketonuria patients', Pediatric Research, 45, pp. 474 - 481,

Journal articles | 1998

Gayther SA; Gorringe KL; Ramus SJ; Huntsman D; Roviello F; Grehan N; Machado JC; Pinto E; Seruca R; Halling K; MacLeod P; Powell SM; Jackson CE; Ponder BAJ; Caldas C, 1998, 'Identification of germ-line E-cadherin mutations in gastric cancer families of European origin', Cancer Research, 58, pp. 4086 - 4089

Journal articles | 1997

Ramus SJ; Friedman LS; Gayther SA; Ponder BAJ; Bobrow LG; Looji MVD; Papp J; Olah E, 1997, 'A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2', Nature Genetics, 15, pp. 14 - 15,

Journal articles | 1997

Ramus SJ; Kote-Jarai Z; Friedman LS; Van Der Looij M; Gayther SA; Csokay B; Ponder BAJ; Olah E, 1997, 'Analysis of BRCA1 and BRCA2 mutations in hungarian families with breast or breast-ovarian cancer [4]', American Journal of Human Genetics, 60, pp. 1242 - 1246

Journal articles | 1996

Ramus SJ; Cotton RGH, 1996, 'Single-tube chemical cleavage of mismatch: Successive treatment with hydroxylamine and osmium tetroxide', BioTechniques, 21, pp. 216 - 220,

Journal articles | 1996

Treacy E; Pitt JJ; Seller K; Thompson GN; Ramus S; Cotton RGH, 1996, 'In vivo disposal of phenylalanine in phenylketonuria: A study of two siblings', JOURNAL OF INHERITED METABOLIC DISEASE, 19, pp. 595 - 602,

Journal articles | 1995

Ramus SJ; Cotton RGH, 1995, 'Mutations Ivs4nt1, 47delCT, and G148S identified in the phenylalanine hydroxylase gene by RT‐PCR of illegitimate transcripts and chemical cleavage of mismatch', Human Mutation, 6, pp. 250 - 251,

Journal articles | 1995

Ramus SJ; Cotton RGH, 1995, 'Polymorphism in the 3′ untranslated region of the phenylalanine hydroxylase gene detected by enzyme mismatch cleavage: evolution of haplotypes', Human Genetics, 96, pp. 741 - 743,

Journal articles | 1995

Ramus SJ; Pitt DB; Cotton RGH, 1995, 'Genotype/phenotype correlations: Intellectual phenotypes in untreated PKU patients', International Pediatrics, 10, pp. 92 - 94

Journal articles | 1995

Ramus SJ; Treacy EP; Cotton RGH, 1995, 'Characterization of phenylalanine hydroxylase alleles in untreated phenylketonuria patients from Victoria, Australia: Origin of alleles and haplotypes', American Journal of Human Genetics, 56, pp. 1034 - 1041

Journal articles | 1993

Cotton RGH; Dahl HHM; Forrest S; Howells DW; Ramus SJ; Bishop RE; Dianzani I; Saleeba JA; Palombo E; Anderson MJ; Milner CM; Campbell RD, 1993, 'Analysis of Sequence Contexts Flanking T·G Mismatches Leads to Predictions about Reactivity of the Mismatched T to Osmium Tetroxide', DNA and Cell Biology, 12, pp. 945 - 949,

Journal articles | 1993

Dianzani I; Camaschella C; Saglio G; Ferrero GB; Ramus S; Ponzone A; Cotton RGH, 1993, 'Molecular analysis of contiguous exons of the phenylalanine hydroxylase gene: Identification of a new PKU mutation', Journal of Medical Genetics, 30, pp. 228 - 231,

Journal articles | 1993

Ramus SJ; Forrest SM; Pitt DB; Saleeba JA; Cotton RGH, 1993, 'Comparison of genotype and intellectual phenotype in untreated PKU patients', Journal of Medical Genetics, 30, pp. 401 - 405,

Journal articles | 1992

Ramus SJ; Forrest SM; Cotton RGH, 1992, 'Illegitimate transcription of phenylalanine hydroxylase for detection of mutations in patients with phenylketonuria', Human Mutation, 1, pp. 154 - 158,

Journal articles | 1992

Ramus SJ; Forrest SM; Saleeba JA; Cotton RGH, 1992, 'CpG hotspot causes second mutation in codon 408 of the phenylalanine hydroxylase gene', Human Genetics, 90, pp. 147 - 148,

Journal articles | 1992

Saleeba JA; Ramus SJ; Cotton RGH, 1992, 'Complete mutation detection using unlabeled chemical cleavage', Human Mutation, 1, pp. 63 - 69,

Journal articles | 1991

Dianzani I; Camaschella C; Saglio G; Forrest SM; Ramus S; Cotton RGH, 1991, 'Simultaneous screening for β-thalassemia mutations by chemical cleavage of mismatch', Genomics, 11, pp. 48 - 53,

Journal articles | 1991

Dianzani I; Ramus S; Cotton RGH; Camaschella C, 1991, 'A SPONTANEOUS MUTATION CAUSING UNSTABLE Hb HAMMERSMITH: DETECTION OF THE β42 TTT→TCT CHANGE BY CCM AND DIRECT SEQUENCING', British Journal of Haematology, 79, pp. 127 - 129,
Working Papers | 2023

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Blake Gilks C; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; AOCS Group ; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Rinda Soong T; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2023, Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma., ,
Preprints | 2024

Asadi-Aghbolaghi M; Farahani H; Zhang A; Akbari A; Kim S; Chow A; Dane S; OCEAN Challenge Consortium ; OTTA Consortium ; Huntsman D; Gilks B; Ramus S; Köbel M; Karnezis A; Bashashati A, 2024, Machine Learning-driven Histotype Diagnosis of Ovarian Carcinoma: Insights from the OCEAN AI Challenge,

Preprints | 2024

Barnes DR; Tyrer JP; Dennis J; Leslie G; Bolla MK; Lush M; Aeilts AM; Aittomäki K; Andrieu N; Andrulis IL; Anton-Culver H; Arason A; Arun BK; Balmaña J; Bandera EV; Barkardottir RB; Berger LPV; de Gonzalez AB; Berthet P; Białkowska K; Bjørge L; Blanco AM; Blok MJ; Bobolis KA; Bogdanova NV; Brenton JD; Butz H; Buys SS; Caligo MA; Campbell I; Castillo C; Claes KBM; GEMO Study Collaborators ; EMBRACE Collaborators ; Colonna SV; Cook LS; Daly MB; Dansonka-Mieszkowska A; de la Hoya M; deFazio A; DePersia A; Ding YC; Domchek SM; Dörk T; Einbeigi Z; Engel C; Evans DG; Foretova L; Fortner RT; Fostira F; Foti MC; Friedman E; Frone MN; Ganz PA; Gentry-Maharaj A; Glendon G; Godwin AK; González-Neira A; Greene MH; Gronwald J; Guerrieri-Gonzaga A; Hamann U; Hansen TVO; Harris HR; Hauke J; Heitz F; Hogervorst FBL; Hooning MJ; Hopper JL; Huff CD; Huntsman DG; Imyanitov EN; kConFab Investigators ; Izatt L; Jakubowska A; James PA; Janavicius R; John EM; Kar S; Karlan BY; Kennedy CJ; Kiemeney LALM; Konstantopoulou I; Kupryjanczyk J; Laitman Y; Lavie O; Lawrenson K; Lester J; Lesueur F; Lopez-Pleguezuelos C; Mai PL; Manoukian S; May T; McNeish IA; Menon U; Milne RL; Modugno F; Mongiovi JM; Montagna M; Moysich KB; Neuhausen SL; Nielsen FC; Noguès C; Oláh E; Olopade OI; Osorio A; Papi L; Pathak H; Pearce CL; Pedersen IS; Peixoto A; Pejovic T; Peng P-C; Peshkin BN; Peterlongo P; Powell CB; Prokofyeva D; Pujana MA; Radice P; Rashid MU; Rennert G; Richenberg G; Sandler DP; Sasamoto N; Setiawan VW; Sharma P; Sieh W; Singer CF; Snape K; Sokolenko AP; Soucy P; Southey MC; Stoppa-Lyonnet D; Sutphen R; Sutter C; Teixeira MR; Terry KL; Thomsen LCV; Tischkowitz M; Toland AE; Van Gorp T; Vega A; Velez Edwards DR; Webb PM; Weitzel JN; Wentzensen N; Whittemore AS; Winham SJ; Wu AH; Yadav S; Yu Y; Ziogas A; Berchuck A; Couch FJ; Goode EL; Goodman MT; Monteiro AN; Offit K; Ramus SJ; Risch HA; Schildkraut JM; Thomassen M; Simard J; Easton DF; Jones MR; Chenevix-Trench G; Gayther SA; Antoniou AC; Pharoah PDP, 2024, Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.,

Preprints | 2024

Dicks EM; Tyrer JP; Ezquina S; Jones M; Baierl J; Peng P-C; Diaz M; Goode E; Winham SJ; Dörk T; Van Gorp T; De Fazio A; Bowtell D; Odunsi K; Moysich K; Pavanello M; Campbell I; Brenton JD; Ramus SJ; Gayther SA; Pharoah PDP, 2024, Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Data from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Data from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Figure 1 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Figure 1 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Figure 2 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Figure 2 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Figure 3 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Figure 3 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Figure 4 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Figure 4 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S1 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S1 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S10 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S10 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S2 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S2 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S3 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S3 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S4 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S4 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S5 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S5 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S6 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S6 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S7 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S7 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S8 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S8 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S9 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Figure S9 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S1 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S1 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S10 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S10 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S11 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S11 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S12 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S12 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S13 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S13 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S14 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S14 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S15 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S15 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S16 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S16 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S17 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S17 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S18 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S18 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S19 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S19 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S2 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S2 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S20 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S20 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S3 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S3 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S4 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S4 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S5 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S5 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S6 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S6 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S7 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S7 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S8 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S8 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S9 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Supplementary Table S9 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Table 1 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Table 1 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Table 2 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Other | 2024

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Gilks CB; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Soong TR; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, Table 2 from Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma,

Preprints | 2024

Weir A; Lee S; Li M; Tan CW; Ramus S; Davidson N, 2024, IdentifiHR: predicting homologous recombination deficiency in high-grade serous ovarian carcinoma using gene expression,

Other | 2023

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes,

Other | 2023

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes,

Other | 2023

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes,

Other | 2023

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes,

Other | 2023

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes,

Other | 2023

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes,

Other | 2023

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes,

Other | 2023

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2023, Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Data from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Data from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Figure 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Figure 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Figure 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Figure 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Figure 3 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Figure 3 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Figure 4 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Figure 4 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Methods 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Methods 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 3 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 3 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 4 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 4 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 5 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 5 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 6 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Other | 2023

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Köbel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, Supplementary Table 6 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma, ,

Conference Abstracts | 2022

Mahony DO; Ramus SJ; Southey M; Hadjisavvas A; Meagher NS; Antoniou AC; Goldgar D; Spurdle A; Michailidou K, 2022, 'Use of ovarian cancer tumour pathology characteristics to aid classification of Variants of Uncertain Significance (VUS) in the BRCA1 and BRCA2 genes', in EUROPEAN JOURNAL OF HUMAN GENETICS, SPRINGERNATURE, Vol. 30, pp. 418 - 419,

Conference Abstracts | 2022

Mahony DO; Ramus SJ; Southey MC; Hadjisavvas A; Antoniou AC; Goldgar DE; Spurdle AB; Michailidou K, 2022, 'Classification of Variants of Uncertain Significance (VUS) in the BRCA1 and BRCA2 Genes Based on Ovarian Tumor Pathology Characteristics', in GENETIC EPIDEMIOLOGY, WILEY, Vol. 46, pp. 520 - 521,

Conference Abstracts | 2022

Meagher NS; Hamilton PT; Anglesio MS; Harris HR; Konecny GE; Schildkraut JM; Talhouk A; Friedlander ML; Pearce CL; Pike MC; Kobel M; Doherty JA; Goode EL; Nelson BH; DeFazio A; Ramus SJ, 2022, 'Multi-modal immune profiling of mucinous ovarian carcinoma: analysis from the Ovarian Tumor Tissue Analysis/Multidisciplinary Ovarian Cancer Outcomes Group consortia', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 208,

Conference Papers | 2022

Minh TP; Berchuck A; Goode EL; Goodman MT; Hanley GE; Richardson J; Grout B; Chase A; Deurloo CM; Karlan BY; Van Gorp T; Matsuo K; McLean K; Pike MC; Schildkraut JM; Terry KL; DeFazio A; Webb PM; Pharoah PDP; Ramus SJ; Pearce CL, 2022, 'Environmental factors associated with residual disease after ovarian cancer primary cytoreduction surgery', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, LA, New Orleans, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), LA, New Orleans, 08 April 2022 - 13 April 2022,

Conference Abstracts | 2022

Phung MT; Berchuck A; Goode EL; Goodman MT; Hanley GE; Richardson J; Grout B; Chase A; Deurloo CM; Karlan BY; Van Gorp T; Matsuo K; McLean K; Pike MC; Schildkraut JM; Terry KL; DeFazio A; Webb PM; Pharoah PDP; Ramus SJ; Pearce CL, 2022, 'Abstract 2248: Environmental factors associated with residual disease after ovarian cancer primary cytoreduction surgery', in Cancer Research, American Association for Cancer Research (AACR), Vol. 82, pp. 2248 - 2248,

Conference Abstracts | 2022

Pitiyarachchi O; Lee YC; Ramus SJ; defazio A; Friedlander M, 2022, 'Rates of somatic variants in homologous recombination DNA repair deficiency genes in older patients with high-grade serous ovarian carcinoma', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 30 - 30,

Preprints | 2021

Heinze K; Nazeran T; Lee S; Krämer P; Cairns E; Chiu D; Leung SCY; Kang EY; Meagher N; Kennedy C; Boros J; Kommoss F; Vollert H-W; Heitze F; du Bois A; Harter P; Grube M; Kraemer B; Staebler A; Kommoss FKF; Heublein S; Sinn H-P; Singh N; Laslavic A; Elishaev E; Olawaiye A; Moysich K; Modugno F; Sharma R; Brand A; Harnett P; DeFazio A; Fortner R; Lubinski J; Lener M; Tołoczko-Grabarek A; Cybulski C; Gronwald H; Gronwald J; Coulson P; El-Bahrawy M; Jones M; Schoemaker M; Swerdlow A; Gorringe K; Campbell I; Cook L; Gayther S; Carney M; Shvetsov Y; Hernandez B; Wilkens L; Goodman M; Mateoiu C; Linder A; Sundfeldt K; Kelemen L; Gentry-Maharaj A; Widschwendter M; Menon U; Bolton K; Alsop J; Shah M; Jimenez-Linan M; Pharoah PDP; Brenton J; Cushing-Haugen K; Harris H; Doherty J; Gilks B; Ghatage P; Huntsman D; Nelson G; Tinker A; Lee C-H; Goode E; Nelson B; Ramus S; Kommoss S; Talhouk A; Köbel M; Anglesio M, 2021, Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma,

Conference Abstracts | 2021

Meagher N; Koebel M; Anderson L; Tan A; Bolithon A; Anglesio M; Cohen P; Crowe P; Doherty J; Fasching P; Harris H; Hogdall E; Huntsman D; James P; Karlan B; Kelemen L; Kommoss S; Konecny G; Gorringe K; Modugno F; Park S; Pharoah P; Staebler A; Sundfeldt K; Thorne H; Wu A; DeFazio A; Friedlander M; Ramus S, 2021, 'Pattern of invasion in stage I mucinous ovarian cancer is prognostic within 2-years of diagnosis', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 17, pp. 47 - 48,

Conference Papers | 2021

Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Kobel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH,

Conference Papers | 2021

Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Abstract 1045: Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy', in Cancer Research, American Association for Cancer Research (AACR), pp. 1045 - 1045,

Preprints | 2020

Dareng EO; Tyrer JP; Barnes DR; Jones MR; Yang X; Aben KKH; Adank MA; Agata S; Andrulis IL; Anton-Culver H; Antonenkova NN; Aravantinos G; Arun BK; Augustinsson A; Balmaña J; Bandera EV; Barkardottir RB; Barrowdale D; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Bjorge L; Black A; Bogdanova NV; Bonanni B; Borg A; Brenton JD; Budzilowska A; Butzow R; Buys SS; Cai H; Caligo MA; Campbell I; Cannioto R; Cassingham H; Chang-Claude J; Chanock SJ; Chen K; Chiew Y-E; Chung WK; Claes KBM; Colanna S; Cook LS; Couch FJ; Daly MB; Dao F; Davies E; de la Hoya M; Putter RD; Dennis J; DePersia A; Devilee P; Diez O; Ding YC; Doherty JA; Domchek SM; Dörk T; Bois AD; Dürst M; Eccles DM; Eliassen HA; Engel C; Evans DG; Fasching PA; Flanagan JM; Foretova L; Fortner RT; Friedman E; Ganz PA; Garber J; Gensini F; Giles GG; Glendon G; Godwin AK; Goodman MT; Greene MH; Gronwald J; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hansen TVO; Harris HR; Hartman M; Heitz F; Hildebrandt MAT; Høgdall E; Høgdall CK; Hopper JL; Huang R-Y; Huff C; Hulick PJ; Huntsman DG; Imyanitov EN; Isaacs C; Jakubowska A; James PA; Janavicius R; Jensen A; Johannsson OT; John EM; Jones ME; Kang D; Karlan BY; Karnezis A; Kelemen LE; Khusnutdinova E; Kiemeney LA; Kim B-G; Kjaer SK; Komenaka I; Kupryjanczyk J; Kurian AW; Kwong A; Lambrechts D; Larson MC; Lazaro C; Le ND; Leslie G; Lester J; Lesueur F; Levine DA; Li L; Li J; Loud JT; Lu KH; Lubiński J; Machackova E; Mai PL; Manoukian S; Marks JR; Matsuno RK; Matsuo K; May T; McGuffog L; McLaughlin JR; McNeish IA; Mebirouk N; Menon U; Miller A; Milne RL; Minlikeeva A; Modugno F; Montagna M; Moysich KB; Munro E; Nathanson KL; Neuhausen SL; Nevanlinna H; Yie JNY; Nielsen HR; Nielsen FC; Nikitina-Zake L; Odunsi K; Offit K; Olah E; Olbrecht S; Olopade OI; Olson SH; Olsson H; Osorio A; Papi L; Park SK; Parsons MT; Pathak H; Pedersen IS; Peixoto A; Pejovic T; Perez-Segura P; Permuth JB; Peshkin B; Peterlongo P; Piskorz A; Prokofyeva D; Radice P; Rantala J; Riggan MJ; Risch HA; Rodriguez-Antona C; Ross E; Rossing MA; Runnebaum I; Sandler DP; Santamariña M; Soucy P; Schmutzler RK; Setiawan VW; Shan K; Sieh W; Simard J; Singer CF; Sokolenko AP; Song H; Southey MC; Steed H; Stoppa-Lyonnet D; Sutphen R; Swerdlow AJ; Tan YY; Teixeira MR; Teo SH; Terry KL; Terry MB; Thomassen M; Thompson PJ; Vestrheim Thomsen LC; Thull DL; Tischkowitz M; Titus L; Toland AE; Torres D; Trabert B; Travis R; Tung N; Tworoger SS; Valen E; van Altena AM; van der Hout AH; Van Nieuwenhuysen E; van Rensburg EJ; Vega A; Edwards DV; Vierkant RA; Wang F; Wappenschmidt B; Webb PM; Weinberg CR; Weitzel JN; Wentzensen N; White E; Whittemore AS; Winham SJ; Wolk A; Woo Y-L; Wu AH; Yan L; Yannoukakos D; Zavaglia KM; Zheng W; Ziogas A; Zorn KK; Easton D; Lawrenson K; DeFazio A; Sellers TA; Ramus SJ; Pearce CL; Monteiro AN; Cunningham J; Goode EL; Schildkraut JM; Berchuck A; Chenevix-Trench G; Gayther SA; Antoniou AC; Pharoah PDP, 2020, Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk,

Conference Papers | 2020

Garsed D; Pandey A; Fereday S; Alsop K; Wouters M; Saner F; Kennedy C; Pearce C; Pike M; Ramus S; Kobel M; deFazio A; Goode E; Nelson B; Bowtell D, 2020, 'Abstract IA05: Molecular analysis of exceptional response in high-grade serous ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. IA05 - IA05, presented at Abstracts: AACR Special Conference on Advances in Ovarian Cancer Research; September 13-16, 2019; Atlanta, GA,

Preprints | 2020

Glubb D; Thompson D; Aben KKH; Alsulimani A; Amant F; Annibali D; Attia J; Barricarte A; Beckmann M; Berchuck A; Bermisheva M; Bernardini M; Bischof K; Bjorge L; Bodelon C; Brand A; Brenton J; Brinton L; Bruinsma F; Buchanan D; Burghaus S; Butzow R; Cai H; Carney M; Chanock S; Chen C; Chen XQ; Chen Z; Cook L; Cunningham J; Vivo ID; deFazio A; Doherty J; Dörk T; Bois AD; Dunning A; Dürst M; Edwards T; Edwards R; Ekici A; Ewing A; Fasching P; Ferguson S; Flanagan J; Fostira F; Fountzilas G; Friedenreich C; Gao B; Gaudet M; Gawełko J; Gentry-Maharaj A; Giles G; Glasspool R; Goodman M; Gronwald J; OPAL Study Group ; AOCS Group ; Harris H; Harter P; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Høgdall E; Høgdall C; Holliday E; Huntsman D; Huzarski T; Jakubowska A; Jensen A; Jones M; Karlan B; Karnezis A; Kelley J; Khusnutdinova E; Killeen J; Kjaer S; Klapdor R; Köbel M; Konopka B; Konstantopoulou I; Kopperud R; Koti M; Kraft P; Kupryjanczyk J; Lambrechts D; Larson M; Marchand LL; Lele S; Lester J; Li A; Liang D; Liebrich C; Lipworth L; Lissowska J; Lu L; Lu K; Macciotta A; Mattiello A; May T; McAlpine J; McGuire V; McNeish I; Menon U; Modugno F; Moysich K; Nevanlinna H; Odunsi K; Olsson H; Orsulic S; Osorio A; Palli D; Park-Simon T-W; Pearce C; Pejovic T; Permuth J; Podgorska A; Ramus S; Rebbeck T; Riggan M; Risch H; Rothstein J; Runnebaum I; Scott R; Sellers T; Senz J; Setiawan W; Siddiqui N; Sieh W; Spiewankiewicz B; Sutphen R; Swerdlow A; Szafron L; Teo SH; Thompson P; Thomsen LCV; Titus L; Tone A; Tumino R; Turman C; Vanderstichele A; Edwards DV; Vergote I; Vierkant R; Wang Z; Wang-Gohrke S; Webb P; White E; Whittemore A; Winham S; Wu X; Wu A; Yannoukakos D; Spurdle A; O’Mara T, 2020, Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers,

Preprints | 2020

Kar S; Considine D; Tyrer J; Plummer J; Chen S; Dezem F; Barbeira A; Rajagopal P; Rosenow W; Antón F; Bodelon C; Chang-Claude J; Chenevix-Trench G; deFazio A; Dörk T; Ekici A; Ewing A; Fountzilas G; Goode E; Hartman M; Heitz F; Hillemanns P; Høgdall E; Høgdall C; Huzarski T; Jensen A; Karlan B; Khusnutdinova E; Kiemeney L; Kjaer S; Klapdor R; Köbel M; Li J; Liebrich C; May T; Olsson H; Permuth J; Peterlongo P; Radice P; Ramus S; Riggan M; Risch H; Saloustros E; Simard J; Szafron L; Thompson C; Vierkant R; Winham S; Zheng W; Doherty J; Berchuck A; Lawrenson K; Im H; Manichaikul A; Pharoah P; Gayther S; Schildkraut J, 2020, Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies new candidate susceptibility genes for breast and ovarian cancer,

Preprints | 2020

Kar S; Lindström S; Hung R; Lawrenson K; Schmidt M; O’Mara T; Glubb D; Tyrer J; Schildkraut J; Chang-Claude J; Alsulimani A; Antón F; Beeghly-Fadiel A; Bjørge L; Bodelon C; Brauch H; Burghaus S; Campa D; Carney M; Chen C; Chen Z; Daly M; Bois AD; Ekici A; Ewing A; Fasching P; Flanagan J; Gawelko J; Giles G; Hamilton R; Harris H; Heitz F; Hildebrandt M; Hillemanns P; Huang R-Y; Imaz L; Irmejs A; Jakubowska A; Jensen A; John E; Kannisto P; Karlan B; Khusnutdinova E; Kiemeney L; Kjaer S; Klapdor R; Kleiblova P; Köbel M; Konopka B; Krakstad C; Lessel D; Lophatananon A; May T; Mieszkowska A; Monteiro A; Moysich K; Muir K; Nielsen S; Odunsi K; Olsson H; Park-Simon T-W; Permuth J; Peterlongo P; Podgorski A; Prentice R; Radice P; Risch H; Runnebaum I; Rzepecka I; Scott R; Setiawan V; Siddiqui N; Sieh W; Śpiewankiewicz B; Szafron L; Thompson C; Titus L; Turnbull C; Usmani N; van Altena A; Vega-Gliemmo A; Vergote I; Vierkant R; Vijai J; Winham S; Winqvist R; Yu H; the PRACTICAL consortium, CRUK, BPC3, CAPS, PEGASUS ; Lambrechts D; Thompson D; Goode E; Zheng W; Tomlinson I; Berchuck A; Ramus S; Chanock S; Easton D; Chenevix-Trench G; Gayther S; Spurdle A; Eeles R; Kraft P; Pharoah P, 2020, Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations, ,

Conference Papers | 2020

Millstein J; Budden T; Goode EL; Anglesio MS; Talhouk A; Huntsman DG; Bowtell DD; Brenton JD; Doherty JA; Pharoah PPD; Ramus SJ, 2020, 'Abstract IA12: The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. IA12 - IA12, presented at Abstracts: AACR Special Conference on Advances in Ovarian Cancer Research; September 13-16, 2019; Atlanta, GA,

Conference Papers | 2020

Pavanello M; Dicks E; Song H; Ariff A; Bolithon A; Intermaggio MP; Pinese M; Moysich K; Odunsi KO; Goode E; Bowtell DD; Fasching P; Doherty JA; Modugno F; Kjær SK; Webb PM; Wu A; deFazio A; James P; Subramanian D; Campbell I; Gayther SA; Pharoah PDP; Ramus SJ, 2020, 'Abstract B37: Germline mutations in new susceptibility genes for non-high-grade serous ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. B37 - B37,

Conference Papers | 2020

Talhouk A; George J; Wang C; Goode E; Ramus S; Doherty J; Bowtell D; Anglesio M, 2020, 'Abstract A03: PrOTYPE (Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE): The development and validation of a clinical-grade consensus classifier for the molecular subtypes of high-grade serous tubo-ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. A03 - A03, presented at Abstracts: AACR Special Conference on Advances in Ovarian Cancer Research; September 13-16, 2019; Atlanta, GA,

Preprints | 2019

Fachal L; Aschard H; Beesley J; Barnes DR; Allen J; Kar S; Pooley KA; Dennis J; Michailidou K; Turman C; Soucy P; Lemaçon A; Lush M; Tyrer JP; Ghoussaini M; Marjaneh MM; Jiang X; Agata S; Aittomäki K; Alonso MR; Andrulis IL; Anton-Culver H; Antonenkova NN; Arason A; Arndt V; Aronson KJ; Arun BK; Auber B; Auer PL; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bialkowska K; Blanco AM; Blomqvist C; Blot W; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Borg A; Bosse K; Brauch H; Brenner H; Briceno I; Brock IW; Brooks-Wilson A; Brüning T; Burwinkel B; Buys SS; Cai Q; Caldés T; Caligo MA; Camp NJ; Campbell I; Canzian F; Carroll JS; Carter BD; Castelao JE; Chiquette J; Christiansen H; Chung WK; Claes KBM; Clarke CL; Collaborators GEMOS; Collaborators EMBRACE; Collée JM; Cornelissen S; Couch FJ; Cox A; Cross SS; Cybulski C; Czene K; Daly MB; la Hoya MD; Devilee P; Diez O; Ding YC; Dite GS; Domchek SM; Dörk T; dos-Santos-Silva I; Droit A; Dubois S; Dumont M; Duran M; Durcan L; Dwek M; Eccles DM; Engel C; Eriksson M; Evans DG; Fasching PA; Fletcher O; Floris G; Flyger H; Foretova L; Foulkes WD; Friedman E; Fritschi L; Frost D; Gabrielson M; Gago-Dominguez M; Gambino G; Ganz PA; Gapstur SM; Garber J; García-Sáenz JA; Gaudet MM; Georgoulias V; Giles GG; Glendon G; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Greene MH; Grip M; Gronwald J; Grundy A; Guénel P; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Harrington PA; Hartikainen JM; Hartman M; He W; Healey CS; Heemskerk-Gerritsen BAM; Heyworth J; Hillemanns P; Hogervorst FBL; Hollestelle A; Hooning MJ; Hopper JL; Howell A; Huang G; Hulick PJ; Imyanitov EN; Isaacs C; Iwasaki M; Jager A; Jakimovska M; Jakubowska A; James P; Janavicius R; Jankowitz RC; John EM; Johnson N; Jones ME; Jukkola-Vuorinen A; Jung A; Kaaks R; Kang D; Karlan BY; Keeman R; Kerin MJ; Khusnutdinova E; Kiiski JI; Kirk J; Kitahara CM; Ko Y-D; Konstantopoulou I; Kosma V-M; Koutros S; Kubelka-Sabit K; Kwong A; Kyriacou K; Laitman Y; Lambrechts D; Lee E; Leslie G; Lester J; Lesueur F; Lindblom A; Lo W-Y; Long J; Lophatananon A; Loud JT; Lubinski J; MacInnis RJ; Maishman T; Makalic E; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Martinez ME; Matsuo K; Maurer T; Mavroudis D; Mayes R; McGuffog L; McLean C; Mebirouk N; Meindl A; Middha P; Miller N; Miller A; Montagna M; Moreno F; Mulligan AM; Muñoz-Garzon VM; Muranen TA; Narod SA; Nassir R; Nathanson KL; Neuhausen SL; Nevanlinna H; Neven P; Nielsen FC; Nikitina-Zake L; Norman A; Offit K; Olah E; Olopade OI; Olsson H; Orr N; Osorio A; Pankratz VS; Papp J; Park SK; Park-Simon T-W; Parsons MT; Paul J; Pedersen IS; Peissel B; Peshkin B; Peterlongo P; Peto J; Plaseska-Karanfilska D; Prajzendanz K; Prentice R; Presneau N; Prokofyeva D; Pujana MA; Pylkäs K; Radice P; Ramus SJ; Rantala J; Rau-Murthy R; Rennert G; Risch HA; Robson M; Romero A; Rossing CM; Saloustros E; Sánchez-Herrero E; Sandler DP; Santamariña M; Saunders C; Sawyer EJ; Scheuner MT; Schmidt DF; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Schöttker B; Schürmann P; Scott C; Scott RJ; Senter L; Seynaeve CMD; Shah M; Sharma P; Shen C-Y; Shu X-O; Singer CF; Slavin TP; Smichkoska S; Southey MC; Spinelli JJ; Spurdle AB; Stone J; Stoppa-Lyonnet D; Sutter C; Swerdlow AJ; Tamimi RM; Tan YY; Tapper WJ; Taylor JA; Teixeira MR; Tengström M; Teo SH; Terry MB; Teulé A; Thomassen M; Thull DL; Tibiletti MG; Tischkowitz M; Toland AE; Tollenaar RAEM; Tomlinson I; Torres D; Torres-Mejía G; Troester MA; Tung N; Tzardi M; Ulmer H-U; Vachon CM; van Asperen CJ; der Kolk LEV; van Rensburg EJ; Vega A; Viel A; Vijai J; Vogel MJ; Wang Q; Wappenschmidt B; Weinberg CR; Weitzel JN; Wendt C; Wildiers H; Winqvist R; Wolk A; Wu AH; Yannoukakos D; Zhang Y; Zheng W; Pharoah PDP; Chang-Claude J; García-Closas M; Schmidt MK; Milne RL; Kristensen VN; French JD; Edwards SL; Antoniou AC; Chenevix-Trench G; Simard J; Easton DF; Kraft P; Dunning AM, 2019, Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes,

Conference Abstracts | 2019

Garsed DW; Pandey A; Fereday S; Alsop K; Wouters MC; Saner F; Beach JA; Milne K; Kennedy CJ; Hendley J; Traficante N; Pearce CL; Pike MC; Ramus SJ; Kobel M; Nelson BH; Goode EL; deFazio A; Bowtell DD, 2019, 'The genomic landscape of high-grade serous ovarian cancer in long-term survivors', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019,

Conference Papers | 2019

Garsed DW; Pandey A; Fereday S; Alsop K; Wouters MC; Saner F; Beach JA; Milne K; Kennedy CJ; Hendley J; Traficante N; Pearce CL; Pike MC; Ramus SJ; Köbel M; Nelson BH; Goode EL; deFazio A; Bowtell DD, 2019, 'Abstract 2722: The genomic landscape of high-grade serous ovarian cancer in long-term survivors', in Molecular and Cellular Biology / Genetics, American Association for Cancer Research, pp. 2722 - 2722, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA,

Conference Abstracts | 2019

Millstein J; Budden T; Goode EL; Anglesio MS; Talhouk A; Huntsman DG; Bowtell DD; Brenton JD; Doherty JA; Pharoah PPD; Ramus SJ, 2019, 'The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 26, pp. 20 - 21, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019,

Conference Papers | 2019

Nazeran T; Mason M; Lee S; Gibson-Wright B; Milne K; Goode E; Ramus S; Huntsman D; Nelson B; Talhouk A; Kobel M; Anglesio M, 2019, 'Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Cancers', in LABORATORY INVESTIGATION, NATURE PUBLISHING GROUP, MD, National Harbor, presented at 108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity, MD, National Harbor, 16 March 2019 - 21 March 2019,

Conference Papers | 2019

Nazeran T; Mason M; Lee S; Gibson-Wright B; Milne K; Goode E; Ramus S; Huntsman D; Nelson B; Talhouk A; Kobel M; Anglesio M, 2019, 'Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Cancers', in MODERN PATHOLOGY, NATURE PUBLISHING GROUP, MD, National Harbor, presented at 108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity, MD, National Harbor, 16 March 2019 - 21 March 2019,

Conference Abstracts | 2019

Pavanello M; Dicks E; Song H; Ariff A; Bolithon A; Intermaggio MP; Pinese M; Moysich K; Odunsi KO; Goode E; Bowtell DD; Fasching P; Doherty JA; Modugno F; Kjaer SK; Webb PM; Wu A; deFazio A; James P; Subramanian D; Campbell I; Gayther SA; Pharoah PDP; Ramus SJ, 2019, 'Germline mutations in new susceptibility genes for non-high-grade serous ovarian cancer.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 26, pp. 98 - 99, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019,

Conference Abstracts | 2019

Saner FAM; Garsed DW; Beach JA; Pandey A; Fereday S; Alsop K; Wouters MCA; Traficante N; Pearce CL; Pike MC; de Fazio A; Ramus SJ; Kobel M; Goode EL; Nelson BH; Bowtell DDL, 2019, 'LONG-TERM SURVIVAL IN WOMEN WITH HIGH-GRADE SEROUS OVARIAN CANCER: INTERPLAY BETWEEN RB1 AND BRCA1/2', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, BMJ PUBLISHING GROUP, Vol. 29, pp. A146 - A147,

Preprints | 2019

Song H; Dicks E; Tyrer J; Intermaggio M; Chenevix-Trench G; Bowtell D; Traficante N; AOCS Group ; Brenton J; Goranova T; Hosking K; Piskorz A; Van Oudenhove E; Doherty JA; Harris H; Rossing MA; Dürst M; Dörk T; Bogdanova N; Modugno F; Moysich K; Odunsi K; Ness R; Karlan B; Lester J; Jensen A; Kjaer S; Høgdall E; Campbell I; Lazaro C; Pujana MA; Cunningham J; Vierkant R; Winham S; Hildebrandt MAT; Huff C; Li D; Wu X; Yu Y; Permuth J; Levine D; Schildkraut J; Riggan M; Berchuck A; Webb P; OPAL Study Group ; Cybulski C; Gronwald J; Jakubowska A; Lubiński J; Alsop J; Harrington P; Chan I; Menon U; Pearce C; Wu A; de Fazio A; Kennedy C; Goode E; Ramus S; Gayther S; Pharoah PDP, 2019, Population based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high grade serous ovarian cancer,

Preprints | 2019

Zhang H; Ahearn T; Lecarpentier J; Barnes D; Beesley J; Jiang X; O’Mara T; Qi G; Zhao N; Bolla M; Dunning A; Dennis J; Wang Q; Ful ZA; Aittomäki K; Andrulis I; Anton-Culver H; Arndt V; Aronson K; Arun B; Auer P; Azzollini J; Barrowdale D; Becher H; Beckmann M; Behrens S; Benitez J; Bermisheva M; Bialkowska K; Blanco A; Blomqvist C; Bogdanova N; Bojesen S; Bonanni B; Bondavalli D; Borg A; Brauch H; Brenner H; Briceno I; Broeks A; Brucker S; Brüning T; Burwinkel B; Buys S; Byers H; Caldés T; Caligo M; Calvello M; Campa D; Castelao J; Chang-Claude J; Chanock S; Christiaens M; Christiansen H; Chung W; Claes KBM; Clarke C; Cornelissen S; Couch F; Cox A; Cross S; Czene K; Daly M; Devilee P; Diez O; Domchek S; Dörk T; Dwek M; Eccles D; Ekici A; Evans DG; Fasching P; Figueroa J; Foretova L; Fostira F; Friedman E; Frost D; Gago-Dominguez M; Gapstur S; Garber J; García-Sáenz J; Gaudet M; Gayther S; Giles G; Godwin A; Goldberg M; Goldgar D; González-Neira A; Greene M; Gronwald J; Guénel P; Häberle L; Hahnen E; Haiman C; Hake C; Hall P; Hamann U; Harkness E; Heemskerk-Gerritsen BAM; Hillemanns P; Hogervorst FBL; Holleczek B; Hollestelle A; Hooning M; Hoover R; Hopper J; Howell A; Huebner H; Hulick P; Imyanitov E; kConFab Investigators ; ABCTB Investigators ; Isaacs C; Izatt L; Jager A; Jakimovska M; Jakubowska A; James P; Janavicius R; Janni W; John E; Jones M; Jung A; Kaaks R; Kapoor PM; Karlan B; Keeman R; Khan S; Khusnutdinova E; Kitahara C; Ko Y-D; Konstantopoulou I; Koppert L; Koutros S; Kristensen V; Laenkholm A-V; Lambrechts D; Larsson S; Laurent-Puig P; Lazaro C; Lazarova E; Lejbkowicz F; Leslie G; Lesueur F; Lindblom A; Lissowska J; Lo W-Y; Loud J; Lubinski J; Lukomska A; MacInnis R; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Martinez ME; Matricardi L; McGuffog L; McLean C; Mebirouk N; Meindl A; Menon U; Miller A; Mingazheva E; Montagna M; Mulligan AM; Mulot C; Muranen T; Nathanson K; Neuhausen S; Nevanlinna H; Neven P; Newman W; Nielsen F; Nikitina-Zake L; Nodora J; Offit K; Olah E; Olopade O; Olsson H; Orr N; Papi L; Papp J; Park-Simon T-W; Parsons M; Peissel B; Peixoto A; Peshkin B; Peterlongo P; Peto J; Phillips K-A; Piedmonte M; Plaseska-Karanfilska D; Prajzendanc K; Prentice R; Prokofyeva D; Rack B; Radice P; Ramus S; Rantala J; Rashid M; Rennert G; Rennert H; Risch H; Romero A; Rookus M; Rübner M; Rüdiger T; Saloustros E; Sampson S; Sandler D; Sawyer E; Scheuner M; Schmutzler R; Schneeweiss A; Schoemaker M; Schöttker B; Schürmann P; Senter L; Sharma P; Sherman M; Shu X-O; Singer C; Smichkoska S; Soucy P; Southey M; Spinelli J; Stone J; Stoppa-Lyonnet D; EMBRACE Study ; GEMO Study Collabora , 2019, Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses,

Conference Abstracts | 2018

Chan I; Dicks E; Intermaggio M; Song H; Tyrer J; Zhu Q; Moysich K; Odunsi K; Pharoah P; Gayther S; Pinese M; Ramus S, 2018, 'Identification of 17 Candidate Ovarian Cancer Genes from Whole-exome Sequencing in 15 Ovarian Cancer Families', in AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, WILEY, Vol. 58, pp. 16 - 16,

Preprints | 2018

Jiang X; Finucane HK; Schumacher FR; Schmit SL; Tyrer JP; Han Y; Michailidou K; Lesseur C; Kuchenbaecker KB; Dennis J; Conti DV; Casey G; Gaudet MM; Huyghe JR; Albanes D; Aldrich MC; Andrew AS; Andrulis IL; Anton-Culver H; Antoniou AC; Antonenkova NN; Arnold SM; Aronson KJ; Arun BK; Bandera EV; Barkardottir RB; Barnes DR; Batra J; Beckmann MW; Benitez J; Benlloch S; Berchuck A; Berndt SI; Bickeböller H; Bien SA; Blomqvist C; Boccia S; Bogdanova NV; Bojesen SE; Bolla MK; Brauch H; Brenner H; Brenton JD; Brook MN; Brunet J; Brunnström H; Buchanan DD; Burwinkel B; Butzow R; Cadoni G; Caldés T; Caligo MA; Campbell I; Campbell PT; Cancel-Tassin G; Cannon-Albright L; Campa D; Caporaso N; Carvalho AL; Chan AT; Chang-Claude J; Chanock SJ; Chen C; Christiani DC; B.M. Claes K; Claessens F; Clements J; Collée JM; Correa MC; Couch FJ; Cox A; Cunningham JM; Cybulski C; Czene K; Daly MB; deFazio A; Devilee P; Diez O; Gago-Dominguez M; Donovan JL; Dörk T; Duell EJ; Dunning AM; Dwek M; Eccles DM; Edlund CK; Velez Edwards DR; Ellberg C; Evans DG; Fasching PA; Ferris RL; Liloglou T; Figueiredo JC; Fletcher O; Fortner RT; Fostira F; Franceschi S; Friedman E; Gallinger SJ; Ganz PA; Garber J; García-Sáenz JA; Gayther SA; Giles GG; Godwin AK; Goldberg MS; Goldgar DE; Goode EL; Goodman MT; Goodman G; Grankvist K; Greene MH; Gronberg H; Gronwald J; Guénel P; Håkansson N; Hall P; Hamann U; Hamdy FC; Hamilton RJ; Hampe J; Haugen A; Heitz F; Herrero R; Hillemanns P; Hoffmeister M; Høgdall E; Yun-Hong C; Hopper JL; Houlston R; Hulick PJ; Hunter DJ; Huntsman DG; Idos G; Imyanitov EN; Ingles SA; Isaacs C; Jakubowska A; James P; Jenkins MA; Johansson M; Johansson M; John EM; Joshi AD; Kaneva R; Karlan BY; Kelemen LE; Kühl T; Kay-Khaw T; Khusnutdinova E; Kibel AS; Kiemeney LA; Kim J; Kjaer SK; Knight JA; Kogevinas M; Kote-Jarai Z; Koutros S; Kristensen VN; Kupryjanczyk J; Lacko M; Lam S; Lambrechts D; Landi MT; Lazarus P; Le ND; Lee E; Lejbkowicz F; Heinz-Lenz J; Leslie G; Lessel D; Lester J; Levine DA; Li L; Li CI; Lindblom A; Lindor NM; Liu G; Loupakis F; Lubinński J; Maehle L; Maier C; Mannermaa A; Marchand LL; Margolin S; May T; McGuffog L; Meindl A; Middha P; Miller A; Milne RL; MacInnis RJ; Modugno F; Montagna M; Moreno V; Moysich KB; Mucci L; Muir K; Mulligan AM; Nathanson KL; Neal DE; Ness AR; Neuhausen SL; Nevanlinna H; Newcomb PA; Newcomb LF; Nielsen FC; Nikitina-Zake L; Nordestgaard BG; Nussbaum RL; Offit K; Olah E; Al Olama AA; Olopade OI; Olshan AF; Olsson H; Osorio A; Pandha H; Park JY; Pashayan N; Parsons MT; Pejovic T; Penney KL; Peters WHM; Phelan CM; Phipps AI; Plaseska-Karanfilska D; Pring M; Prokofyeva D; Radice P; Stefansson K; Ramus SJ; Raskin L; Rennert G; Rennert HS; van Rensburg EJ; Riggan MJ; Risch HA; Risch A; Roobol MJ; Rosenstein BS; Rossing MA; Ruyck KD; Saloustros E; Sandler DP; Sawyer EJ; Schabath MB; Schleutker J; Schmidt MK; Setiawan VW; Shen H; Siegel EM; Sieh W; Singer CF; Slattery ML; Sorensen KD; Southey MC; Spurdle AB; Stanford JL; Stevens VL; Stintzing S; Stone J; Sundfeldt K; Sutphen R; Swerdlow AJ; Tajara EH; Tangen CM; Tardon A; Taylor JA; Teare MD; Teixeira MR; Terry MB; Terry KL; Thibodeau SN; Thomassen M; Bjørge L; Tischkowitz M; Toland AE; Torres D; Townsend PA; Travis RC; Tung N; Tworoger SS; Ulrich CM; Usmani N; Vachon CM; Nieuwenhuysen EV; Vega A; Aguado-Barrera EM; Wang Q; Webb PM; Weinberg CR; Weinstein S; Weissler MC; Weitzel JN; West CML; White E; Whittemore AS; H-Wichmann E; Wiklund F; Winqvist R; Wolk A; Woll P; Woods M; Wu AH; Wu X; Yannoukakos D; Zheng W; Zienolddiny S; Ziogas A; Zorn KK; Lane JM; Saxena R; Thomas D; Hung RJ; Diergaarde B; McKay J; Peters U; Hsu L; García-Closas M; Eeles RA; Chenevix-Trench G; Brennan PJ; Haiman CA; Simard J; Easton DF; Gruber SB; D.P. Pharoah P; Price AL; Pasaniuc B; Amos CI; Kraft P; Lindström S, 2018, Shared heritability and functional enrichment across six solid cancers,

Conference Abstracts | 2018

Millstein J; Budden T; Anglesio M; Talhouk A; Beeghly-Fadiel A; Berchuck A; Chenevix-Trench G; deFazio A; Fasching PA; Gayther S; Garcia M; Goode EL; Henderson M; Konecny GE; Orsulic S; Huntsman D; Bowtell D; Doherty J; Pharoah P; Ramus SJ, 2018, 'A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Vol. 36,

Conference Abstracts | 2018

Natanzon Y; Kobel M; Winham SJ; Armasu SM; McCauley BM; Vierkant RA; Cunningham JM; Bowtell D; Campbell IG; Chang-Claude J; deFazio A; Fasching PA; Goodman MT; Karlan BY; Modugno F; Moysich KB; Ness RB; Sieh W; Pharoah PD; Ramus SJ; Goode EL, 2018, 'Tumor-infiltrating CD8-positive T-lymphocytes in tubo-ovarian high-grade serous cancer are associated with multiple germline variants in 22q12.1 in a genome-wide association analysis', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, IL, Chicago, Vol. 78, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), IL, Chicago, 14 April 2018 - 18 April 2018,

Conference Papers | 2017

Manchanda R; Gaba F; Bottla K; Mousa K; Burnell M; Kalsi J; Gentry-Maharaj A; Antoniou A; Blyuss O; Zaikin A; Lee A; Lanceley A; Sanderson S; Waller J; Gayther S; Ramus S; Wallis Y; Skates S; Menon U; Jacobs I, 2017, 'PREDICTING RISK OF OVARIAN MALIGNANCY IMPROVED SCREENING AND EARLY DETECTION FEASIBILITY STUDY (PROMISE-FS)', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, pp. 1944 - 1944,

Conference Abstracts | 2017

Meagher NS; deFazio A; Russell K; Voss A; Ramus SJ; Friedlander ML, 2017, 'Mucinous Ovarian Cancers of Uncertain Primary (MO-CUP) - Does the Site of Origin Really Matter?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 13, pp. 73 - 73,

Conference Papers | 2016

Chornokur G; Lin H-Y; Monteiro A; Schildkraut J; Goode EL; Pharoah PDP; Gayther SA; Ramus S; Sellers TA; Phelan CM, 2016, 'Abstract A50: Mitochondrial metabolism gene variants are associated with risk and survival in epithelial ovarian cancer (EOC)', in Molecular Cancer Research, American Association for Cancer Research (AACR), pp. A50 - A50, presented at Abstracts: AACR Special Conference: Metabolism and Cancer; June 7-10, 2015; Bellevue, WA,

Conference Abstracts | 2016

Lee AW; Bomkamp A; Bandera EV; Jensen A; Ramus SJ; Goodman MT; Rossing MA; Modugno F; Moysich KB; Chang-Claude J; Rudolph A; Gentry-Maharaj A; Terry KL; Gayther SA; Cramer DW; Doherty JA; Schildkraut JM; Kjaer SK; Ness RB; Menon U; Berchuck A; Mukherjee B; Roman L; Pharoah PD; Chenevix-Trench G; Wu AH; Pike MC; Pearce CL, 2016, 'A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, LA, New Orleans, Vol. 76, presented at 107th Annual Meeting of the American-Association-of-Cancer-Research (AACR), LA, New Orleans, 16 April 2016 - 20 April 2016,

Conference Abstracts | 2016

Lee AW; Ness RB; Roman LD; Terry KL; Schildkraut JM; Chang-Claude J; Doherty JA; Menon U; Cramer DW; Gayther SA; Risch H; Gentry-Maharaj A; Goodman MT; Modugno F; Eilber U; Moysich KB; Berchuck A; Rossing MA; Jensen A; Wicklund KG; Cushing-Haugen KL; Hogdall E; Rudolph A; Thompson PJ; Wilkens LR; Kjaer SK; Carney ME; Stram DO; Ramus SJ; Wu AH; Pike MC; Pearce CL, 2016, 'Association between menopausal estrogen-only therapy and ovarian carcinoma risk', in Obstetrical and Gynecological Survey, Vol. 71, pp. 470 - 471,

Conference Abstracts | 2016

2016, 'Proffered papers and posters presented at the Sixth International Symposium on Hereditary Breast and Ovarian Cancer—BRCA: Challenges and Opportunities: Presented by the Hereditary Breast and Ovarian Cancer Foundation in collaboration with the Program in Cancer Genetics, McGill University; Centre Mont-Royal, Montreal, QC; 10–13 May 2016.', in Current oncology (Toronto, Ont.), MultiMed Inc., Vol. 23, pp. e284 - e319,

Conference Abstracts | 2015

Earp MA; Winham SJ; Armasu SM; Fridley BL; Larson MC; Fogarty ZC; Kalli KR; Wang C; Keeney GL; Cunningham JM; Ramus S; Kobel M; Goode EL, 2015, 'Comparison of pathology versus IHC-based ovarian carcinoma histology assignment using gene expression, DNA methylation, and clinical outcome data', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015,

Conference Abstracts | 2015

Lawrenson K; Kar S; Kuckenbaeker K; Edwards S; Li Q; Tyrer J; Beesley J; Michailidou K; Ramus S; Dunning A; Couch F; Monteiro A; Simard J; Freedman M; Easton D; Chenevix-Trench G; Pharoah P; Antoniou A; Gayther S, 2015, 'Common functional mechanisms underlying pleiotropy at the 19p13.1 breast and ovarian cancer cusceptibility locus', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015,

Conference Abstracts | 2015

Lin H-Y; Xiong Y; Tyrer J; Marchion DC; Monteiro ANA; Berchuck A; Schildkraut JM; Goode EL; Ramus SJ; Gayther SA; Pharoah PDP; Narod SA; Sellers TA; Phelan CM, 2015, 'Investigation of small GTPase genes in epithelial ovarian cancer.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, FL, Orlando, Vol. 22, presented at AACR Special Conference on Advances in Ovarian Cancer Research - Exploiting Vulnerabilities, FL, Orlando, 17 October 2015 - 20 October 2015,

Conference Abstracts | 2015

Permuth-Wey J; Reid BM; Chen YA; Lin H-Y; Monteiro A; Chen Z; Berchuck A; Chenevix-Trench G; Doherty J; Gayther S; Goode E; Iversen E; Pearce L; Pharoah PDP; Phelan C; Ramus S; Rossing MA; Schildkraut J; Sellers T, 2015, 'Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015,

Conference Abstracts | 2015

Reid BM; Permuth-Wey J; Chen YA; Lin H-Y; Monteiro A; Chen Z; Berchuck A; Chenevix-Trench G; Doherty J; Gayther S; Goode EL; Iversen E; Pearce L; Pharoah P; Phelan C; Ramus S; Rossing MA; Schildkraut J; Sellers T, 2015, 'Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015,

Conference Abstracts | 2015

Sellers TA; Reid BM; Chen YA; Lin H-Y; Richards E; Teer J; Monteiro A; Chen Z; Berchuck A; Chenevix-Trench G; Doherty J; Goode E; Iverson E; Pearce L; Pharoah P; Phelan C; Ramus S; Rossing MA; Schildkraut J; Cheng J; Gayther S; Permuth-Wey J, 2015, 'Evidence that long non-coding RNA variants associate with epithelial ovarian cancer risk', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015,

Conference Abstracts | 2014

Berchuck A; Kuchenbaecker K; Ramus SJ; Tyrer JP; Gayther SA; Pharoah PDP; Antoniou AC; Chenevix-Trench G, 2014, 'IDENTIFICATION OF SIX NOVEL, COMMON VARIANT GENETIC SUSCEPTIBILITY LOCI FOR INVASIVE EPITHELIAL OVARIAN CANCER', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, pp. 13 - 13,

Conference Abstracts | 2014

Buckley MA; Shen HC; Mendoza-Fandino GA; Woods NT; Gjyshi A; French J; Lawrenson K; Song H; Tyrer J; Carvalho RS; Valle A; Chen A; Yoder S; Bloom G; Tsai Y-Y; Yang A; Hughes TR; Qu X; Cicek M; Larson M; Goode E; Fridley B; Ramus S; Chenevix-Trench G; Pharoah P; Sellers TA; Gayther S; Monteiro ANA, 2014, 'Functional analysis of the 9p22 locus implicates the transcriptional regulation of BNC2 as a mechanism in ovarian cancer predisposition', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 74, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014,

Conference Abstracts | 2014

Davis SJ; Sheppard KE; Anglesio MS; Menon U; Gronwald J; Wu A; Kommoss S; Pfisterer J; du Bois A; Hilpert F; Ramus SJ; Huntsman DG; Pearson RB; Simpson KJ; Campbell IG; Gorringe KL, 2014, 'ENHANCED GAB2 EXPRESSION IS CHARACTERISTIC OF A CLINICALLY DISTINCT PI3K-DEPENDENT SUBTYPE OF HIGH-GRADE SEROUS AND ENDOMETRIOID OVARIAN CANCER', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, pp. 256 - 257,

Conference Abstracts | 2014

Kelemen LE; Tyrer J; Phelan CM; Ramus SJ; Berchuck A; Gayther SA; Goode EL; Pearce CL; Schildkraut JM; Chenevix-Trench G; Monteiro AN; Goodman MT; Sellers TA; Pharoah PP, 2014, 'GWAS identifies risk variants for mucinous ovarian carcinoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 74, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014,

Conference Abstracts | 2014

Millstein J; Anglesio MS; Goode EL; Karlan BY; Konecny G; Leong HS; Levine DA; Dering J; Wang C; Johnatty SJ; Chenevix-Trench G; Pharoah PDP; Doherty JA; Rossing MA; Bowtell DD; Huntsman DG; Ramus SJ, 2014, 'PROGNOSTIC MARKERS FOR HIGH GRADE SEROUS OVARIAN CANCER AND VALIDATION USING LARGE SCALE NANOSTRING EXPRESSION PROFILING: AN OTTA CONSORTIUM STUDY.', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, pp. 382 - 383,

Conference Abstracts | 2014

Permuth-Wey J; Chen YA; Chen Z; Berchuck A; Chenevix-Trench G; Doherty J; Gayther S; Goode EL; Iversen E; Monteiro ANA; Pearce L; Pharoah PDP; Phelan CM; Pirie A; Ramus S; Rossing MA; Schildkraut JM; Sellers TA, 2014, 'Exome genotyping array identifies rare and low-frequency variants that may be associated with ovarian cancer risk', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 74, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014,

Conference Abstracts | 2014

Ramus SJ; Song H; Dicks E; Intermaggio M; Hayward J; Tyrer JP; Gronwald J; Kjaer SK; Wittemore A; Karlan B; Odunsi K; Menon U; Bowtell DD; Goode EL; Pharoah PDP; Gayther SA, 2014, 'Whole exome and targeted resequencing, of population based ovarian cancer cases and controls, identifies susceptibility genes for ovarian cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, WA, Seattle, Vol. 21, presented at 10th Biennial Ovarian Cancer Research Symposium, WA, Seattle, 08 September 2014 - 09 September 2014,

Conference Abstracts | 2013

Amankwah EK; Tyrer J; Lin H-Y; Tsai Y-Y; Chen Z; Han G; Qu X; Goode E; Cunninghan J; Iverson E; Ramus S; Berchuck A; Schildkrautt J; Monteiro A; Gayther S; Narod S; Pharoah P; Sellers TA; Phelan C, 2013, 'Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013,

Conference Abstracts | 2013

Anglesio MS; Talhouk A; Kalloger SE; Haffari G; Mackenzie R; Cheung M; Senz J; Chow C; Lau S; Intermaggio M; Ramus SJ; du Bois A; Pfisterer J; McAlpine JN; Kommoss F; Gilks B; Kommoss S; Huntsman DG, 2013, 'Rapid RNA-based histotyping of ovarian carcinomas', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 19,

Conference Abstracts | 2013

Charbonneau B; Knutson K; Vierkant RA; Cunningham JM; Fogarty ZC; Kalli KR; Maurer MJ; Oberg AL; Fridley BL; Preston CC; Pharoah PDP; Ramus SJ; Phelan CM; Odunsi K; Moysich K; Goode EL, 2013, 'Polymorphisms in regulatory T cell related genes and ovarian cancer survival', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013,

Conference Abstracts | 2013

Chornokur G; Tyrer J; Lin H-Y; Han G; Qu X; Chen Z; Tsai Y-Y; Goode EL; Cunningham JM; Iversen E; Ramus SJ; Berchuk A; Schildkraut JM; Monteiro A; Gayther SA; Narod SA; Pharoah P; Sellers TA; Phelan CM, 2013, 'Variation in transmembrane transport genes influence epithelial ovarian cancer risk and histopathologic subtype.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013,

Conference Abstracts | 2013

Jim H; Tyrer J; Lin H-Y; Han G; Qu X; Goode EL; Chen Z; Tsai Y-Y; Cunningham JM; Iversen E; Ramus S; Berchuck A; Schildkraut J; Monteiro A; Gayther S; Narod SA; Sellers TA; Pharoah P; Phelan CM, 2013, 'Variation in circadian rhythm genes influence epithelial ovarian cancer risk and invasiveness', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013,

Conference Abstracts | 2013

Lawrenson K; Song H; Lee J; Tyrer J; Ramus S; Pharoah P; Gayther S, 2013, 'Long non-coding RNAs as functional targets of germline genetic variation at ovarian cancer susceptibility loci.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013,

Conference Abstracts | 2013

Lee SL; Kalloger SE; Ramus SJ; Goode E; Duggan M; Huntsman D; Gilks BC; Martin K, 2013, 'Biomarker Based Ovarian Carcinoma Typing: A Retrospective Analysis of the OTTA Consortium', in LABORATORY INVESTIGATION, NATURE PUBLISHING GROUP, MD, Baltimore, Vol. 93, pp. 285A - 285A, presented at 102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), MD, Baltimore, 02 March 2013 - 08 March 2013,

Conference Abstracts | 2013

Lee SL; Kalloger SE; Ramus SJ; Goode E; Duggan M; Huntsman D; Gilks BC; Martin K, 2013, 'Biomarker Based Ovarian Carcinoma Typing: A Retrospective Analysis of the OTTA Consortium', in MODERN PATHOLOGY, NATURE PUBLISHING GROUP, MD, Baltimore, Vol. 26, pp. 285A - 285A, presented at 102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), MD, Baltimore, 02 March 2013 - 08 March 2013,

Conference Abstracts | 2013

Phelan CM; Lin HY; Ramus SJ; Song H; Iversen E; Narod SA; Gayther SA; Goode EL; Sellers TA; Pharoah PDP, 2013, 'IMMUNOMODULATORY GENE VARIANTS ARE ASSOCIATED WITH EPITHELIAL OVARIAN CANCER (EOC) RISK AND HISTOPATHOLOGIC SUBTYPE', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, Vol. 23,

Conference Abstracts | 2013

Ramus SJ; Koebel M; Sieh W; Anglesio MS; Millstein J; Bowtell DD; Brenton JD; Hogdall E; Pharoah PDP; Goode EL; Huntsman DG, 2013, 'The ovarian tumor tissue analysis (OTTA) consortium', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 19,

Conference Abstracts | 2012

Beesley J; Pickett H; Johnatty S; Chen X; Li JJ; Rider D; Stutz M; Lambrecht D; Chang-Claude J; Dork T; Goodman M; Kiemmney B; Bandera E; Kelemen L; Wang-Gorke S; Campbell I; Gayther S; Ramus S; Goode E; Reddel R; Chenevix-Trench G, 2012, 'Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer', in Hereditary cancer in clinical practice, Vol. 10, pp. A86 - A86,

Conference Abstracts | 2012

Bolton KL; Chenevix-Trench G; Goh C; Sadetzki S; Ramus SJ; Gayther SA; Chanock SJ; Antoniou AC; Pharoah PDP, 2012, 'A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival', in Hereditary cancer in clinical practice, Vol. 10, pp. A27 - A27

Conference Abstracts | 2012

Charbonneau B; Bamlet WR; Vierkant RA; Cunningham JM; Kalli KR; Rider DN; Fridley BL; Tyrer J; Dennis J; Ramus S; Pharoah PD; Phelan CM; Goode EL, 2012, 'NF-kB Polymorphisms and Ovarian Cancer Risk', in GENETIC EPIDEMIOLOGY, WILEY-BLACKWELL, WA, Stevenson, Vol. 36, pp. 741 - 742, presented at Annual Meeting of the International-Genetic-Epidemiology-Society (IGES), WA, Stevenson, 18 October 2012 - 20 October 2012,

Conference Abstracts | 2012

Charbonneau B; White KL; Schildkraut JM; Palmieri RT; Iversen E; Berchuck A; Vierkant RA; Rider DN; Cicek MS; Sutphen R; Birrer MJ; Pharoah PPD; Song H; Tyler J; Gayther SA; Ramus SJ; Wentzensen N; Yang HP; Garcia-Closas M; Phelan CM; Cunningham JM; Fridley BL; Sellers TA; Goode EL, 2012, 'Subtype-specific ovarian cancer risk associated with SNPs in IL1A', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72,

Conference Abstracts | 2012

Lawrenson K; Song H; Tyrer J; Ramus SJ; Phelan C; Lee J; Wozniak E; Karevan R; Pharoah PDP; Gayther SA, 2012, 'Functional effects of SNPs in non-coding RNAs at the 3q25 ovarian cancer susceptibility locus', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72,

Conference Abstracts | 2012

Permuth-Wey J; Lin H-Y; Tsai Y-Y; Chen Z; Chen YA; Barnholtz-Sloan J; Birrer MJ; Chanock S; Cramer DW; Cunningham JM; Fenstermacher D; Fridley B; Garcia-Closas M; Gayther SA; Gentry-Maharaj A; Gonzalez-Bosquet J; Iversen E; Jim H; McLaughlin J; Menon U; Monteiro A; Narod SA; Phelan CM; Ramus S; Risch H; Song H; Sutphen R; Terry KL; Tyrer J; Vierkant RA; Wentzensen N; Lancaster JM; Cheng JQ; Berchuk A; Pharoah PDP; Schildkraut JM; Goode EL; Sellers TA, 2012, 'MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment study', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72,

Conference Abstracts | 2011

Berchuck A; Pharoah P; Ramus S; Gayther S; Palmieri R; Pearce C; Couch F; Antonio A; Goode E; Schildkraut J; Chenevix-Trench G; Sellers T; Risch H, 2011, 'Association of KRAS SNP rs61764370 with risk of invasive epithelial ovarian cancer: Implications for clinical testing', in GYNECOLOGIC ONCOLOGY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 121, pp. S2 - S3,

Conference Abstracts | 2011

Jones C; Morris J; Sher T; Ghani S; Jacobs IJ; Hogdall E; Blaakaer J; Kruger-Kjaer S; Christensen L; Hogdall C; Ramus S; Gayther S; MacKay A, 2011, 'Microarray CGH profiling predicts survival after a diagnosis of epithelial ovarian cancer and identifies novel candidate therapeutic targets', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 71,

Conference Abstracts | 2011

Lawrenson K; Notaridou M; Wozniak E; Ramus SJ; Gayther SA, 2011, 'Functional analysis of candidate genes at ovarian cancer susceptibility loci', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 71,

Conference Papers | 2010

Bolton KL; Tyrer J; Song H; Ramus S; Jones C; Notaridou M; Chanock SJ; Garcia-Closas M; Chenevix-Trench G; Gayther S; Pharoah PDP, 2010, 'Abstract 4729: A genome-wide association study of ovarian cancer prognosis identifies a novel locus for aggressive serous cancer on 19p13', in Cancer Research, American Association for Cancer Research (AACR), pp. 4729 - 4729, presented at Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC,

Conference Abstracts | 2010

Goode EL; Chenevix-Trench G; Song H; Ramus SJ; Bolton K; Vierkant RA; Berchuck A; Lawrenson K; Palmieri R; Tsai Y-Y; Sellers TA; Gayther SA; Pharoah PPD, 2010, 'New ovarian cancer susceptibility loci identified', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 70,

Conference Abstracts | 2008

Elmasry K; Ramus S; Whittaker J; Luo Z; Gammerman A; Lu K; Ayhan A; Singh N; McGluggage G; Jacobs I; Gayther S, 2008, 'Genetic diagnosis and clinical outcome in patients with synchronous ovarian and endometrial cancer', in GYNECOLOGIC ONCOLOGY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 108, pp. S65 - S65,

Conference Abstracts | 2008

Ramus SJ; Vierkant RA; Jonhatty S; Schildkraut JM; Pharoah PD; Chenevix-Trench G; Pearce CL; Berchuck A; Goode EL, 2008, 'Ovarian Cancer Association Consortium analysis of seven candidate ovarian cancer susceptibility polymorphisms', in GYNECOLOGIC ONCOLOGY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 108, pp. S29 - S30,

Conference Abstracts | 2008

Southey M; Jenkins M; Ramus S; Dowty J; Dite G; Byrnes G; Giles G; McCredie M; Hopper J, 2008, 'Identifying the early-onset cases of breast and colorectal cancers most likely to carry a germline mutation in a "high-risk" cancer predisposition gene', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, FRANCE, Lyon, Vol. 6, pp. 208 - 208, presented at 20th Meeting of the European-Association-for-Cancer-Research, FRANCE, Lyon, 05 July 2008 - 08 July 2008,

Conference Abstracts | 2005

Song HL; Ramus S; Kjaer SK; DiCioccio R; Tyrer J; Quaye L; Shadforth D; Hogdall E; Hogdall C; Whittemore A; Easton DF; Ponder BA; Pharoah PP; Gayther SA, 2005, 'A systemic study of polymorphisms in mismatch repair genes and predisposition to ovarian cancer.', in CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, AMER ASSOC CANCER RESEARCH, MD, Baltimore, Vol. 14, pp. 2730S - 2730S, presented at 4th Annual Conference on Frontiers in Cancer Prevention Research, MD, Baltimore, 30 October 2005 - 02 November 2005,

Conference Abstracts | 1997

Ramus SJ; Baer R; Foster NA; Dunning AM; Harrington PA; Gayther SA; Ponder BAJ; Bowcock A, 1997, 'Screening for mutations in the BARD1 gene in families with ovarian cancer.', in AMERICAN JOURNAL OF HUMAN GENETICS, CELL PRESS, Vol. 61, pp. A79 - A79,

Conference Papers | 1995

Ramus S; Cotton RGH, 1995, 'CCM - Chemical cleavage of mismatch', in Landegren U (ed.), LABORATORY PROTOCOLS FOR MUTATION DETECTION, OXFORD UNIV PRESS, SWEDEN, VISBY, pp. 50 - 53, presented at 3rd International Workshop on Mutation Detection - Mutation Detection 1995, SWEDEN, VISBY, 18 May 1995 - 21 May 1995,

Conference Abstracts | 1993

COTTON RGH; RAMUS SJ; FORREST SM; PITT DB, 1993, 'GENOTYPE CANNOT BE USED TO ACCURATELY PREDICT THE INTELLECTUAL PHENOTYPE OF UNTREATED PHENYLKETONURIA (PKU) PATIENTS', in AMERICAN JOURNAL OF HUMAN GENETICS, UNIV CHICAGO PRESS, Vol. 53, pp. 142 - 142,

Conference Abstracts | 1993

RAMUS SJ; COTTON RGH, 1993, 'A NEW PHENYLKETONURIA (PKU) MUTATION DETECTED BY ILLEGITIMATE TRANSCRIPTION RESULTS IN RNA MISSPLICING - FOUNDER EFFECT AND PKU IN AUSTRALIA', in AMERICAN JOURNAL OF HUMAN GENETICS, UNIV CHICAGO PRESS, Vol. 53, pp. 1218 - 1218,

Current

National Health and Medical Research Council 2022-2026
�� L3 Investigator grant: Development of clinical tests to improve treatment for ovarian cancer patients.

National Health and Medical Research Council 2021-2026
�� Prospective Ovarian Cancer Cohort to Authenticate Stratification of Prognosis in Ovarian Tumours (POCCA-SPOT)

Department of Defence 2016-2023
�� Multidisciplinary Ovarian Cancer Outcomes Group (MOCOG).

Recently completed

Cancer Australia 2018-2022
�� The contribution of rare alleles to non high grade serous ovarian cancer.

Cancer Council NSW 2018-2021
�� Moving towards personalised treatments for ovarian cancer.

National Institute of Health (NIH) USA 2014-2019
�� Identifying prognostic markers and therapeutic targets for serous ovarian cancer.

National Institute of Health (NIH) 2014-2019
�� The contribution of rare alleles to ovarian cancer in the population.

Rivkin Center for Ovarian Cancer Research. Pilot grant. 2018-2019
�� Genetic susceptibility to non high grade serous ovarian cancer.

2022 NHMRC Elizabeth Blackburn Investigator Grant Award for basic science.

The aim of my research program is to improve ovarian cancer risk prediction and prognosis, by using large international consortia that are adequately powered to have an impact for patients.

��

Improving risk prediction for ovarian cancer.

The aim is to identify women at increased risk of ovarian cancer before they develop the disease, by studying inherited changes in their DNA. We are identifying two types of changes.

1) Common variants

Finding large numbers of changes, each with a very small increased risk.

These changes are identified by performing Genome Wide Association Studies (GWAS) in large numbers of cases and controls from two international consortia. The Ovarian Cancer Association Consortium (OCAC)��and Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

2) Rare variants

Finding changes that are rare in the population but have a moderate increased risk.

These changes are identified by performing whole exome sequencing (WES) and large-scale validation by targeted sequencing in large numbers of cases and controls. High grade serous ovarian cancer (HGSOC): We have screened 80 genes in up to 6,000 ovarian cancer cases and 6,000 unaffected controls. Non HGSOC: We have screened 32 genes in 2,000 ovarian cancer cases and 2,000 unaffected controls.

Improving prognosis for Ovarian Cancer

The aim is to identify markers that can group women with similar changes in their tumours and determine their prognosis. Being able to predict how well a woman may respond to current treatments may identify a group of women who need alternative treatments. These studies are performed through the Ovarian Tumour Tissue Analysis (OTTA) Consortium.

1) Validation of prognostic markers by immunohistochemistry (IHC)

Analysis of individual biomarkers using large scale centralised staining and scoring of tissue microarrays (TMA).

2) Identifying new prognostic markers for HGSOC

Large scale genomic analysis of formalin fixed paraffin embedded (FFPE) tumours using the latest technologies such as NanoString RNA expression, screening for somatic mutations using TamSeq and DNA copy number using shallow whole genome sequencing (sWGS).

American Association for Cancer Research (AACR)

Ovarian Tumor Tissue Analysis (OTTA) Consortium

Ovarian Cancer Association Consortium (OCAC)

Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

��

Joint lead of steering committee OTTA

Member of steering committee OCAC

Member of genotyping committee OCAC

Member of data access committee OCAC

Member of data access committee OTTA

Member of pathology working group CIMBA

��������Ƶ

Follow

Professor Susan Ramus

Follow me

��Ƶ